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Abstract 
Transcriptional regulation of gene expression in eukaryotes has evolved over millions of years. The 
regulatory pathways of nuclear receptors represent an evolutionarily ancient, but conserved 
mechanism with associated accessory proteins, many of them forming a functional nexus known 
as the Mediator complex involved in transcription. Despite the versatility of the pathway, e.g. 
through the adoption of new regulatory functions in phylogenetically more recent Metazoa, we 
hypothesise that the intrinsic potential of the NR-Mediator axis to directly translate a stimulus to 
a biological response is conserved across species, and additional regulation could also be achieved 
through secondary functions of its essential members. 
To support the hypothesis, we assessed the ligand-binding capability of retinoic X receptor in 
Trichoplax adhaerens and provided evidence to support the concept that this capability was 
already present at the base of metazoan evolution. 
With regards to the potential secondary functions, we took inspiration from previous research and 
identified the Mediator subunit 28 (MED28) as the only known member having documented 
nuclear and cytoplasmic dual roles, and thus possessing the potential to transmit signals from the 
cellular structural states to the nucleus. Due to the lack of significant sequence conservation and a 
robust experimental toolset, we chose to characterise the presumed MED28 orthologue W01A8.1 
in Caenorhabditis elegans. Our results suggest that W01A8.1 is in fact, with a high degree of 
certainty, a member of the Perilipin family thus, unveiling the previously unknown Perilipin-
dependent regulation of lipid metabolism in Nematoda. This effort led to the reannotation as PLIN-
1 (PeriLIpiN). 
Keeping in line with the hypothesis, we subsequently identified F28F8.5 as the most probable 
orthologue of MED28 in C. elegans, which also consequently led to its reannotation as MDT-28 
(MeDiaTor). 
The work showed that the Mediator subunit 28 is a conserved member of the Mediator complex, 
which has a potential to connect regulation of transcription with cytoplasmic events. Together with 
the conserved NR signalling, it supports the hypothesis that the general architecture of the NR-
Mediator signalling axis has been conserved throughout evolution of Metazoa. Additionally, I argue 
and make a case for Perilipin having a potential indirect and direct role in the regulation of gene 
expression. This incentivises further research on ‘Proteome’ signalling as a general principle. 
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Abstrakt 
Transkripční regulace genové exprese eukaryotních organismů se vyvinula během milionů let. 
Regulační cesta jaderných receptorů představuje evolučně starý, ale zachovalý mechanismus 
zahrnující asociované akcesorní proteiny, z nichž mnohé tvoří funkční strukturu známou jako 
Mediátorový komplex, který je účastný v transkripci. Hypotézujeme, že přes universalitu této cesty, 
v níž vnitřní potenciál NR-Mediátorové cesty zachovalý napříč druhy, přímo překládá regulační 
signál do biologické odpovědi zapojením nových adaptačních funkcí ve fylogeneticky novějších 
Metazoidních organizmech a přídavná regulace může být dosažena sekundárními funkcemi 
základních členů této regulace.  
Pro podporu této hypotézy jsme studovali schopnost vazby ligandu retinoidního X receptoru ve 
vločkovci Trichoplax adhaerens a přinesli důkaz podporující koncept, že tato schopnost byla 
přítomna již na počátku metazoidní evoluce.  
S ohledem na možné sekundární funkce, majíce inspiraci z našeho předcházejícího výzkumu, jsme 
identifikovali Mediátorovou podjednotku 28 (MED28) jako jediný známý člen s dokumentovanou 
duální cytoplasmatickou a jadernou funkcí a mající tedy potenciál přenášet signály z jaderných 
strukturních stavů do jádra. V důsledku chybění významné zachovalosti sekvence, ale dostupnosti 
experimentálních přístupů, jsme se rozhodli charakterizovat předpokládaný ortolog MED28, 
W01A8.1 v Caenorhabditis elegans. Naše výsledky ukazují, že W01A8.1 je s velkým stupněm 
pravděpodobnosti člen proteinové rodiny perilipinů, což odhaluje v hlísticích dříve neznámou 
regulaci lipidního metabolismu závislou na perilipinu. Tato práce vedla ke změně klasifikace 
proteinu PLIN-1 (PeriLIpiN). 
Ve shodě s touto hypotézou jsme dále identifikovali F28F8.5 jako nejvíce pravděpodobný ortolog 
MED28, který byl také následně klasifikován jako MDT-28 (MeDiaTor). Práce ukázala, že 
mediátorová podjednotka 28 je zachovalý člen Mediátorového komplexu, který má potenciál 
spojovat regulaci transkripce s cytoplasmatickými jevy. Společně se zachovalou signalizací NR to 
podporuje hypotézu, že generální architektura osy NR-Mediátorové signalizace byla zachována 
během evoluce Metazoa. 
Následně navrhuji koncept, že Perilipin také může mít přímou a nepřímou úlohu v regulaci genové 
exprese, přičemž uvádím podpůrné argumenty, které motivují k dalšímu výzkumu obecného 
principu signalizace cestou proteomu. 
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Introduction 
Scope and aims of the work 
It is an established concept that the mechanisms involved in the regulation of gene expression are 
highly conserved in eukaryotes. The general scope and aims of work were as following: 
• To explore the basic conserved mechanisms that play an intrinsic role in modulating gene 
expression in metazoans. 
• To identify protein(s) that are responsible for integrating complex environmental, metabolic, 
structural and stress-related cues and to relay this vital information to the transcriptional 
machinery. 
• To gain a basic mechanistic understanding of how such protein(s) would function in a cell-
specific manner. 
Premises, hypotheses and goals of the thesis 
Nuclear receptors are highly conserved transcription factors that are, in contrast to the other type 
of signalling pathways, capable of directly translating ligand binding into the regulation of gene 
expression through the Mediator complex. Thus, they make a direct link between stimulus and 
biological response, this potential of the system eases evolution. This is exemplified by the 
expansion of NRs in phylogenetically more recent metazoan organisms, such as nematodes (284 
nuclear receptors) and mammals like humans (48 nuclear receptors), and by the formation of 
specialised endocrine tissues in vertebrates. 
Therefore, it can be hypothesised that this intrinsic evolutionary potential of the NR-Mediator 
signalling axis, which is governed by its core function, would be conserved throughout metazoan 
evolution. As the general pathway architecture probably needs to be maintained, further plasticity 
of the pathway could eventually be achieved through the acquisition of secondary function by its 
essential members. 
Among the members of the Mediator complex, the subunit 28 is the only member with proven 
cytoplasmic as well as nuclear functions. This makes it a candidate example protein that can 
integrate signalling between cytoplasmic structures and regulation of gene expression. 
However, a comparative sequence analysis suggested significant differences between known 
vertebrate MED28 subunits and the denominated nematode orthologue in C. elegans. This 
indicated either a possible divergent evolution of the MED28 subunit or the acquisition of the 
Mediator domain in an unrelated gene that led to the annotation as the MED28 orthologue in 
nematodes. 
To support this hypothesis, we set the following goals: 
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1. To show that NR-ligand interaction is conserved at the base of metazoan evolution. 
2. To characterise the denominated MED28 orthologue (W01A8.1) in C. elegans. 
3. In the case of non-divergent evolution, identify the true orthologue in C. elegans. 
4. If another orthologue would be identified, then to access potential overlapping roles. 
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The underlying principles and background information: A 
review of literature 
Regulation of gene expression 
To start a step by step dissection of the complex regulatory mechanisms by starting at the source 
of all information i.e. at the DNA level. I will primarily focus on eukaryotic cell systems. In this 
section, I would like to highlight the major control points of gene regulation with regards to 
transcription mainly. Furthermore, I keep the focus on NR dependent transcriptional regulation 
and the role that Mediator complex plays as an effector. 
Basic gene architecture and epigenetic control of gene expression 
The very first layer of regulation is seen at the very structure of DNA itself and also the local 
environment it is sitting in i.e. the nucleus. The type of control is the so-called ‘Epigenetic Control’ 
of gene expression (Klose and Bird, 2006). This a relatively broad term representing a complex 
array of structural and chemical changes that are made to the DNA polymer as well as the protein 
molecules (e.g. histones) that the DNA molecule is wrapped around. 
 
Figure 1 
Illustration showing the basic organisation of DNA and its relation to histones. Chromatin is made up of 
discrete structures called nucleosomes. A nucleosome is essentially DNA around 4 histone molecules. As 
depicted here each aspect of this is under tight regulation with the help of covalent modifications directly 
being made to the very molecules themselves. Adapted and modified under Creative Commons Attribution 
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License 3.0 from Professor Le Dinh Luong, Genetics. OpenStax CNX. Jul 29, 2009 
http://cnx.org/contents/cbba1ce8-b158-45af-a907-b99e32dff7be@1.1. 
A well-known chemical modification of DNA is the methylation of the Cytosine residues. This 
modification isn’t just present in a random haphazard manner but rather when determining which 
Cytosine residues in DNA are targets for methylation, greater than 90% of methylated Cytosines 
are found in the dinucleotide pattern also known as a ‘CpG’ pattern (Bird, 1986). Keeping things 
simple one can conclude from what we presently know is that DNA methylation status of a 
promoter region is connected with the gene’s transcriptional activity. To generalize methylation is 
a repressive mark. 
 
Figure 2 
A functional level depiction of the basic structure of a gene and its transcriptional control modules based 
on Levine and Tjian (2003). DNA sequences shown here are an idealised example of a Pol II dependent 
gene. The ‘cis-regulatory’ elements shown here are the focus of this dissertation. TSS: Transcription start site. 
The other essential chapter of epigenetics includes the protein scaffold of DNA, the histones. The 
very discovery of histones and its modifications led to the hypothesis of the ‘histone code’ (Strahl 
and Allis, 2000; Jenuwein and Allis, 2001). Which essentially proposed that the transcription of 
genetic information encoded in DNA is in part regulated by chemical modifications to histone 
proteins, primarily on their unstructured ends. There are a few major types of histone 
modifications have been rather well characterised. These include methylation, acetylation, 
ubiquitination and phosphorylation (Fig. 1) (Strahl and Allis, 2000). 
At a functional level, metazoan genes contain highly structured regulatory DNAs that direct 
complex patterns of expression in many different cell types during development (Fig 2). A typical 
eukaryotic gene as shown in Fig. 2 is likely to contain several enhancers that can be located in 5ʹ 
and 3ʹ regions, as well as within introns. Each enhancer is responsible for a subset of the total gene 
expression pattern; they usually mediate expression within a specific tissue or cell type. A typical 
enhancer is around 500 bp in length and contains several binding sites called ‘cis-regulatory’ 
elements for different sequence-specific protein/transcription factors (discussed 
below) (Davidson, 2001). The core promoter is usually composed of ∼60 bp at the transcription 
start site (Smale and Kadonaga, 2003). This elaborate organisation of the regulatory DNA sequence 
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permits the detailed control of gene expression. Indeed, a defining feature of eukaryotic gene 
regulation is the use of multiple enhancers, silencers and promoters to control the activities of a 
single transcription unit with the help of several protein complexes as discussed below. 
Transcription factors and their functional relation to chromatin 
Differential gene expression is essential to the very concept of multicellularity in eukaryotic 
organisms. Genes need to be turned activated and repressed with high spatiotemporal specificity 
in order to drive organogenesis and post-developmental physiology of any multicellular 
organism (Imamoto, 1973; Levine and Tjian, 2003). Today it is a well-established concept that more 
‘complex organisms’ don’t necessarily have more genes, but rather a more complex way of 
controlling their regulation (Phillips 2008). Eukaryotes rely on a group of proteins known 
as transcription factors (TFs), which allow them to finely influence the spatiotemporal activity of 
genes and thus in turn complexity. The yeast genome encodes a total of about 300 transcription 
factors. In contrast, the genome of C. elegans and Drosophila encodes at least 1,000 transcription 
factors in each organism. For humans, the analyses of the complete genome sequence estimated 
the presence up to 3,000 sequence-specific DNA-binding TFs (Vaquerizas et al., 2009). There are 
several way of classifying TFs, but they are often classified according to the tertiary structure of 
their DNA-binding domains (Latchman, 2004). In terms of the basic structure of TFs (Latchman, 
1997), one can describe them by domain-based approach, each TF protein should essentially have 
the following domains: 
• DNA-binding domain (DBD) that binds to specific sequences of DNA known as ‘cis-regulatory’ 
elements (Fig. 2) 
• Trans-activating domain (TAD), which contains attachment sites for other proteins such as co-
regulators namely the Mediator Complex 
• Signal-sensing domain (SSD) / Ligand binding domain (LBD), this is an optional domain sensing 
external signals and, in response, transmits these signals to the rest of the transcription 
complex. 
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Figure 3 
Illustration showing an overview of a functional relationship between cis-regulatory elements, trans-
regulatory factors, histone modification and their effect on transcriptional initiation. This figure is essentially 
a compound view of the process depicted in Fig. 1 and Fig. 2. Red dotted circle: represents the focus of this 
part of the dissertation. The region shows an intricate mechanism of how TF/NRs are recruited to enhancer 
elements and set a highly regulated chain of events leading to Pol II-dependent RNA transcript production. 
HAT and SWI/SNF are histone remodelling complexes associated with the initiation of transcription. Figure 
adapted and modified with permission from Kratochwil and Meyer, (2014).  
Nuclear Receptors as a superclass of transcription factors 
Nuclear receptors (NRs) belong to one of the most abundant classes of transcription factors found 
in metazoans. They serve a wide variety of functions involved in gene expression, such as 
development, reproduction, metabolism, inflammation and toxicology (Laudet and Gronemeyer, 
2002; Laudet and Gronemeyer, 2002a). Many NRs function as ligand-activated transcription factors 
thus providing a direct link between signalling molecules (either extra- or intra-cellular) and 
transcriptional responses. Thanks to computational bioinformatics many NRs have been 
discovered in various organisms. Surprisingly some so-called ‘simpler organisms’ like C. elegans 
have a far larger repertoire of NRs encoded in their genome compared to humans. NRs in C. 
elegans underwent an explosive expansion and divergence, which resulted in astounding 284 
receptors, compared to 48 for humans and 21 for flies (Maglich et al., 2001; Robinson-Rechavi et 
al., 2005; Taubert et al., 2011). In an evolutionary context, direct access to the control centre (DNA 
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& Nucleus) provides a functional and practical edge over an extensive signalling cascade based 
expressional regulation, which in a sense eases evolution (Babonis and Martindale, 2017), this 
hypothesis explains the vast expansion of NRs in nematodes (Taubert et al., 2011). 
Many NRs identified have no known natural ligand, and are hence referred to as ‘nuclear orphan 
receptors’ (Robinson-Rechavi, 2003). Despite many advances in the field of molecular biology for 
many NRs, in particular, orphan NRs, the mechanism of transcriptional activation, recruitment of 
coactivators, and agonist-mediated activation remains obscure. Lack of discovery of many ligands 
for orphan receptor does not necessarily mean that all documented orphan NRs will remain orphan 
but rather hints towards the challenge in finding them. However, a possibility does exist that many 
NRs may function in a ligand-independent fashion, this may be an impossible fact to prove. Thus, 
this issue of whether all NRs have endogenous ligands is still a debated (Schupp and Lazar, 2010). 
As a general proof of concept, I outline the mechanism of action of well-characterised ligand-
dependent and some orphan NRs. As previously stated NRs belong primarily to transcription factor 
superclass, and like other transcription factors, they contain a distinct DNA binding domain that 
allows for target sequence recognition, a transactivation domain that possesses the ability to 
activate transcription through either interaction with cofactors or post-translational modifications. 
And they also contain a ligand binding domain, whose name is self-explanatory of its function (Fig. 
4). 
 
Figure 4 
Basic structural anatomy of NR protein sequence. Nuclear receptors are composed of independent 
functional domains that include the DBD and LBD, the primary functions of which are to recognize specific 
DNA sequences and ligands, respectively. Nuclear receptors generally possess two transcription activation 
functions/domains (AF-1 and -2) located at the N and C termini. Adapted form Giguère, (1999).  
Many research groups have focused on every aspect of the NR anatomy, of my interest is the 
(trans)activation domain. Many NRs have at least two activation domains, the ligand-independent 
activation function (AF)-1, which generally resides in the N-terminal region, and the ligand-
dependent AF-2, which is localised in the C-terminal ligand-binding domain (LBD). Full 
transcriptional activity of an NR is achieved through a synergism between both of its AFs. 
Moreover, the transcriptional potential of each activation function is dependent on extrinsic 
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determinants such as the gene promoter, binding partners, cofactors, cell type, and post-
translational modifications. All AF-1/N-terminal regions of NRs studied so far are the least 
conserved region among NRs, both in size and sequence, for example, the N-terminal domains of 
the vitamin D receptor and the mineralocorticoid receptor are 23 and 602 amino acid residues 
long, respectively (Krust et al., 1986; Segraves, 1991). Consequently, the activation ability of AF-1 
domains has been shown to vary considerably between different NRs. This is in contrast to the AF-
2 domain, localised within the LBD, which is much more conserved. In fact, the AF-2 domain 
consists of a surface created by different structural elements in the LBD (Wärnmark et al., 2003). 
The textbook model of nuclear receptor action is often represented by an inactive cytoplasmic 
receptor in a complex with cytoplasmic chaperones that, upon ligand binding, translocates to the 
nucleus and activates gene expression (Fig. 4). This model holds true for many steroid 
receptors (Pratt, 1997), many other NRs are constitutively nuclear and often bound to DNA 
response elements in the absence of their ligand. It is also now widely accepted that in the absence 
of ligands, many nuclear receptors can act as a strong repressor of gene transcription (Hörlein et 
al., 1995; Baniahmad et al., 1992; Chen and Evans, 1995; Damm et al., 1989; Sap et al., 1989; 
Graupner et al., 1989). Anatomy paves the way for function when it comes to the mechanism of 
action for NRs. A critical aspect of an NR’s function is its ability to specifically bind DNA regulatory 
elements to exert its function as a transcriptional initiator and controller. To modulate the 
transcription of their target genes, nuclear receptors interact with co-regulatory proteins. Nuclear 
receptors have been shown to associate with various components of the general transcription 
machinery, co-repressors, co-activators, and the co-integrator CBP (CREB-binding protein)/p300. 
Co-repressor proteins may function by recruiting histone deacetylases, thus producing a repressive 
epigenetic mark (Biddie and Hager, 2009; Hager et al., 2009; Misteli, 2001; Cohen et al., 2000). 
Upon ligand binding, the repressor complex dissociates from the receptor, which is then free to 
interact with the co-activator complex (Perissi et al., 2004; le Maire et al., 2010). The receptor/co-
activator complex may contain more than co-activators, including regulatory non-coding RNA 
molecules referred to as SRA, p/CAF (p 300/CBP-associated factor), CBP/p300, and other 
components (Lanz et al., 1999). SRC-1, p/CAF, and CBP have been shown to possess intrinsic 
histone acetylase activity leading to a de-repression of the chromatin structure (Kim et al., 2001). 
The molecular mechanisms through which nuclear receptors recruit the aforementioned co-
regulator complexes (Fig. 5) are relatively well understood by Watson et al., (2012a). The NRs 
utilises its AF domains to carry out the recruitment.  Experiments have identified critical sequence 
motifs in co-regulator proteins that mediate ligand-dependent interactions with nuclear receptors, 
the ligand-dependent recruitment of co-regulatory molecules is a feature of the AF-2 domain in 
particular. Many of the co-activator complexes recruited to nuclear receptors do so through a 
conserved motif with the sequence LxxLL (Heery et al., 1997). An analogous sequence motif 
(LxxH/IIxxxI/L) can be found in co-repressor proteins (Nagy et al., 1999; Hu and Lazar, 1999). Crystal 
structure analysis has demonstrated that NR and co-repressor proteins adopt a conformational 
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change that allows them to bind in the same hydrophobic groove on LBDs and therefore 
recruitment of a co-activator and a co-repressor becomes mutually exclusive (Nolte et al., 1998; 
Xu et al., 2002; Wang et al., 2006; Phelan et al., 2010). As discussed above, the class of co-regulator 
that is recruited to the LBD depends upon the ligand-dependent positioning of the C-terminal helix 
(AF-2) of the receptor. The lack of size and sequence conservation in the AF-1 domain has made 
studying the domain challenging thus not much data is available regarding AF-1 sequence motifs. 
This lack of sequence conservation is in fact partially contributed by the presence of intrinsically 
discorded regions (IDRs), and AF-1 domains belong to a large category of intrinsically disordered 
activation domains. This property of intrinsic disorder is considered to be key to the function of AF-
1 domains (Hilser and Thompson, 2011). Several different co-activators/Mediator subunits, which 
also have IDFs, have been shown to bind to the AF-1 domain (discussed later) (Hilser and 
Thompson, 2011; Warfield et al., 2014). For instance, the TATA box-binding protein (TBP), the 
cAMP response element binding protein-binding protein, the vitamin D receptor-interacting 
protein 150 and the Alteration/deficiency of activation 2 protein (Ada2p) are known to 
bind glucocorticoid receptors’ (GRs) AF-1 domain (Ford et al., 1997; Henriksson et al., 1997; Almlöf 
et al., 1998; Hittelman, 1999). Furthermore, in contrast to AF-2, the AF-1 domains contain many 
post-transcriptional modifications (PTM) such as phosphorylation, acetylation and sumoylation, 
which have been shown to affect the transcriptional activity of NRs (Weigel, 1996; Anbalagan et 
al., 2012). 
In order to further understand the function of NRs, we first need to look at how these TFs are 
classified. There are several ways of classifying NRs, a unified system of NR nomenclature was 
proposed in 1999, the NR superfamily is divided into 7 subfamilies in the Nuclear Receptors 
Nomenclature (1999) and is based on sequence homology suggested by Laudet, (1997) of the 
evolutionary conserved DBDs, as well as LBDs that are consistent with the evolutionary scheme 
based upon a large number of sequenced genomes (King-Jones and Thummel, 2005; Reitzel and 
Tarrant, 2009; Srivastava et al., 2008; Bridgham et al., 2010).  Most NRs bind to DNA as dimers, 
either as homodimers or heterodimers, some, however, bind to DNA as monomers. Therefore, 
some have used this very dimerization ability of NRs to classify them. This classification essentially 
divides the NR superfamily into four classes (Mangelsdorf et al., 1995). Class I receptors are 
recognized by their ability to bind as homodimers to inverted DNA repeats, while Class II receptors 
heterodimerize with the retinoic X receptor (RXR), binding to direct repeats (with exceptions). Class 
III and IV receptors bind as homodimers to direct repeats and extended core sites as monomers, 
respectively.  
Examples of Class I receptors include the glucocorticoid receptors (GRs), estrogen receptors (ERs), 
progesterone receptors (PRs), mineralocorticoid receptors (MRs) and androgen receptors (ARs), 
which, when unliganded, are complexed to chaperones (e.g. Hsp70, Hsp90) in the cytosol and 
dissociate into the nucleus to affect gene expression after ligand-induced allosteric change has 
occurred (Beato, 2000). NR action is then executed depending on the set of associated 
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proteins (Hermanson et al., 2002; Kraus and Wong, 2002), such as co-activators (Cosma, 2002) and 
co-repressors (Privalsky, 2004), as well as chromatin structure by managing access of the 
transcriptional machinery to specific gene sequences (Khorasanizadeh, 2004).  
Class II receptors bind as heterodimer complexes and are also located within the nucleus 
complexed with co-repressors in a repressive cognate state, thus keeping transcription off. After a 
ligand binding induces a conformational change, histone acetylase complexes are recruited, 
reversing the repressive effects and assembly of the basic transcriptional machinery, this will be 
discussed later in detail. The repression is maintained by NCoR and SMRT co-repressor 
complexes (Chen and Evans, 1995; Hörlein et al., 1995) associated with histone 
deacetylases (Watson et al., 2012). Cell-autonomous feedback with several NRs in Class II is 
observed because they bind ligands produced in the same cell (Sever and Glass, 2013). This class 
of receptors includes e.g. retinoic X receptor (RXR), thyroid hormone receptor (TR) and vitamin D 
receptor (VDR).  
Class III NRs function probably similarly as Class I NRs, with homo-dimers binding commonly to 
direct repeats (e.g. HNF4, COUP-TF, RXR) (Rastinejad et al., 2015). Class IV NRs compromise a group 
of NR monomers binding to single DNA half-sites (e.g. ROR, NURR family) (Rastinejad et al., 2015; 
Mangelsdorf et al., 1995). 
 
Figure 5 
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Basic functional outline of the mechanism of action of different classes of NRs. Three different classes of NRs 
are demonstrated here. Class I and III NRs include receptors like AR, GR, ER, MR and HNF4alpha, COUP 
respectively, there are anchored in the cytoplasm by chaperone proteins like Hsp70 and Hsp90. Class II NRs 
include thyroid hormone receptor and the retinoic X receptor, in contrast, these receptors reside in the 
nucleus bound to their specific DNA response elements even in the absence of ligand. As shown here NRs 
can be modulated by ligands that either activate or repress gene targets. Repression is mediated by 
complexes that have corepressors (SMRT/N-CoR and histone deacetylases or HDACs), among other 
components. Activation requires the coactivator complexes (p160 family members and histone 
acetyltransferases or HATs). The repressive and activating complexes block or promote transcription. 
Furthermore, receptors can be organised into distinct oligomeric states such as heterodimers with the 
common partner RXR, homo-dimers, or monomers. The non-steroid receptor heterodimers and many 
homo-dimers bind to direct repeat response elements with various inter-half-site spacings. Steroid receptor 
homodimers mainly use palindromic DNA elements, where the two half-sites are in an inverted repeat 
fashion. Other receptors (not shown here) use monomeric sites extended at their 5′ end with short 
sequences used for selectivity. The illustration was adopted from Rastinejad et al., (2013); Sever and Glass, 
(2013). 
Taken together, transcriptional regulation by nuclear receptors incorporate several major players 
involved in epigenetic modifications, hence understanding the chromatin status and histone code 
is vital to understand the big picture. To summarise, there are three chromatin states in relation 
to NRs, first a normal chromatin in the absence of receptor that displays a basal level of histone 
acetylation and transcription; second a repressive chromatin state with deacetylated histones and 
no transcription in the presence of the unliganded receptor; and lastly an active chromatin with 
high levels of histone acetylation and transcription in the presence of liganded receptor. 
Transcriptional initiation and the Mediator complex 
Having an overlook at how NRs fit into the complex world of gene regulation I now look at the next 
steps required for transcriptional induction. Once bound to DNA and after the initial phase of local 
chromatin remodelling i.e., modifying the chromatin from repressive to an active state, NRs further 
start the process of recruiting general transcription factors and other co-activators namely the 
mediator complex, which then stabilize the preinitiation complex (PIC) containing the RNA 
polymerase II. First, we have to understand what the Mediator complex is before trying to 
dismantle its function. The role that mediator plays in the initiation of transcription is somewhat 
complicated and not all the aspects have been understood to date. 
The Mediator complex, as the name implies, is a multi-subunit complex consisting of 25 to 30 
subunits (yeast and human, respectively) with an overall molecular weight of >1MDa (Bourbon, 
2008; Thompson et al., 1993). It was first discovered in yeast as a transcriptional cofactor (Kelleher 
et al., 1990; Flanagan et al., 1991; Kim et al., 1994), in the past many names have been given to 
the mammalian version of the Mediator complex in literature, such as TRAP (thyroid hormone 
receptor-associated protein) (Fondell et al., 1996), ARC (activator-recruited cofactor) (Näär et al., 
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1999), or DRIP (vitamin D receptor-interacting protein) (Rachez et al., 1998). The Mediator 
complex has been biochemically isolated in at least two forms: the small mediator and the large 
mediator. Structurally as a whole one can think of the complex as four modules; the ‘head’, 
‘middle’, ‘tail’ and the ‘CDK8 kinase’ module. The way in which these modules associate is a matter 
of debate, but from the present experimental data, one can divide the complex into either, the 
smaller, core complex (600 kDa) and the larger mediator (1.2 MDa) (Taatjes, 2002). The head, 
middle and tail modules form a relatively stable ‘core’ structure, the kinase module — which 
consists of four subunits (cyclin-dependent kinase 8, MED12, and MED13, but lacks the MED26 
subunit) associates reversibly with the Mediator (Cevher et al., 2014; Plaschka et al., 2015). The 
CDK8 kinase module behaves in a context-specific manner to either repress or activate 
transcription, depending on the transcription factors and/or target gene promoters (Nemet et al., 
2014). In spite of the structural complexity, the underlying modular architecture, in essence, 
reflects a division of labour at the functional level. 
 
Figure 6 
This illustration is an attempt to depict, from published data (Guglielmi, 2004; Belakavadi et al., 2008; Baumli 
et al., 2005; Larivière et al., 2006; Tsai et al., 2014; Robinson et al., 2015). The four modules: the head module 
(in red), the middle module (in yellow) and tail module (in blue), which function as the main ‘core’ complex 
and the CDK8 kinase module (in green), which is transiently associated with the complex as shown in Fig 5. 
Mediator subunit 14 (MED14), which links all three main modules (head, middle and tail), is indicated in 
orange. The exact localization of five metazoan-specific subunits (MED23, MED25, MED26, MED28 and 
MED30) with the whole complex remains to be designated. These subunits have been shown here in grey 
according to a proposal discussed by Malik, (2016). Furthermore, I try to show documented subunit:NR and 
subunit:protein interaction partners. MED23’s interaction with and an adenovirus protein EA1 and a RAS-
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MAPK-dependent factor ELK1 was shown by Boyer et al., (1999); Wang et al., (2005). MED1’s targeting by 
ligand-inducible NRs have been very well documented (Rachez et al., 1999; Ge et al., 2002; Ge et al., 2007; 
Malik et al., 2002; Hittelman, 1999; Kang et al., 2002; Malik et al., 2004; Ito et al., 2000). Developmental 
pathways also have been shown to converge at the Mediator converge on the Mediator proteins MED12 
and MED13 a few examples include Wnt/β-catenin signalling in D. melanogaster (Carrera et al., 2008; Kim 
et al., 2006a) and a negatively acting neuronal developmental transcription factor REST in Danio 
rerio (zebrafish) (Wang et al., 2006a). Last but not least an interaction of the embryonic stem cell transcription 
factor NANOG has also been observed (Tutter et al., 2008). This illustration was adopted with permission 
from Soutourina, (2017).  
As depicted in the figure above, the Mediator complex has the ability to bind various transcription 
factors and many other proteins and integrate these signals to the basal transcriptional 
machinery (Malik and Roeder, 2010; Taatjes, 2010; Conaway and Conaway, 2011; Allen and 
Taatjes, 2015). Furthermore, it also functions as the initiator of the general transcription factor 
assembly i.e. aids in the formation of the transcription preinitiation complex with Pol II. It is tightly 
associated with the general transcriptional machinery by making contact to RNA polymerase II and 
interacting with transcription factors and is thus by many regarded as a general transcription 
factor (Takagi and Kornberg, 2005). The general transcription factors (GTFs) include TFIIB, TFIID, 
TFIIE, TFIIF and TFIIH (Holstege et al., 1998; Soutourina et al., 2011; Thompson and Young, 1995). 
Formation of the transcription preinitiation complex is nucleated by the TATA-binding protein 
(TBP) at the core promoter site, a subunit of TFIID that binds the TATA element and induces DNA 
looping i.e. enhancer and basal promoter proximation, this has been shown to be a MED1 
dependent process (Poss et al., 2013). In the absence of a TATA sequence, PIC assembly is initiated 
by the association of other subunits of TFIID with other promoter elements (Pugh and Tjian, 1991). 
The next steps essentially involve the loading of the other GTFs on to the core promoter, the 
process of GTF loading is in fact also shown to be Mediator guided (Kornberg, 2007; Poss et al., 
2013). Fig. 7 illustrates a visual summary of the steps involved in Mediator based PIC formation. 
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Figure 7 
This illustration shows the current model of Mediator assisted PIC formation and transcriptional initiation. 
Step one shows the idealised pathway with the attachment of a liganded NR bound an enhancer/regulatory 
element upstream of a transcriptional start site. At this point, the chromatin is in a repressive state. Step 2 
shows the ‘opening’ of the chromatin structure as induced by the recruitment of co-activators as previously 
demonstrated in Fig .2. The resulting chromatin is characterised by distinct covalent modifications. Step 3. 
show the activator-mediated recruitment of the Mediator complex with the CDK8 module. Step 4. is the PIC 
assembly, entailing the GTFs (TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH) and Pol II (Eychenne et al., 2016; 
Esnault et al., 2008; Johnson, 2002; Larivière et al., 2006), followed by the initiation of transcription right after 
the displacement of the CDK8 module with Pol II. After the release of Pol II the CDK8 module reassociates 
with the Mediator and in the likely involved in the elongation phase of transcription (Takahashi et al., 
2011). This illustration was adopted with permission from Soutourina, (2017).  
From the information discussed above, it should be clear that the Mediator is not only the basis 
for regulated transcription, but it is absolutely required for almost all transcription of nearly all Pol 
II-transcribed promoters, in a way it is no less important for transcription than Pol II itself (Eyboulet 
et al., 2015). Not only is the Mediator important for positive regulation but also for negative 
regulation of transcription (Knuesel et al., 2009). Many commonly refer the Mediator as a co-
activator, it is rather a co-activator, a co-repressor, and a general transcription factor all dependent 
upon cellular context (Elmlund et al., 2006). The Mediator may be seen as a signal processor. It 
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transduces regulatory information from enhancers to promoters in the entire evolutionary line-up 
of species from yeast to humans. 
Other functions of the Mediator indeed go far beyond the focus of my dissertation. However, some 
other noteworthy functions include the elongation of the Pol II transcript (Conaway and Conaway, 
2013), chromatin looping (Park et al., 2005) and histone/chromatin modification (Meyer et al., 
2008). This far-reaching potential of the Mediator makes it evident that the extensive and complex 
regulatory ability of the mediator complex, of which much is yet to be discovered. To further 
complicate matters the possibility of post-translational modifications, on the Mediator’s 
subunits, adds another layer of regulation to control gene expression by altering subunit activity in 
countless ways (Nagalingam et al., 2012). 
Mediator at the evolutionarily conserved nexus of cellular signalling 
At this point, it has become more than clear that the Mediator not only functions as a site-
specific/cell-specific manifold for PIC assembly but is also situation-specific transcriptional 
responder i.e. cellular cues, either intra/extracellular converge at this nexus as already pointed out 
in Fig 6. We have already touched on the fact that NRs may have an evolutionary advantage when 
it comes to having a direct link to DNA as stimuli and acute biological responses can be coupled 
without the need for an extensive signalling cascades, which eases evolution (Babonis and 
Martindale, 2017), a hypothesis that may support the huge expansion of NRs in 
nematodes (Taubert et al., 2011). An efficient way of classifying proteins across species is largely 
based on comparing the most conserved regions of the proteins. The Nuclear Receptors 
Nomenclature, (1999) uses sequence homology of the evolutionary conserved DBDs, as well as 
LBDs that are consistent with the evolutionary scheme based upon a large number of sequenced 
genomes. When viewing the Mediator subunits under the evolutionary ‘microscope’ it is 
somewhat more challenging. 
In evolution, Mediator emerged in eukaryotes, coinciding with the emergence of other general 
TFs (Takagi and Kornberg, 2005), and is conserved from unicellular eukaryotes to 
metazoans (Bourbon, 2008). However, throughout eukaryotic evolution, the primary sequences, 
the subunit composition, and function of Mediator diversified but structural homologues of all 
Mediator subunits are present in yeast and humans (Poss et al., 2013; Bourbon, 2008).  Poor 
sequence conservation between yeast and human Mediator is observed on the basis of multiple 
sequence alignments and secondary structure features, although a set of conserved Mediator 
subunits have been identified in most eukaryotes. Lack of high sequence homology in the subunits 
is due to the similar phenomenon seen in the AF1 domains of NRs (Wärnmark et al., 2003). In most 
metazoan, plant and fungi Mediator subunits exist intrinsically disordered regions (IDRs) (Tóth-
Petróczy et al., 2009), their presence might partially explain the divergence of Mediators’ primary 
sequences as these generally tend to diverge more rapidly over the course of time (van der Lee et 
al., 2014). However, it is relevant to point out that even though the sequence conservation is 
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relatively weak for some subunits, the location of IDRs within the primary is similar, suggesting 
general structural conservation (Nagulapalli et al., 2015). This structural conservation is what plays 
a vital role in Mediator’s adaptability, both conformational and regulatory, and its capacity for 
multiple protein-protein interactions (Tóth-Petróczy et al., 2009). In part one can also explain the 
Mediator’s divergence by the increasing diversity of its binding partners like DNA-binding 
TFs/NRs. The subunit composition depends on the organism, and the overall number of Mediator 
subunits increased during eukaryotic evolution. Although many of the basic functions of Mediators 
are conserved from yeast to human (TF binding and Pol II recruitment) some of the more advanced 
capabilities like binding to various chromatin/Pol II-associated factors is not possible in yeast as 
they are simply not found in the yeast genome (Jishage et al., 2012; Hu et al., 2006a; Lai et al., 
2013; Kuuluvainen et al., 2014). 
Specialised roles of Mediator subunits in the context of cellular signal 
processing 
Defining each of many documented roles of the Mediator are far beyond complex for the purposes 
of my dissertation. The aim here is to show the ’transducible’ capability of the Mediator or rather 
it being at an endpoint of evolutionary conserved diverse signalling pathways. As visualised in Fig. 
6, some Mediator subunits have shown major interactions with many NRs. Namely, MED1 is a 
target of ligand-inducible nuclear receptors. MED1 provides a docking surface for nuclear 
receptors that entails interfacing between a given NR and the transcriptional machinery. In the 
case of MED1, the AF2 domains of receptors are predominantly responsible for the interactions, 
which contain the conserved LXXLL sequence motif (Zhu et al., 1997). NRs that have identified as 
MED1 regulators include the ligand-bound thyroid hormone receptor, vitamin D receptor (Rachez 
et al., 1999), peroxisome proliferator-activated receptor-γ (PPARγ) (Ge et al., 2002; Ge et al., 
2007), hepatocyte nuclear factor 4α (HNF4α) (Malik et al., 2002), glucocorticoid 
receptor (Hittelman, 1999) and the oestrogen receptor (Kang et al., 2002). Interestingly, for MED1 
regulation of PPARγ in cultured mouse embryonic fibroblasts, these LXXLL motifs are not required, 
which may suggest that MED1 regulation of gene transcription through alternative mechanisms in 
a context-dependent manner (Ge et al., 2007). Jia et al., (2014) have reported how the functional 
relationship of MED1 and NRs is interconnected in liver metabolism regeneration and 
carcinogenesis. Liver function is heavily dependent upon members of the NR family (Wagner et al., 
2011), examples include peroxisome proliferator-activated receptors (PPARs), pregnane X receptor 
(PXR), liver X receptor (LXR), constitutive androstane receptor (CAR), farnesoid X receptor (FXR), 
glucocorticoid receptor (GR), and others. The reason for this high ‘NR’ dependence may be the fact 
that the liver has a ‘ligand’ rich milieu and the liver cells have evolved and adapted using these 
ligands to regulate energy homeostasis, detoxification of xenobiotics, and the formation and 
excretion of bile acids. MED15 subunit is another excellent and interesting example of a diversified 
capability of individual subunits. It was identified as a target of sterol regulatory element-binding 
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protein 1α (SREBP1α) and is a key effector of SREBP-dependent gene regulation and control of lipid 
homeostasis in Metazoans (Yang et al., 2006). Furthermore, as reported by Taubert et al., (2006) 
that MED15 in C. elegans coordinates expression of metabolic genes involved in lipid metabolism 
by interacting with NHR-49, which is one of the major controllers of fasting response and β-
oxidation genes. At the same time, MED15 has also been implicated as a target subunit for the 
conserved transforming growth factor-β (TGFβ)/Nodal/Activin/Smad2 developmental signalling 
pathway (Kato et al., 2002). Perhaps the fascinating role of MED15 hasn’t even been thoroughly 
characterised. In an exhaustive immunoprecipitation-mass spectrometry study performed 
by Malovannaya et al., (2011) showed that the interaction network of MED15 was distinct relative 
to other Mediator subunits, suggesting it may function independently of Mediator. The authors 
suggested that the protein is found in two exclusive complexes: the known Mediator complex, but 
also interacts separately with an E3-ligase TRIM11, which sequesters MED15 subunit away from 
the main body of the Mediator complex in a relatively stable and discrete complex. Up until now, 
most, if not all, examples of Mediator subunits that I have illustrated here are showing these 
subunits as signal receivers or rather transducers, of other established signalling systems like NR, 
and their role in PIC assembly. However, MED12 subunit might function independently as a 
regulator of TGFβ signalling in the cytoplasm where it negatively regulates TGF-βR2 through 
physical interaction (Huang et al., 2012). Keeping that in mind a C. elegans RNAi screen identified 
MED12 as a highly connected ‘hub’ gene that regulated numerous signalling pathways (Lehner et 
al., 2006), and others have linked MED12 to WNT–β-catenin signalling pathways and Hox gene 
expression (Kim et al., 2006a; Moghal and Sternberg, 2003; Yoda et al., 2005). These roles point 
to a traditional role as a member of the Mediator complex, i.e. acting as an end-point of signalling 
cascades. The last subunit that I would like to divert most of my attention to and is the focus of this 
dissertation is the subunit 28. MED28 subunit was shown to be involved in regulating smooth 
muscle (SMC) development. RNAi of MED28 in NIH3T3 and myoblast C2C12 cell lines lead to up-
regulation of smooth muscle genes, whereas over-expression of MED28 repressed the expression 
of these genes. This data also showed for the very first time that MED28 functions as a negative 
regulator of SMC differentiation in concert with other Mediator subunits including MED6, MED8, 
and MED18 within the Mediator head module (Beyer et al., 2007). MED28 as a gene sequence had 
already been previously identified as an endothelial cell gene and was named endothelial-derived 
gene EG-1, its expression was associated with a stimulated state in endothelial and epithelial cells, 
and it was proposed to play a role in tumour angiogenesis (Liu et al., 2002). Later research, 
identified it as a protein that interacts with the cytoskeletal protein merlin/Neurofibromin 2, it 
localises beneath the plasma membrane, it interacts with the actin cytoskeleton and also binds the 
well-characterised adapter protein Grb2 (Wiederhold et al., 2004). Other studies have found that 
MED28 also interacts with the Src family members (c-Src and Lck) and the binding results in the 
activation of c-Src without causing an over-expression of the c-Src (Lu et al., 2006) secondly Lck 
(Src family kinase) can phosphorylate MED28 (Lee et al., 2006). Huang et al., 2012a provides 
evidence for MED28 transcriptionally up-regulating genes involved in cell migration namely MEK-
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1 and MM2 in breast cancer. Based on the available literature regarding MED28 one can only say 
that much further analysis in need to understand this multifaceted protein. During the 
development of our publications (Chughtai et al., 2015; Kostrouchová et al., 2017) a 
comprehensive review of the Mediator complex, its subunits and predicted functions in C. elegans 
were published by Grants et al., (2015). As our model organism of choice was C. elegans, a 
tabulated list of Mediator subunits in C. elegans and a predicted structural model from the 
comprehensive review has been added here. 
Table 1 was based on the comprehensive review of the Mediator complex in C. elegans by Grants 
et al., (2015) (adapted with permission). MED28’s sequence number has been corrected based on 
the evidence provided by my colleagues and myself in the two publications (Chughtai et al., 2015; 
Kostrouchová et al., 2017). 
Table 1: Listing the 29 putative C. elegans Mediator subunits, their mammalian orthologues and sequence 
number. ✩ W01A8.1 gene is now annotated as plin-1. ✢F28F8.5 gene encodes MDT-28 the true orthologue 
of mammalian MED28. 
C. elegans subunit Mammalian orthologue Sequence number 
MDT-1.1 MED1 Y71F9B.10 
MDT-1.2 MED1L T23C6.1 
MDT-4 MED4 ZK546.13 
MDT-6 MED6 Y57E12AL.5 
MED-7 MED7 Y54E5B.3 
MDT-8 MED8 Y62F5A.1 
MDT-9 MED9 Y62E10A.11 
MDT-10 MED10 T09A5.6 
MDT-11 MED11 R144.9 
MDT-12 MED12 F47A4.2 
MDT-13 MED13 K08F8.6 
MDT-14 MED14 C38C10.5 
MDT-15 MED15 R12B2.5 
 MED16 Absent? 
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MDT-17 MED17 Y113G7B.18 
MDT-18 MED18 C55B7.9 
MDT-19 MED19 Y71H2B.6 
MDT-20 MED20 Y104H12D.1 
MDT-21 MED21 C24H11.9 
MDT-22 MED22 ZK970.3 
MDT-23 MED23 F39B2.4 
MDT-24 MED24 F56H9.5 
 MED25 Absent? 
MDT-26 MED26 C25H3.6 
MDT-27 MED27 T18H9.6 
MDT-28 MED28 W01A8.1✩ Corrected F28F8.5✢ 
MDT-29 MED29 K08E3.8 
MDT-30 MED30 F44B9.7 
MDT-31 MED31 F32H2.2 
CDK-8 CDK8 F39H11.3 
CIC-1 CycC H14E4.5 
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Figure 8 
Model showing hypothetical adaptation of C. elegans Mediator, based on human Mediator. Subunits 
labelled with dashed outline lack apparent C. elegans orthologues. Additionally, Mediator’s involvement in 
developmental and physiological pathways from known data has been added. Furthermore, the subunit of 
interest, MDT-28, has been highlighted with thick dashed red outline. Based on our work the true orthologue 
sequence number has been listed F28F8.5. This illustration was adapted with permission from Grants et al., 
(2015). 
Lipid droplets 
For many decades lipid droplets (LDs) had been perceived as inert fat particles, used for storing fat 
and thus were largely ignored by researchers. The process of lipid storage considered to be 
relatively benign in which excess fatty acids are converted to neutral lipids and deposited in 
cytoplasmic inclusions. It was however observed that these fatty cytoplasmic inclusions 
are ubiquitous found and in most eukaryotic cells and even in prokaryotic cells (Alvarez and 
Steinbüchel, 2002; Murphy, 1990; Ratledge, 1991; Wältermann and Steinbüchel, 2005). Within and 
among organisms, LDs physically range greatly in size (diameter < 1–100 μm) this is largely 
dependent on the cell type e.g. the cytoplasm of adipocytes is essentially an LD, but biochemically 
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each LD consists of a phospholipid monolayer that surrounds a core of neutral lipids, such as sterol 
esters or triacylglycerols. 
During the last few decades, there has been a growing interest in these intracellular organelles as 
dynamic regulators of lipid metabolism and their role beyond keeping fat in check. A real interest 
in LDs began after the discovery of a lipid droplet surrounding protein called Perilipin back in the 
1991 (Greenberg et al., 1991).  Greenberg and colleagues sparked scientific interest by showing a 
hormonally regulated major phosphoprotein located in the adipocyte and they coined the term 
Perilipin. They suggested that Perilipin may provide more than just a structural role due to its ability 
to respond to acute hormone-induced changes in phosphorylation, including the addition of 
phosphate by A-kinase and removal of these same phosphates by an insulin-stimulated 
phosphatase. This discovery was really a milestone in understanding a whole spectrum of 
metabolic disorders such as metabolic syndrome, insulin resistance and type II diabetes. 
Due to a massive recent interest in lipid biology, there have been many speculations into the role 
of LDs and the associated proteins beyond that of storing fat. These roles are key to understanding 
not only lipid biology but also the regulation of gene expression, I would discuss this later in detail 
in the discussion of this thesis. 
 
Figure 9 
Schematic representation of a cytoplasmic lipid droplet adopted with permission from Walther and Farese, 
(2012). In this representation, one can clearly see a seemingly simple architecture of the LD which essentially 
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consists of triglycerides and cholesterol esters surrounded by a phospholipid monolayer. And last but not 
least a rather complex array of associated proteins, among them Perilipin being the most abundant. As 
described later in detail these proteins are responsible for regulating the size and metabolic activities of 
lipidic core. Cellular cytoplasm contains an emulsion of LDs in the cytosol. The LD phase of the emulsion 
provides a large interface for interactions with amphipathic molecules. The LD surface comprises polar, 
amphipathic lipids. In mammalian LDs, phosphatidylcholine (PC) is the main surface phospholipid, followed 
by phosphatidylethanolamine (PE) and phosphatidylinositol (Bartz et al., 2007). Compared with other 
membranes, LDs are deficient in phosphatidylserine and phosphatidic acid but enriched in lyso-PC and lyso-
PE. The primary neutral lipids of the LD core are sterol esters (SEs) and triacylglycerols (TGs). Their relative 
amount varies between cell types. For example, yeast LDs have a mix of SE and TG, possibly arranged in 
layers (Czabany et al., 2008). LDs of adipocytes contain primarily TG, and those of macrophage foam cells 
contain mostly SE. Neutral lipid synthesis is catalysed by various enzymes as discussed later. 
Introducing the Perilipin family of proteins 
The Perilipin family of proteins have been associated with surfaces of LDs and all carry a conserved 
11-mer repeat motif. Previously the Perilipin protein family was known as PAT family of proteins, 
the name was PAT was derived from names of three proteins, PERILIPIN, ADRP, and TIP47, with 
each having highly related N-terminal sequences and common affinity for intracellular neutral lipid 
storage droplets. The protein coat of lipid droplets can vary between droplets within a cell, 
between metabolic conditions, and between cell types. The current knowledge is based on several 
proteomic studies (Jolivet et al., 2017; Siegler et al., 2017; Khan et al., 2015; Ding et al., 2012). 
Furthermore, these studies also identified many other proteins which include proteins involved in 
lipid metabolism and transport, intracellular trafficking, signalling, chaperone function, RNA 
metabolism, and cytoskeletal organisation. This heterogeneity of the protein coat is consistent 
with the dynamic changes in morphology and intracellular location that lipid droplets undergo 
according to the metabolic state or developmental stage of the cell or organism. 
However, the most abundant protein group found on LDs is the Perilipin family. Mammalian 
genome expresses five unique proteins belonging to this family albeit in a tissue-specific and 
metabolic state-dependent manner. The table below provides an overview of the Perilipin family 
members and functional information. In 2010 the unified nomenclature for the mammalian 
Perilipin-related and PAT-family of intracellular proteins was established (Kimmel et al., 2010). 
Table 2: Overview of the Perilipin protein family in mammals. Adopted from Itabe et al., (2017). 
Proteins Alternative 
name 
Major 
expression 
sites 
Other expression sites Function 
PLIN1 Perilipin A White adpose 
tissue 
cardiac muscle, brown 
adipose tissue 
hormone-induced lipolysis, 
large LD stabilization 
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PLIN2 ADRP, ADFP 
(human 
ADRP), 
Adipophilin 
Liver premature adipocytes, 
macrophages, 
sebocytes, mammary 
gland epithelia, 
ubiquitously expressed 
adipocyte differentiation, 
small LD generation, LD 
stabilization 
PLIN3 TIP47 ubiquitous skeletal muscle, 
neutrophils, mast cells, 
retinal pigment 
epithelium, sebocytes 
LD stabilization 
(compensation of PLIN2), 
PGE2 production, 
intracellular trafficking 
PLIN4 S3-12 White adpose 
tissue 
hMSC (induced during 
differentiation), skeletal 
muscle 
human adipocyte 
differentiation 
PLIN5 MLDP, 
OXPAT, 
LSDP5 
cardiac 
muscle, brown 
adipose tissue, 
skeletal 
muscle 
islet β-cells, hepatic 
stellate cells 
LD stabilization, FA supply 
to mitochondria 
 
Figure 10 
Schematic representation of the PLIN family of proteins showing relevant domains, adopted with permission 
from Bickel et al., (2009).   
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To better understand the relevance of the LD protein coat we need to understand the proteins 
listed in table 2 in a bit more detail. The most well studied member of the family is PLIN1. Most 
commonly found on adipocyte LDs, which is phosphorylated by cAMP-dependent protein kinase 
(PKA) during adrenalin-dependent acute lipolysis.  Perilipin proteins lack putative transmembrane 
domains, and it is not completely clear how Perilipins are associated with the surfaces of lipid 
droplets. Although the PAT domain contributes to the proteins’ association with LDs, other 
determinants of LD surface targeting have been suggested, including various other parts of 
Perilipin proteins. Several investigations of deletion mutants have showed that N- and C-terminal 
regions and central portions of PLIN1 and PLIN2 are required for LD targeting (Garcia et al., 2002; 
Targett-Adams et al., 2003). A recent publication demonstrated that the 11-mer repeat forms 
amphipathic helices that bind micelles and LDs (Rowe et al., 2016). Accordingly, various point 
mutations within the 11-mer repeats of PLIN1–3 led to a changed amphipathic amino acid 
alignment and thus abolished the association with LDs. 11-mer repeats can be found in other 
proteins, including apolipoproteins and the Parkinson’s disease protein α-synuclein (Bussell and 
Eliezer, 2003), which binds LD-associated proteins in lipid-loaded neurons of the hippocampus 
(Cole et al., 2001). Moreover, a four-helix bundle structure that resembles that of apolipoprotein 
E (apoE) was identified in a study of the 3-dimensional structure of the C-terminal region of 
PLIN3 (Hickenbottom et al., 2004), and similar structures were predicted in homology analyses of 
PLIN1, PLIN2, and PLIN5 (Rowe et al., 2016; Bickel et al., 2009). PLIN4 has unique structural 
characteristics, it happens to lack a PAT domain and has a polypeptide length of almost three times 
the length those of other PLIN proteins. However, like PLIN1, PLIN4 is expressed in adipocytes and 
it is found on LDs; its 11-mer repeat is likely crucial for LD surface targeting. 
Evolutionary aspect of Perilipins 
As pointed out earlier prokaryotic and eukaryotic cells contain LDs, which are surrounded by 
proteins. Yang et al., (2012) tried to show functional conservatism of the LD proteome from 
bacteria to humans. Furthermore, the work points out that in mammals, the lipid particles found 
in blood have a similar general structure to intracellular LDs and are surrounded by apolipoproteins 
(APOs). Yang et al. (2012) suggest that LD proteins have properties in common with APOs.  In fact, 
the apolipoprotein A-V has been found on LDs in hepatoma cells (Shu et al., 2007), apolipoprotein 
A-I has been found on LDs in white adipose tissue (Kanshin et al., 2009), and APOA-I and APOE have 
been found on LDs of skeletal muscle cells (Zhang et al., 2011).  A very interesting study conducted 
by Hickenbottom et al., (2004) compared the sequence similarities between Perilipin family and 
apolipoproteins. They show that the sequence similarities have a clear functional analogy but are 
distant enough to leave uncertain whether they arose by convergent or divergent evolution. 
Furthermore, logically thinking it is very unsurprising to discover a close structural relationship 
between lipid droplet coating proteins and apolipoproteins. The lipidic core of both droplets and 
lipoprotein particles consists of triglycerides and cholesterol centrally surrounded by a monolayer 
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of phospholipids (Feingold and Grunfeld, 2000). On a functional level the associated proteins are 
also analogous i.e. they stabilise assembly, provide docking sites for the appropriate receptors and 
regulatory proteins, and regulate access to the underlying lipids. Hickenbottom et al., (2004) 
and Chong et al., (2011) show that the C-Terminal of PLIN 3 and PLIN 2 contain APOE like domains. 
All things considered, it seems that these APO-like proteins are a group of evolutionarily conserved 
proteins involved in fat storage and trafficking as well have evolved the ability to target intracellular 
or extracellular lipid-filled structures covered with a phospholipid monolayer. 
Yang et al., (2012) studied the evolutionary relationship among 61 APO-like proteins, from seven 
species and grouped them based on protein similarity using Molecular Evolutionary Genetics 
Analysis software. The results showed genes clustered into six groups, each group including at least 
one human APO. Fascinatingly in the first group, four human PLIN family proteins were similar to 
the Caenorhabditis elegans APOs. In the second group, Drosophila Lsd2 showed similarity to 7 
mammalian APOL subfamily proteins. Ten plant oleosin proteins showed similarity to mammalian 
APOD and APOH in group 3. Interestingly, the bacterial MLDS (RHA1 ro02104) was found to be 
close to mammalian APOC-I/APOC-II in group 4, indicating that APO-like proteins maybe 
evolutionarily older than Perilipin family of proteins. Plant fibrillarin (FIB) family proteins have been 
found in the plastoglobules of A. thaliana and have no enzymatic activity. These seven FIB proteins 
were clustered with four plant caleosin proteins, Drosophila Lsd1, and mammalian APOA-I in group 
6. However, sequence alignments showed that sequence similarity among different groups is very 
low. Therefore, their apparent similarity may be due more to the similarity of their predicted 
structures than to similarity of amino acid sequences. Based upon the information provided one 
can logically speculate that these APO-like proteins may be evolutionarily conserved as the 
structural proteins of lipid droplets. 
Overview of eukaryotic lipid metabolism 
To better understand lipid droplets and associated proteins, one has to consider the cellular 
biochemical context. Therefore, I have tried to provide a brief overview of some of some of the 
relevant biochemical pathways involved in the synthesis and degradation of fat. One could 
dedicate several books to the biochemistry of lipid metabolism and that would beyond the context 
of this thesis I will try to focus only the most relevant parts need to show the role of LDs in 
regulating lipid metabolism. Tissues store triacylglycerols in lipid droplets when exogenous fatty 
acids are plentiful and available for import and esterification. Cellular LDs emerge from the 
endoplasmic reticulum (ER) and LD formation is coupled to the synthesis of neutral lipids, 
predominantly triacylglycerides (TAGs) and sterol esters (SE). 
To make things simplified we can begin with very first biochemical building blocks produced after 
glycolysis acetyl-CoA. The first step of fatty acid (FA) synthesis requires the conversion of acetyl-
CoA to malonyl-CoA. Acetyl-CoA is also used as the primary building block for the synthesis of 
cholesterol via the mevalonate pathway. Fatty acids are stored for future use as triacylglycerides 
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in all cells, but primarily in adipocytes. TAGs constitute molecules of glycerol to which three fatty 
acids have been esterified. Predominantly saturated fatty acids are found in TAGs. The major 
building block for the synthesis of TAGs, in cells other than adipocytes, is glycerol. Adipocytes lack 
glycerol kinase, therefore, dihydroxyacetone phosphate (DHAP), produced during glycolysis, is 
used as a precursor for TAG synthesis in adipocytes. This means that adipocytes must have glucose 
to oxidise for them to store fatty acids in the form of TAGs. DHAP can also be used as a backbone 
precursor for TAG synthesis but does so to a much lesser extent than glycerol in cells other than 
adipocytes. The incorporated fatty acids into TAGs require activation to become acyl-CoAs, this is 
dependent on the action of FA synthase. FA synthase elongates acyl-chains, stepwise, to form 
palmitic acid. Medium and long chain FAs are then activated to acyl-CoA by long-chain Acyl-CoA 
synthetase (ACSL). Several acylation steps along glycerolipid biosynthetic pathways, mediated 
through acyltransferases GPAT, AGPAT, and DGAT, incorporate fatty acyl-CoA to eventually form 
TAG. LD storage prevents FA accumulation and lipotoxicity. Both TAG and CE are stored within LDs 
(Wang, 2016). LD expansion also requires the phospholipid content to also increase. This is likely 
critical during the initial stages of the LD growth process, in which the nascent structures grow 
rapidly. Major phospholipids in yeast and mammals include phosphatidylcholine (50-60%) 
followed by phosphatidylethanolamine (20–30%) (Tauchi-Sato et al., 2002; Bartz et al., 2007). 
There are two major pathways that contribute to phosphatidylcholine synthesis: the Kennedy 
pathway for de novo synthesis of phospholipids and the Lands cycle. A short overview of the 
Kennedy pathway has been incorporated into the diagram below. 
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Figure 11 
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The diagram here is a schematic overview of the biochemical pathways involved in triacylglycerol synthesis 
and lipolysis. Furthermore, a simplified lipid droplet with related proteins is also included. The scheme was 
adopted and modified with permission from Tirinato et al., (2017). The abbreviations shown in the scheme 
are as follows: FA-coA and MUFA/PUFA-coA are in general referred to as FA-CoA. AMP: adenosine 
monophosphate; ATP: adenosine triphosphate; ACATs: acyl-coA cholesterol acyltransferases; ACS: acyl-coA 
synthetase; AGPATs: 1-acyl-glycerol-3-phosphate acyltransferases; ATGL: adipose tissue triacylglycerol 
lipase; CEH: cholesteryl ester hydrolase; CEs: cholesteryl esters; CoA: coenzyme A; DAG: diacylglycerol; 
DGAT: diacylglycerol acyltransferase; DHAP: dihydroxyacetone phosphate; DHAP-OR: dihydroxyacetone 
phosphate oxidoreductase; DHAPAT: dihydroxyacetone phosphate acyltransferase; ER: endoplasmic 
reticulum; FA: fatty acid; FA-CoA: fatty acyl-coenzyme A; FFA: free fatty acid; sFA: saturated FA; FASN: fatty 
acid synthase; GLYK: glycerol kinase; GPATs: glycerol-3-phosphate acyltransferases; cGPDH: cytosolic 
glycerol-3-phosphate dehydrogenase; mGPDH: mitochondrial glycerol-3-phosphate dehydrogenase; HSL: 
hormone-sensitive lipase; LDAPs: lipid droplet-associated proteins; LP-CH: lipoprotein involved in 
transporting cholesterol; MAG: 1-acylglycerols; MGL: monoacylglycerol lipase; MUFA: monounsaturated 
FA; NAD: nicotinamide adenine dinucleotide; NADH: reduced nicotinamide adenine dinucleotide; NADP: 
nicotinamide adenine dinucleotide phosphate; NADPH: reduced nicotinamide adenine dinucleotide 
phosphate; P: phosphate; PA-P: phosphatidic acid; PAP: phosphatidic acid phosphatase; PUFA: 
polyunsaturated FA; SCDs: stearoyl-CoA desaturases; TAG: triacylglycerol; TCA: tricarboxylic acid cycle.  
The next important aspect to consider the lipolytic or rather catabolism of the stored fats from 
LDs. In this aspect, the role of the Perilipin family of proteins has been thoroughly studied.  As one 
can already speculate the release of metabolic energy from fatty acids, is controlled by a complex 
series of interrelated cascades that result in the activation of triglyceride hydrolysis. My focus is 
not really on the generation of ATP through beta and alpha-oxidation but rather the focus is on the 
enzymatic cascade involved in the release of free fatty acids from LDs. In terms of the enzymatic 
cascade, the primary intracellular lipases are adipose triglyceride lipase (ATGL) and hormone-
sensitive lipase (HSL). Other important pathways involved in LD degradation include the 
lipoautophagic pathway, for this reason, another important group of enzymes to consider are 
the lysosomal acid lipases. Although from an enzymatic point of view lipolysis is relatively simple, 
the regulation behind is rather complex. I will discuss more details regarding the catabolic process 
of lipids as perilipins play a central role in regulating enzymatic access. 
Perilipin as a regulator of lipolysis 
In a fed state the increased fatty acid availability allows for delivery of free fatty acids to adipocytes 
and insulin promotes glucose uptake to support triacylglycerol synthesis. When extracellular fatty 
acid supplies dwindle e.g. when energy is required for the exercise or in a fasting state, hormones 
initiate signalling cascades that increase kinase activity to activate lipolytic pathways in adipocytes. 
As discussed in previous sections, PLIN1 is one of the major targets of hormonal activation 
cascades. Intracellular signalling leads to the subsequent phosphorylation of perilipins, lipases, and 
cofactors for lipases initiates the translocation of lipases from the cytoplasm to lipid droplets and 
enables protein-protein interactions to assemble the lipolytic complex on the Perilipin scaffold 
surrounding lipid droplets. The final scaffold allows the lipases to gain access to lipid substrates 
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and lipolysis of stored triacylglycerols follows (Duncan et al., 2007; Lafontan and Langin, 2009). 
Lipolysis is catalysed by lipases that cycle between the cytoplasm or cytoplasmic surfaces of the 
endoplasmic reticulum and the surfaces of lipid droplets. 
To better understand the formation of the lipolytic cascade we first need to know the individual 
proteins involved. A very important enzyme known as ATGL belongs to the family of patatin 
domain-containing proteins and it preferentially hydrolyses triglycerides (Granneman et al., 2007; 
Granneman et al., 2011). The patatin domain had originally been discovered in lipid hydrolases of 
certain plants and had been named after the most abundant protein of the potato tuber and 
because some members of the family act as phospholipases, the proteins were originally named 
patatin-like phospholipase domain-containing protein A1 to A9 (PNPLA1–PNPLA9) (Rydel et al., 
2003; Wilson et al., 2006). The expression and enzyme activity of ATGL are both under complex 
regulation. The expression of ATGL is regulated by peroxisome proliferator-activated receptor 
(PPAR) agonists, glucocorticoids, fasting, FoxO1 activation, mTOR complex 1 (mTORC1)-dependent 
signalling (Zimmermann et al., 2004; Kim et al., 2006; Kershaw et al., 2007; Chakrabarti et al., 
2010). Increased insulin release and food intake both result in decreased expression of 
ATGL (Kralisch et al., 2005). The most interesting or perhaps the most well-studied control of ATGL 
is known to be at the post-transcriptional level. Phosphorylation of ATGL has been reported but 
the physiological significance of the phosphorylation hasn’t been fully established (Kim et al., 2016; 
Ahmadian et al., 2011). To date an important regulatory mechanism for ATGL activation involves 
the interaction with another LD associated co-activator protein called CGI-58 in equimolar 
concentration, several studies show that the patatin domain within the αβα sandwich fold is 
responsible for enzyme activity and a protein-protein interaction with CGI-58, whereas the C-
terminal part of the enzyme, has a regulatory function and mediates LD interaction of the 
enzyme (Lass et al., 2006; Yang et al., 2010; Schweiger et al., 2008; Gruber et al., 2010). CGI-58 co-
activator gene was originally identified as comparative gene identification-58. The term 
comparative gene identification (CGI) was coined due to the computational methods used to 
identify protein sequences that were highly conserved across various species and CGI-58 was 
originally discovered in a comparative screen of proteomes of humans and C. elegans. The official 
nomenclature for CGI-58 is α/β hydrolase domain-containing protein-5 (ABHD5; also identified as 
1-acylglycerol-3-phosphate O-acyltransferase), owing to the presence of an α/β hydrolase domain 
commonly found in esterases, thioesterases, and lipases (Granneman et al., 2007; Yamaguchi et 
al., 2004). 
The first identified and most highly characterised lipase is hormone-sensitive lipase (HSL), an 
enzyme with strong diacylglycerol and cholesterol ester hydrolase activity, and weaker 
triacylglycerol, monoacylglycerol, and retinyl ester hydrolase activity in vitro (Lass et al., 2011). HSL 
is highly expressed in white and brown adipose tissue, and at lower levels in a variety of tissues. 
The activity of Adipose HSL is controlled by two distinct mechanisms in response to hormonal 
stimulation: first, the enzyme is phosphorylated by cAMP-dependent PKA leading to an increase of 
the intrinsic enzyme activity. HSL is known to be phosphorylated at multiple sites, some sites being 
 39 
more important than others for enzyme activity (Krintel et al., 2008). Phosphorylation also 
promotes the translocation of HSL from the cytoplasm to the surfaces of lipid droplets to gain 
access to substrate lipids (Holm, 2003). Besides PKA, other kinases have also been shown to 
phosphorylate HSL and regulate the enzyme’s activity. The list includes extracellular signal-
regulated kinase, glycogen synthase kinase-4, Ca2+/calmodulin-dependent kinase II, and AMP-
activated kinase (Olsson et al, 1986; Garton et al., 1989). Second, phosphorylated HSL interacts 
with the LD protein PLIN1, which itself is a target of PKA phosphorylation. 
Several studies collectively showed that PLIN1 is a strategic scaffold at the LD surface for the 
coordinated assembly and disassembly of multi-protein lipolytic complexes upon PLIN1 
phosphorylation or dephosphorylation (Greenberg et al., 2001; Granneman et al., 2009; Miyoshi 
et al., 2007; Miyoshi et al., 2006). Under basal (e.g., fed or insulin-stimulated) conditions the LD-
bound PLIN1 is in an unphosphorylated state, and the two major lipolytic enzymes, ATGL and HSL, 
are cytosolic. Furthermore, in the basal state, the C-terminus of unphosphorylated PLIN1 
separately recruits the co-activator CGI-58/ABHD5 to the LD, adding another layer of protection 
against the lipolytic activity. Thus, under basal conditions, lipases are sequestered from LDs and 
lipolysis is suppressed (Brasaemle et al., 2000; Su et al., 2003; Sztalryd et al., 2003; Shen et al., 
2009). 
Upon hormonal stimulation, adenylyl cyclase is activated via Gαs-GTP, causing cAMP accumulation, 
and this PKA is activated (Viswanadha and Londos, 2008). Under these conditions, PLIN1, CGI-58, 
and HSL are phosphorylated by PKA, with a consequent reorganisation of the LD scaffold that is 
essential for the greater than 50-fold activation of cellular lipolytic rates. Furthermore, the C-
terminal phosphorylation of PLIN1 disrupts interaction with CGI-58 (Taylor et al., 2012). However, 
CGI-58 remains bound at the LD surface and the PKA mediated phosphorylation of CGI-58 
enhances its ability to recruit and activate ATGL, which catalyses the initial step of lipolysis, 
converting TAG to DAG and releasing FAs (Greenberg et al., 1991). 
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Figure 12 
In the basal state, the PLIN1 is found at the surface of the lipid droplet in a complex with CGI-58/ABDH5. 
ATGL activity is kept quiescent through the autoinhibitory C-terminus of the lipase. Upon lipolytic stimulation 
through hormonal signalling, PKA, is activated and phosphorylates serine residues on PLIN1, on HSL and 
CGI-58/ABDH5. This results in the following; firstly CGI-58/ABDH5 dissociates from PLIN1 and recruits ATGL. 
Secondly, phosphorylated HSL translocates to the droplet surface and associates with PLIN1 and lipolysis 
commences. AMPK based phosphorylation has not been well studied but some studies do provide evidence 
for a role in lipid metabolism. Image taken and modified from Sztalryd and Brasaemle, (2017) with 
permission. 
I would like to emphasise that I have only exemplified Perilipin 1 as a standard model for enzymatic 
lipolysis. However, this standard model is relatively simplified especially with regards to other 
PLINs. A great example is Perilipin 5, it binds HSL under basal conditions on LDs while restricting 
the lipolysis of stored triacylglycerols i.e. works as a blocker of lipolysis in a basal state (Wang et 
al., 2009). The C-terminal of Perilipin 5 contains overlapping binding sequences for ATGL and 
ABHD5. In contrast, the C-terminus of Perilipin 1 is only able to bind ABHD5 and not ATGL; 
moreover, the sequence of the ABHD5 binding site is not conserved among Perilipin 1 and Perilipin 
5 (Wang et al., 2011; Granneman et al., 2009a; Granneman et al., 2011). Perilipin 5 is an effective 
protector of stored triacylglycerols from lipolysis under basal conditions while recruiting lipolytic 
proteins/enzymes to LDs; however, upon hormonal signalling activate PKA phosphorylates Perilipin 
5 and lipolysis increases (Wang et al., 2011; Pollak et al., 2015). 
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Perilipin 2, as previously stated, is a major LD associated Perilipin in cells not expressing Perilipin 1 
or Perilipin 5. Perilipins 1 and 5 exert specific and distinct control over lipolysis, as controlled by 
PKA-mediated phosphorylation of themselves, lipases, and co-factors, Perilipin 2 only plays a 
modest role in attenuating lipolysis and is not known to be phosphorylated by PKA. It is 
substantially more permissive to lipolysis than either Perilipin 1 or Perilipin 5 and does not 
effectively recruit lipases to lipid droplets through protein binding interactions under either basal 
or hormonally stimulated conditions that activate PKA. Instead, the overexpression of Perilipin 2 in 
cells reduces the access of ATGL to lipid droplets, thus attenuating lipolysis (Wang et al., 2011; 
Wang et al., 2009; Bell et al., 2008; Listenberger et al., 2007). 
Accessory pathways of lipid droplet catabolism  
The consumption of fats from LDs is a highly regulated process. However, with recent research, it 
has become evident that LDs are taken up by autophagy as an alternative route for lipid 
mobilisation and LD destruction (Singh et al., 2009). Autophagy, in general, is considered to be a 
conserved cellular pathway that delivers cytoplasmic contents to lytic compartments for 
breakdown and recycling in eukaryotes, full discussion into details of the mechanism behind 
autophagy, in general, is beyond the scope of this thesis. However, I try to provide an overview of 
autophagy in general, to provide an understanding of lipophagy. LD autophagy, termed lipophagy 
or lipoautophagy, which delivers LDs to lytic compartments for degradation, is mediated through 
actions of autophagic (Atg) proteins and might represent a selective type of autophagy, targeting 
LDs specifically for destruction. Lipophagy, together with lipolysis, plays a critical role in energy 
metabolism during fasting. Though these two types of pathways for fat mobilisation appear to be 
distinct in their molecular mechanisms, recent evidence has revealed crosstalk between 
them (Singh and Cuervo, 2012). 
Cells defective in autophagy are unable to consume dysfunctional proteins and aged organelles 
during nutrient deprivation, resulting in their death. At the organismal level, autophagy is critical 
for physiology and development and autophagy defects have been linked to numerous human 
diseases. The molecular mechanisms of autophagy were revealed by genetic and biological studies 
in yeast and in higher eukaryotes. To date, three major types of autophagic mechanisms known 
macroautophagy, microautophagy and chaperone-mediated autophagy (CMA), differing in cargo 
delivery, have been characterised (Yang and Klionsky, 2010; Sahu et al., 2011; Cuervo and Wong, 
2014). Unlike macroautophagy that involves autophagosome formation prior to fusion with the 
lysosomes, microautophagy involves a direct engulfment of cytoplasmic contents by modifying 
membranes of lytic compartments, such as lysosomes or late endosomes (Santambrogio and 
Cuervo, 2011). In both cases, the resulting internal vesicles in the lumen are subsequently 
degraded by hydrolases within lytic compartments. By contrast, CMA involves a direct 
translocation and degradation of cytosolic proteins in lysosomes (Cuervo and Wong, 2014). 
However, only macroautophagy and chaperone-mediated autophagy (CMA) have been shown to 
degrade LDs and associated proteins. 
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Kaushik and Cuervo, (2015) recently demonstrated that CMA can also modulate intracellular 
lipolysis by selectively removing PLINs from discrete regions from the surface of LDs. The follow up 
by Kaushik and Cuervo, (2016) revealed the requirement of an AMPK-mediated phosphorylation 
event in the selective degradation of PLINs and subsequent triggering of lipolysis. The group further 
showed that the dependence on AMPK activity for the degradation of PLIN2 by CMA and found 
that degradation of PLIN2 is required prior to lipolysis. Activation of AMPK facilitates both the 
priming of a subset of PLIN2 molecules for their removal by CMA as well as activation of 
downstream lipolytic mechanisms, such as the described AMPK-dependent stimulation of 
macroautophagy and fatty acid oxidation (Long and Zierath, 2006). 
 
Figure 13 
Schematic representation of autophagy leading to lipid droplet degradation used with permission 
from Sztalryd and Brasaemle, (2017). PLINs provide a so called autophagic barrier and removal of PLINs from 
the LD surface is known to be mediated by CMA. AMPK may play a role in priming the protein for CMA. 
After PLINs are tagged with Hsc70 the process of Lamp-2A based recognition and eventual lysosomal 
degradation. The removal of PLINs leaves the LD helpless against not only classical lipases but also allows 
the increased binding of autophagy effector proteins to the LD surface. This leads the LD to be sequestered 
by autophagosomes. Autophagosomes eventually fuse with lysosomes to form autolysosomes where 
lysosomal lipases degrade triacylglycerols into free FAs. 
Trichoplax adhaerens as a model organism 
In the Phylum Placozoa, Trichoplax adhaerens is the only named species (with 19 reported 
lineages (Eitel et al., 2013)) and so far, it is considered to be one of the simplest metazoan 
organisms containing only six types of cells without any kind of mesenchymal tissue (Ringrose et 
al., 2013; Smith et al., 2014). The species are found inhabiting pelagic marine environments around 
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the world within a temperature range between 10°C - 32°C and show seasonal variations such as 
higher abundance in summer. Analysis of all available data identified Placozoa as the most basal 
diploblast group (Schierwater et al., 2009) and placozoan morphology (disk-shaped and lacking 
symmetry) fits the placula hypothesis of metazoan evolution proposed by Otto Bütschli in 1884, 
requiring only minor differentiation processes (Schierwater et al., 2009a). 
In terms of Placozoan morphology, it is a disk-shaped animal built by six different cell types 
and locomotes by ciliary gliding. The body can be divided into a ventral plate made up of ventral 
ciliated epithelial cells with microvilli, cells containing large lipophilic inclusions (lipophil cells) and 
gland cells (Ruthmann et al., 1986). The dorsal surface of Trichoplax is bounded by a thin layer of 
dorsal epithelium composed of ciliated epithelial cells, that together with the ventral plate, 
surround crystal cells containing birefringent crystals. Fiber cells contact other cell types through 
their branching processes (Smith, 2014). Stem cells are thought to be present around the margins 
of the whole animal, however, they haven't been reported morphologically (Martinelli and Spring, 
2004; Jakob et al., 2004).  One can also observe shiny spherical dark granules, which are probably 
found on the dorsal side and may represent lipid inclusions but may also be involved in defence 
mechanism against predators (Jackson et al., 2009). Although little is known about the functions 
of the 6 described cell types it is known that the animal feeds by external digestion underneath its 
ventral plate, ventral epithelial cells are thought to be engaged in nutrient uptake are thought to 
resemble cells of the digestive tract because of the presence of microvilli (Halanych, 2004). The 
gland cells are now proposed to be neurosecretory, rather than digestive enzymes 
secretors (Halanych, 2004; Smith et al., 2014). 
 
Figure 14 
 44 
Laboratory culture and Illustration of Trichoplax adhaerens. A) Shows the multiple individuals of Trichoplax 
adhaerens feeding on pink coloured mix culture of algae and cyanobacteria labelled by the green box. 
Individual animals have been marked with black boxes. B)  Drawing of Trichoplax adhaerens body plan. Shiny 
spheres are not depicted and are probably located in dorsal epithelial cells (DEC). Ventral epithelial cells 
(VEC) are ciliated and possess numerous microvilli. Reprinted from Smith et al., (2014), with permission. 
In a laboratory environment, T. adhaerens usually reproduces by binary fission, however, 
development of embryos until a certain stage has been observed (Eitel et al., 2011). Despite the 
presence of embryos sexual reproduction has never been observed, molecular analysis revealed 
allele shuffling, indicating sexual reproduction in this species (Signorovitch et al., 2005). The 
genome of Trichoplax was sequenced and published back in 2008 and contains approximately 98 
million base pairs with over 11,500 protein-coding genes (Srivastava et al., 2008). Genomic analysis 
also reveals large blocks of conserved synteny relative to vertebrate genomes.  Furthermore, an 
extensive set of transcription factors associated with metazoan development (e.g. patterning), as 
well as differentiation and cell type specification, such as essential components of TGF-ß signalling, 
GATA family zinc-finger transcription factors that are involved in cardiac and blood cell fates in 
vertebrates, can be found. Moreover, the genome contains several genes coding for putative ECM 
proteins, despite the fact that no extracellular matrix (ECM) was identified to date. 
Taken together, it is extremely fascinating, that the placozoan genome codes for and transcribes 
several genes associated with ‘higher’ animals without apparent correlate present in the animals' 
morphology (Schierwater et al., 2009). 
With regards to NRs, the receptors and their network have mainly been studied in more complex 
organisms already in possession of an extensive endocrine network. Genomic analysis of Trichoplax 
adhaerens has already revealed a possibility of four highly conserved nuclear receptors, namely 
orthologues of HNF4 (NR2A), RXR (NR2B), ERR (NR3B) and COUP-TF (NR2F). Despite the fact that 
this basal metazoan only contains four NRs, the study of NRs in Trichoplax presents an interesting 
challenge due to lack of versatile methods and analytical techniques proven to work in a controlled 
laboratory setting such as effective RNAi, GFP-labelling and CRISPR/Cas9 based gene modification. 
Caenorhabditis elegans as a model organism 
Caenorhabditis elegans is rather a small (about 1mm in length) well differentiated free-living soil 
organism. It belongs to the phylum Nematoda it can feed on bacteria as a source of nutrition, it 
can be easily cultivated in large numbers in a laboratory environment and finally having a 
transparent body type makes it even more of an attractive model system for microscopy. Using C. 
elegans as a model organism for studying molecular and developmental biology research started 
in the early 60s. Sydney Brenner was the first scientist to propose using C. elegans as a model 
organism for studying biology (Brenner, 1974). By providing a robust yet easy system to investigate 
the very fundamental processes of physiology and anatomical development several Nobel prizes 
have been given to scientist studying biological events in C. elegans. The first was awarded to 
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Sydney Brenner, John Sulston and Robert Horvitz in medicine or physiology for genetics and organ 
development and programmed cell death. The second went to Craig Mello and Andrew Fire for 
discovering the mechanism of RNA interference. interference. A Nobel prize in chemistry for the 
discovery and development of green fluorescent protein is associated with C. elegans. 
In 1998, the whole genome sequence of C. elegans was completed (C. elegans Sequencing 
Consortium, 1998), the size of the genome is relatively small compared to that of human, it is about 
100 million base pairs long. The complete sequence meant quick and easy access to genetic 
information.  Even though the absolute size of the human genome is much larger than the worm’s 
genome, it still codes for about 20,000 genes, the 100 Mb worm genome is 30 times 
smaller (International Human Genome Sequencing Consortium, 2004). Consequently, about 26% 
of the worm genome is exonic, compared to 1-2% of the human genome (Dupuy, 2004). In 
addition, the majority of intergenic regions are less than 2kb, and introns with a 65 bp median 
length are much shorter, compared to humans where the median length of introns is about 3 
kb (Spieth, 2006). 
One of the very interesting features of C. elegans, which is in a way advantageous over similar 
animal systems like Drosophila, is its deterministic cell development. The fate of each cell is more 
or less genetically predefined, each larval stage, as well as the adult worm, has the same number 
of somatic cells. As far as the sex of the organism is concerned, it can be either found as a 
hermaphrodite or as a male. C. elegans has five pairs of autosomes and a single pair of sex 
chromosomes (hermaphrodites) (Costa et al., 1988).  The sexual determination in C. elegans is 
similar to that of Drosophila, so that the ratio of sex chromosomes to autosomes determines the 
sex of the animal. A XX combination of the 6th chromosome pair will produce a hermaphrodite 
while a XO combination will produce a male. The most common sex in nature is the hermaphrodite. 
When males mate with hermaphrodites they tend to produce progeny that is 50% male, this is 
actually a useful and practical phenotype as it makes checking for positive crosses easier. A 
hermaphrodite contains 959 somatic cells and the male sex contains 1031 somatic cells (with a few 
exceptions) (Wood, 1988). The worm has a relatively high fecundity rate producing approximately 
300 to 350 offspring per hermaphrodite. The figure below represents the typical anatomy of a 
hermaphrodite Caenorhabditis elegans. 
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Figure 15 
Anatomy of an adult hermaphrodite Caenorhabditis elegans used under Creative Common Licence 
from www.wormatlas.org. A) Differential interference contrast image of an adult hermaphrodite, left lateral 
side. Scale bar 0.1 mm. B) Schematic drawing of anatomical structures as seen from left lateral side.  
With regards to metabolic homeostasis, C. elegans maintains its energy balance using many 
physiological processes that include neuroendocrine signalling, storing, mobilising and utilising 
energy stores (Ashrafi, 2007). The worm is not known to have specialised adipocytes, however, it 
is capable of storing its body fat mainly in the form of triglycerides, which is similar to the 
mammalian body fat (Mullaney and Ashrafi, 2009). Several authors have revealed using whole 
animal staining assays with lipophilic dyes that C. elegans body fat is mostly stored in the intestinal 
and skin-like hypodermal cells (Mullaney and Ashrafi, 2009; Mak, 2012). Despite the lack of tissue 
specialisation and compartmentalisation that exist in mammalians, many essential pathways 
required in mammals can also be found phylogenetically preserved in C. elegans to some degree; 
examples include, insulin-like signalling, serotonin signalling, TOR signalling and core metabolic 
pathways including mitochondrial β-oxidation and fatty acid synthesis, elongation and 
desaturation (Apfeld and Kenyon, 1999; Srinivasan et al., 2008; Soukas et al., 2009; Van et al., 2005; 
Watts and Browse, 2002). 
The life cycle of C. elegans is short and temperature dependent. After embryogenesis, which 
partially takes place in the hermaphrodite body and partially outside, the L1 larva hatches. In the 
presence of food, the worm should go through 4 larval stages (L1–L4) and finally develops into an 
adult worm. After which the cycle repeats. 
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Figure 16 
Life cycle of Caenorhabditis elegans at 22°C. 0 min is fertilization. Numbers in blue along the arrows indicate 
the length of time the animal spends at a certain stage. First cleavage occurs at about 40 min. post-
fertilization. Eggs are laid outside at about 150 min. post-fertilization and during the gastrula stage. The 
length of the animal at each stage is marked next to the stage name in micrometers (μm). Figure taken 
from www.wormatlas.org and used under Creative Common Licence. (Altun and Hall, 2009.). 
As demonstrated in the figure above, if the conditions are unfavourable, the larva might enter the 
dauer stage. Animals in the dauer stage are very resistant to miscellaneous types of stresses. Genes 
that regulate entry into the dauer phase are strongly linked to ageing and longevity (Inoue et al., 
2007; Hu et al., 2006). Larval development can even be arrested at the L1 stage (Baugh, 2013). The 
normal life span is around 2–3 weeks but under laboratory conditions, the lifespan may be longer 
and it depends on conditions (temperature, food availability, etc.). 
  
 48 
Study reasoning and strategy 
Firstly, we chose to study the NR complement in probably one of the most basal metazoans, 
Trichoplax adhaerens, to address the question, whether the ligand-binding capability of NRs 
already existed at the base of animal evolution. And thus, provide information about the potential 
of NR-Mediator pathway to directly translate stimulus to gene expression. 
We then asked how could a highly conserved pathway be also highly plastic, i.e. have an ability to 
adopt new regulatory functions over time in the course of evolution. C. elegans model system 
presented an excellent opportunity due to its recent phylogenetically expanded NR complement 
(Vohanka et al., 2010; Kostrouchova and Kostrouch, 2015), yet a relatively preserved Mediator 
complex (Grants et al., 2015). Moreover, it is a robust biological model system. 
In our previous research, we had looked at structurally restricted proteins (localised to a specific 
part of the cell) having the potential to transmit the cellular status (of that part the cell) to the 
nucleus and influence gene expression. Due to the central position of the Mediator complex in 
transcriptional regulation we searched for a member of the Mediator complex that may also 
possess a similar ability to act as sensor of cellular states and transmit this towards the 
transcriptional machinery. Until now, the only member known to be displaying such potential was 
the Mediator subunit 28 – MED28 (Sato et al., 2004; Beyer et al., 2007; Wiederhold et al., 2004; Lu 
et al., 2006; Huang et al., 2012a). Furthermore, the originally annotated MED28 orthologue in C. 
elegans (W01A8.1) had not been studied. This prompted a basic comparative protein sequence 
analysis of W01A8.1 with other known vertebral MED28 orthologues. The analysis showed a 
minimal sequence homology (MED28 domain) and suggested a possible divergent evolution of the 
nematode orthologue. Nevertheless, we reasoned that although it is possible that the nematode 
orthologue diversified during evolution, it would require strong evolutionary pressure because 
such a change could hinder the primary function of an essential member of the Mediator complex 
despite contributing towards the plasticity of the Mediator complex. The characterisation 
W01A8.1 in C. elegans could point towards newly evolved mechanisms of gene regulation in 
nematodes. 
However, other possibilities should also be considered in case W01A8.1 would not share the 
common characteristics of a MED28 orthologue, such as the existence of an undescribed true 
orthologue. 
Lastly, upon the existence of a true MED28 orthologue functioning independently to W01A8.1, the 
assessment of W01A8.1 regarding the involvement in the NR-Mediator pathway would shed light 
upon potential overlapping roles.  
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Methods and Materials 
This section of the dissertation is compiled using three different original research publications 
namely Novotný et al. (2017); Chughtai et al. (2015); Kostrouchová et al. (2017). In order to avoid 
unnecessary repetition, I have summarised the underlying principles of the techniques and 
methods employed in all of the above-mentioned publications. For specific details on the 
procedures, I refer to the original articles themselves. 
Animal culture, strains, transgenic lines and genome editing 
In three publications, various strains of the nematode species C. elegans were used. As wild type 
animals, N2 (var. Bristol), were used unless otherwise noted and all strains were maintained as 
described by Brenner (1974). Some of the strains and transgenic lines used in the conducted 
experiments were requested from other research groups and a number of them were created 
through genetic engineering techniques namely CRISPR/Cas9 technology. 
Transgenic lines were prepared using microinjections into gonads of young adult N2 
hermaphrodites as described by Tabara et al., (1999); Timmons et al., (2001); Vohanka et al. 
(2010). Most injections also included mCherry co-injection markers: pCFJ90, pCJ104 and 
pGH8 Dickinson et al., (2013). 
Regarding Trichoplax culture, the animals were cultured in Petri dishes containing filtered artificial 
seawater (Instant Ocean, Spectrum Brands, Blacksburg, VA, USA) with a salinity of approx. 38–40 
ppt. Rhodomonas salina (strain CCAP 978/27), Chlorella sp., Porphyridium cruentum (UTEX B637) 
and other non-classified algae, as well as aquarium milieu established in the laboratory by mixing 
salt water obtained from a local aquarium shop were used to maintain the stock. The cultures were 
kept at approx. 23°C and an automated illumination for 12h/day was used with a conventional light 
bulb on a daylight background from late spring to mid-summer in the laboratory located at 
50.07031N, 14.42934E with laboratory windows oriented eastward. The natural illumination 
included almost direct morning light from 8 AM to 10:30 AM, indirect sunlight for most of the 
daytime and sunlight reflected from a building across the street from 1 PM to 6 PM. Algae were 
maintained as described (Kana et al., 2012; Kana et al., 2014). The experiments were performed 
predominantly during sunny weather. 
Principle and implementation of CRISPR/Cas9 technology in C. elegans 
The discovery and implementation of the clustered regularly interspaced short palindromic repeats 
(CRISPR)-Cas9 system for genetic engineering has completely revolutionised the study of gene 
function not only in Caenorhabditis elegans but also in other organisms (Wang et al., 2016). The 
system allows for the creation of precisely targeted mutations in endogenous genes, this allows 
investigators to examine the relationship between gene function and phenotype. By inserting 
desired coding sequences for a marker or fluorescent protein, the expression and localisation of 
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endogenous proteins can be monitored. The biggest caveats of classical methods, such as extra-
chromosomal arrays have been unintended over-expression and silencing. Reporter gene fusions’ 
versatility has dramatically been enhanced. By inserting a fluorescent protein (FP) into the 
endogenous locus one can use phenotypic assays to access the viability and functionality of the 
resulting fusion protein. Taken together, these advantages allow for more control over 
experiments and consequently greater confidence in the results obtained. An added benefit, apart 
from having transgenes or intended modifications being integrated into the genome, is the fact 
that the CRISPR/Cas9 system is technically easier to implement i.e. no need for microparticle 
bombardment (Praitis et al., 2001) and is universal i.e. no need to special background stains as 
need by the Mos1 transposon system (Robert and Bessereau, 2007; Frøkjær-Jensen et al., 2008; 
Frøkjær-Jensen et al., 2010; Frøkjær-Jensen et al., 2012). 
There are some recent landmark publications highlighting the ease, versatility and time efficiency 
of the CRISPR/Cas9 system in C. elegans. A variety of different approaches have been developed 
for C. elegans and in general, all of these are effective to various degrees, with different strategies 
being best suited to depending on the experimental goal. In principle, one can now make any 
desired change to the C. elegans genome in a matter of weeks. Here I provide a summary of the 
principle of the technique based on the following publications Dickinson et al. (2013); Dickinson et 
al., (2015); Arribere et al., (2014); Zhao et al., (2014); Paix et al., (2015); Dickinson and Goldstein, 
(2016); Ward, (2015). 
The Cas9 is an endonuclease that can be found in Archaea and bacteria where it has evolved as an 
immune defence against phages and plasmids (Hsu et al., 2014). Restriction endonucleases’ 
protein structures recognise particular DNA sequences e.g. BamH I binds DNA at 5’-GGATCC-3’, 
however, the specificity of Cas9 is determined by the sequence of an associated small RNA 
molecule. In bacteria, Cas9 binds two small RNAs: a CRISPR RNA (crRNA), which determines the 
target specificity towards DNA and a trans-activating CRISPR RNA (tracrRNA) that base pairs with 
the crRNA and activates the Cas9 enzyme. For practical reasons one fuse the two to generate a 
chimeric single guide RNA (sgRNA) that allows Cas9 cleavage of DNA substrates (Jinek et al., 2012). 
The 20 base pair guide sequence at the 5ʹ end of the sgRNA directly responsible for the sequence 
cleaved by the endonuclease. The binding is based on the Watson–Crick base pair principle. Apart 
from having the bases paired with the target DNA, the enzyme has to interact with a protospacer-
adjacent motif (PAM) on the target DNA strand. The Cas9 endonuclease found in Streptococcus 
pyogenes is able to recognise the PAM sequence NGG (where N can be any base). To-
date Streptococcus pyogenes Cas9 is the most frequently used for experimental research. The Cas9 
endonuclease from Streptococcus pyogenes can be essentially programmed to cleave any desired 
nucleotide sequence that contains a GG dinucleotide, by simply modifying the sequence at the 5ʹ 
end of the sgRNA. The ease of programming is what makes Cas9 such a powerful and versatile tool 
for genome engineering. 
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Figure 17 
Outline of the basic working principle of the CRISPR-Cas9 system. A shows the Cas9 endonuclease and its 
relationship between sgRNA and target DNA. It recognizes its target DNA through approximately 20 
nucleotide base-pairing interaction between a single guide RNA (sgRNA) and the target DNA strand. Cas9 
also interacts with the protospacer-adjacent motif (PAM) of its DNA target through its PAM-interacting 
domain at its C-terminus. Cas9 uses its two nuclease domains (HNH and RuvC) to cleave the double-
stranded DNA, creating a DSB. The HNH, RuvC, and PAM-interacting domains, as well as an evolutionarily 
divergent wedge domain (WED), all reside in the Cas9 nuclease (NUC) lobe. B represents the plasmid used 
throughout our experiments and was requested developed by Dickinson et al., (2013). The plasmid contains 
a full Cas9 endonuclease gene with C. elegans specific promoter and UTR regions from efficient expression. 
The plasmid also contains a region for expressing sgRNA driven by a C. elegans RNA polymerase III 
promoter. C demonstrates the possible outcomes of Cas9 induced double-stranded breaks (DSBs). DSB 
can be repaired in two possible ways, one is known as non-homologous end joining, leading to random 
insertions/deletions/ORF-shifts, and the other homology-directed repair, ideally ending up with specific 
repair based on the donor DNA. The figures were modified with permission from Wang et al., (2016); 
Dickinson et al., (2013). 
Cas9 can generate a DNA double-strand break at a sequence-specific location within the genome. 
These double-strand breaks are useful because they let the researcher to make use of endogenous 
DNA repair machinery in the cell to generate custom modifications to the genome. Essentially two 
different types of DNA repair strategies have been employed to produce custom modifications in C. 
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elegans. As highlighted in the figure above, once a double-stranded DNA break is created there are 
two naturally occurring mechanisms involved in the repair of the break. One possibility is an error-
prone repair which known as non-homologous end joining (NHEJ) and the other option is template-
based recovery known as homology-directed repair (HDR). When DNA breaks occur for other 
natural reasons they are repaired using either of these mechanisms. By exploiting this pre-existing 
DNA repair system with the power of CRISPR/Cas9 directed breaks one can essentially achieve any 
desired genomic modification. As shown above, the NHEJ is a relatively simple way of repairing 
DNA after a break. Using this approach, the investigator is able to create random deletions or 
insertions or frame shifts, in other words, these changes lead to a gene sequence disruption when 
the Cas9 is directed to a specific gene sequence. 
We applied the NHEJ method to create a gene disruption in the W01A8.1 gene locus. We did this 
by constructing two plasmids carrying CRISPR/Cas9 system, based on Dickinson et al. (2013), each 
coding a sgRNA targeting the second and the sixth exon of the W01A8.1 gene. By doing so we were 
able, through the process of NHEJ repair after the Cas9 induced double-stranded break, to create 
a large deletion. The genomic map, CRISPR/Cas9 targeted sites as well the resulting PCR 
amplification of the deleted segment has been shown below (Figure 18). 
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Figure 18 
Generation of targeted deletions in W01A8.1 gene and selection with extra-chromosomal array. (A) shows 
the genomic region of W01A8.1 gene being targeted by CRISPR/Cas9 sgRNAs at two marked positions +. 
After selection, the mutant CK123 (bottom) was generated and the genomic segment between primers 
#8134 and #8135 was PCR amplified and the resulting amplicon was sequenced from both directions using 
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nested sequencing primers #8136 and #8137. It is clear from the sequencing alignment that a significant 
portion of the gene was disrupted while a small sequence, between the two sgRNA sites, was preserved. (B) 
represents the extra-chromosomal array used for selection with the CRISPR/Cas9 based deletion shown in 
(A). The plasmid is carrying a synthetic version of W01A8.1a fused to gfp and was used as a potential 
balancer if loss of W01A8.1 would be lethal. The plasmid was injected together with mCherry selection 
markers and CRISPR/Cas9 sgRNA plasmids. The sequence alignment and graphics were designed using 
SnapGene software.  
In our experiments, we also employed the HDR pathway with the CRISPR/Cas9 System. As 
illustrated in the diagram above there are multiple ways that the template/donor DNA can be used 
in conjunction with the targeted breaks i.e. for creating specific mutations, gene 
corrections/modification, knock-ins, etc. Under physiological conditions, cells tend to repair a DNA 
break of one chromosome using the homology of the second pair. Thus, when a specific 
modification is needed then one can custom design a sequence of interest, that needs to be used 
as repair template/donor DNA, to be introduced along with the Cas9/sgRNA. Modifications present 
in the repair template are then copied into the genome in an error-free manner. For the HDR to 
work one also has to introduce in the donor DNA with a flanking homologous sequence to the 
region of interest. For example, when a fluorescent protein (FP) tag at the C-terminus is required 
then the ideal location of the beak would be near the end of the gene. The donor DNA would 
contain the FP sequence flanked by about 500-600bp of the gene DNA sequence at the 5’ side and 
500-600bp URT of the gene as the flanking sequence on the3’ side. The image below illustrates the 
concept of flanking homology when introducing a knock-in in this FP being the desired insertion. 
As a note of caution the original DNA sequence to which the sgRNA was being targeted at must be 
altered in the donor DNA if this doesn’t happen by itself. 
 
Figure 19 
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Illustrating the basic concept of HDR. The donor DNA contains homology arms on either side of the desired 
insert sequence (FP). The length of the homology arm can vary. Various publications have used different 
length depending on the size of the insertion sequence. Sometimes the sgRNA targeting sequence isn’t at 
the perfect centre of the flanking region and is thus still present in either one of the homology arms. This 
needs to be mutagenised or modified in order to avoid Cas9 being targeted to the donor DNA.  
We also implemented the HDR technique in several of our experiments. In our experimentation, 
we modified the F28F8.5 gene locus based on the approach from Dickinson et al., (2015). The 
approach uses very large repair templates which also contain a rather large built-in positive 
selection system. Dickinson et al., (2015) refer to this as a Self-Excising Cassette (SEC). In the figure 
below the design of the SEC in relation to FP and a possible modification of the his-72 locus has 
been shown as demonstrated by Dickinson and Goldstein, (2016). In the shown example when the 
FP-SEC-3xFlag is inserted at the N-terminus of the his-72 gene it results in its disruption and no 
transcription of the gene should be possible from this locus as the promoter sequence is severed 
and a large foreign sequence has been inserted. The SEC contains genes and sequences that allow 
for positive selection (roll phenotype and hygromycin resistance) as well as heat shock inducible 
Cre/LoxP system. When the FP-SEC-3xFlag sequence has been inserted it represents an 
intermediate state where the expression of the native gene is blocked, the insert functions as a 
transcriptional reporter. Once the animals are heat shocked then the Cre/LoxP system is activated 
resulting in the removal of the SEC and the result is a fused FP with the protein of interest thus 
resulting in a translational fusion with a functional protein (if the FP doesn’t interfere with the 
natural function of the protein). The technique was used to create F28F8.5 heterozygote mutants 
as well as an N-Terminus fluorescent protein-tagged F28F8.5 line. The map of the genomic 
modification of F28F8.5 has been presented below (Figure 38). In further experimentation, we 
used the SEC method to also genetically modify the W01A8.1 gene to be tagged with a C-Terminus 
FP. 
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Figure 20 
The figure taken with permission from Dickinson and Goldstein, (2016) shows the gene tagging strategy with 
a self-excising selection cassette (SEC). (A) Design of a self-excising cassette for drug selection. SEC contains 
of a drug resistance gene (hygR), a visual marker [sqt-1(d)], and a heat inducible Cre recombinase (hs::Cre). 
SEC is flanked by LoxP sites and placed within a synthetic intron with a FP::3xFlag tag, so that the LoxP site 
that remains after marker excision is within an intron. (B) Illustration of the organization of the his-72 locus 
and the predicted transcripts from the gene before editing (top), after homologous recombination (middle), 
and after SEC removal (bottom). 
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Figure 21 
Schematic representation of the two types of genetic modifications created with CRISPR/Cas9 system. A 
shows the modified natural locus disrupting the F28F8.5 gene sequence. Here the locus is unable to express 
the mRNA of the F28F8.5 gene, instead, the promoter drives the gfp, thus transcribing free GFP like a 
transcriptional reporter. B shows the state of the locus after the removal of the SEC induced through heat 
shock driven by Cre-lox system. After the removal of the SEC, the modified locus is able to natively express 
F28F8.5 mRNA flagged at the 5’ end with gfp. 
Sequence analyses 
The predicted RXR gene models on JGI database (http://jgi.doe.gov/) (Nordberg et al., 2014) were 
screened for the characteristic molecular signature of the DNA binding domain (C-X2-C-Xl3-C-X2-
C-X15-C-X5-C-X9-C-X2-C-X4-C-X4-M) (Kostrouch et al., 1995) and the appropriate predicted gene 
model (protein ID 53515) was selected for further use. The alignments of different RXRs were 
performed by Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) (Sievers et al., 2014) and 
adjusted/exported as an image file using Jalview (http://www.jalview.org). Protein domain 
characterization was performed with SMART – a simple modular architecture research tool 
(Schultz et al., 1998; Letunic et al., 2014). Analysis of HNF4, ERR and COUP-TF were performed 
similarly. Phylogenetic analysis was done on RXR ClustalO alignment using PhyMLv3.1 (Guindon et 
al., 2010) implemented in SeaView v4.6.1 with a 100 bootstrap analysis and SPR distance 
computation. The tree was then visualized using FigTree v1.4.3. 
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Perilipin orthologues and W01A8.1 sequences were chosen from UniProt, NCBI and OMA 
(omabrowser.org) databases. Chordate and nematode sequences were aligned separately using 
the T-Coffee algorithm (Notredame et al., 2000) (server tcoffee.crg.cat) and submitted to PSI-
BLAST (Altschul, 1997) (E-value inclusion threshold <10−3, 5 iterations) and HHpred (Remmert et 
al., 2011; Agarwal et al., 2008) searches as implemented in MPItoolkit (toolkit.tuebingen.mpg.de). 
Repeat detection used HHrepID module in MPItoolkit. Alignments were displayed and analysed 
using Jalview app (www.jalview.org). 
MED28 orthologue sequences were searched in UniProtKB (uniprot.org) and NCBI 
(ncbi.nlm.nih.gov) with BLAST, PSI-BLAST (Altschul, 1997), HHblits (Remmert et al., 2011) and 
HHpred (Söding et al., 2005). The obtained mammalian and insect sequences were aligned using 
T-coffee (Notredame et al., 2000; Di et al., 2011), as well as PROMALS (Pei et al., 2007; Pei et al., 
2007a; Pei et al., 2008) and secondary structure predictions performed with PSIPRED (Jones, 1999; 
Cuff et al., 2000; McGuffin et al., 2000). 
Down-regulation of gene expression by RNA interference 
Down-regulation of any gene using RNA interference is a well-established technique and was not 
only initially discovered in C. elegans but also functions effectively and is easy to use. Several 
methods exist for C. elegans by which genes can be knocked down (Ahringer, 2006). In our 
experiments, we used the injection and the feeding method. We kindly request to refer to the 
original publications for specific details regarding each gene knocked down. The diagram below 
highlights different ways that the worm can be exposed to dsDNA, furthermore, it also illustrates 
the basic cellular pathways involved in the interference process. A summary of the mechanism has 
been published (Grishok, 2005).  In the experiments that we conducted, we used either the 
microinjection or the feeding method. It is believed that the injection method produces the highest 
knockdown effect. The microinjection method requires a gene-specific dsRNA to be produced 
using an in vitro method, we did use the commercially available SP6/T7 Riboprobe® in 
vitro Transcription Systems. After dsRNA is made it is directly injected into the C. elegans gonads. 
The feeding method uses a special strain of E. coli (HT115(DE3)), to produce dsRNA inside the 
bacteria guided by a plasmid encoding the RNA strands. When the worms are feed on the NGM 
plates layered with the E. coli expressing dsRNA, it is absorbed into the organisms spread 
systemically. Gene sid-1/ rsd-8 encodes a transmembrane protein that is known to be important 
for the dsRNA’s systemic spread. 
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Figure 22 
The figure shows the three commonly used techniques to expose C. elegans to specific dsRNA that first has 
to be generated either in vivo (in bacteria) or in vitro (using a transcription system). Once the dsRNA is taken 
up by the cells it forms complexes with several proteins to form the RISC complex (RNA-induced silencing 
complex). Image taken and modified from MLA style: Press release. NobelPrize.org. Nobel Media AB 2019. 
Fri. 22 Feb 2019. <https://www.nobelprize.org/prizes/medicine/2006/press-release/>.  
Fecundity and brood size assay 
Fecundity measurement following RNAi (injection method) was performed using a total of 50 
young adult worms (25 control and 25 inhibited by RNAi specific for W01A8.1). Progeny was 
counted 24 hours and at 48 hours after injections. Brood size assay was performed for W01A8.1 
disrupted animals and controls (n = 15 for each group). The progeny was determined over 6 days. 
The experiments were conducted at room temperature of ∼22 °C. 
Fecundity measurement after RNAi using feeding protocol was performed over two generations to 
maximize the knockdown effect. For this, a semi-synchronized population was isolated using 
standard WormBook bleaching protocol (http://www.wormbook.org/). Hatched L1 stage worms were 
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then placed on NGM agar RNAi (W01A8.1 specific and control) plates at ∼22 °C. Small, 
synchronized populations, of parents (P0) were transferred to fresh RNAi plates and allowed to lay 
progeny (F1). F1 generation animals were transferred to new RNAi plates and F2 generation was 
scored for a total of 21 F1 parents in each group. The experiments were repeated twice to confirm 
the results. 
RNA isolation and cDNA synthesis 
For RNA extraction from C. elegans, cultured nematodes were washed and collected in water. After 
which they were pelleted by brief centrifugation at 200 g. Depending on the exact experiment, 
either the pellet was frozen at -80°C after removal of excess water or directly used for RNA 
extraction. In both cases the pellet was re-suspended in re-suspension buffer (0.5% SDS; 5% 2-
mercaptoethanol; 10mM EDTA; 10mM Tris/HCl (pH 7.5) with proteinase K, gently mixed for 1 min 
and incubated for ca. 20 minutes at 55°C (the time and volume varied depending on the number 
of the worms in each pallet). After lysis TRIzol® Reagent (Invitrogen) was added to the mixture and 
the standard manufacturer’s protocol was followed to obtain total RNA. Samples were then 
treated with DNase I for ca. 30 min at 37°C and again TRIzol-chloroform or phenol-chloroform 
purified and finally precipitated with ethanol the to obtain DNA free total RNA in DEPC water. 
For Trichoplax RNA extraction, several animals were removed and added to TRIZol reagent 
(Invitrogen) and simply mixed until dissolved. After which the standard manufacturer’s protocol 
was used for cDNA synthesis (same as mentioned above for C. elegans). 
Human total RNA was also extracted using TRIzol® Reagent (Invitrogen) from peripheral blood 
lymphocytes and fat tissue under standard manufacturer guidance. 
Complementary DNA (cDNA) was prepared with SuperScript® III First-Strand Synthesis System 
(Invitrogen) using random hexamers and/or oligo(dT) priming based on the standard manufacturer 
guidance. 
Single or multiple worm DNA analysis 
Single animals were placed into 5 µl of worm lysis buffer (10mM Tris–HCl pH 8.3, 50mM KCl, 2.5mM 
MgCl2, 0.45% NP-40, 0.45% Tween 20, 0.01% Gelatin and 500µg/ml fresh proteinase K) in a PCR 
tube. The tube was then frozen at -70°C to -80 °C for 5 min (or longer) before placing the tube into 
a thermal cycler and run under the following conditions: heated to 60°C for 60min to allow for 
worm lysis. Then the proteinase K is inactivated by heating to 95°C for 15-20 mins. Post-lysis, the 
samples were either directly used or stored for later analysis by PCR. For the PCR, a reaction mix 
(45µl) targeting the template of choice was added and cycled for ∼35 times with Q5® Hot Start 
DNA polymerase (New England Biolabs). Similarly, genomic DNA was prepared from selected 
nematode culture plates and used for further screening by PCR and sequencing. 
Transcript quantification 
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For quantitative RT-PCR, the technique described by Ly, Reid, and Snell (2015) was used with 
modifications. For the determination of W01A8.1 and F28F8.5 transcripts we used the Roche 
Universal Probe Library technique (Hoffmann-La Roche, Basel, Switzerland). Universal probe library 
and primers designed with the help of ProbeFinder Assay Design Software were used and qPCR 
was run on LightCycler 2.0 purchased from Roche (Roche, s.r.o. Prague, Czech Republic). An 
average of three sample cDNAs and three control cDNAs were analysed, all containing the same 
amount of RNA for RT for each experiment. The expression of W01A8.1 and F28F8.5 was 
normalized to ama-1. 
The Droplet digital PCR based measurements were performed on a QX100 Droplet Digital PCR 
System (Bio-Rad Laboratories, Hercules, CA, USA). ddPCR was used for accurate quantification of 
small amount RNA obtained from cultured T. adhaerens. For each set of experiments about 4 to 
10 animals were used. 
The quantification was used to determine the effectiveness of RNAi (for W01A8.1 gene) as well as 
to determine the true loss of F28F8.5 gene expression. For the quantification of the expression 
of F28F8.5 in homozygous mutants compared to N2 wild-type we a more efficient method to 
reduce RNA and cDNA loss as the starting samples were very little. Five adult homozygous animals 
with the edited disrupted F28F8.5 gene, recognised by the phenotype, and the same number of 
WT hermaphrodites with a minimum number of formed embryos were manually harvested and 
collected in separate Eppendorf tubes. The reverse transcription from these samples was done 
using the Maxima H Minus cDNA synthesis kit (Thermo Fischer, Waltham, MA, USA) as 
recommended by the manufacturer. 
The details of each of the experiments are thoroughly provided in each respective publication. 
LipidTox staining 
The lipid staining protocol was performed according to O’Rourke et al. (2009) with modifications. 
Approximately 200 – 500 animals were harvested from NGM plates with 1X PBS and washed 
several times to remove bacteria and pelleted at 1,500 g. To the pellet, 500µl 2X MRWB buffer 
(40mM NaCl, 14mM Na2EGTA, 160mM KCl, 0.4mM Spermine, 1mM Spermidine 3HCl, 30mM 
NaPIPES pH 7.4, 0.2% beta-ME) and 100µl of 20% paraformaldehyde were added and the volume 
was adjusted up to 1ml with 1X PBS. The tubes were inverted several times to mix the worms in 
solution after which they were allowed to fix for about an hour at room temperature with gentle 
shaking. 
Animals, after fixation, were then pelleted at 1,500 g and washed 3 times with 1ml Tris–HCl buffer 
(100mM, pH 7.4). After the third wash, the supernatant was discarded with a remaining volume of 
100µl to which 650µl of Tris-HCL buffer followed by 250µl of fresh/frozen reduction buffer (100mM 
Tris-Cl pH 7.4, 40mM DTT) was added. Worms were then left to shake for about 30mins at room 
temperature. Worms were washed 3 times in 1X PBS after reduction. After the final PBS wash, the 
volume was brought up to 0.5ml and then 0.5ml of LipidTox (Red) (1:500 dilution) (Invitrogen) was 
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added making a final volume of 1ml and concentration of 1:1000 of LipidTox. The worms were left 
in the dark for at least an hour shaking before viewing. 
Microinjections 
Microinjections of plasmids, DNA amplicons or dsRNA into gonads of young adult hermaphrodites 
were done using an Olympus IX70 microscope equipped with a Narishige microinjection system 
(Olympus, Tokyo, Japan). 
Microscopy and Imaging 
Fluorescence microscopy and Nomarski optics microscopy were done using an Olympus BX60 
microscope equipped with DP30BW CD camera (Olympus, Tokyo, Japan). For live imaging the 
worms were anaesthetized with levamisole and placed on a cover glass with a thin layer of 2% 
agarose. 
Coherent Anti-Stokes Raman Scattering Microscopy (CARS) 
The following diagram represents the working principle of the CARS microscopy used for lipid 
analysis in living cells as published by Potcoava et al., (2014). We utilised the method to analyse fat 
content in living animals. The CARS systems allow visualisation of lipids of specific categories by 
tuning into symmetric CH2 vibrations of specific fat composing molecules (Zumbusch et al., 2013). 
 
Figure 23 
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The Principle of Raman scattering mechanisms of (a) spontaneous Raman and (b) narrowband CARS shown 
by Jablonski diagram (energy level diagram). Arrows represent photons (longer length denotes higher 
photon energy), V is the vibrational level, ΩR is the resonant vibrational frequency of a given vibrational mode. 
For CARS, the laser source consists of two time-locked pulse trains of different wavelengths (pump + stokes) 
such that the difference in photon energy corresponds to the vibrational mode to be imaged. The anti-
Stokes photon is detected indicating the strength of the signal at a given vibrational mode. Image used 
from Potcoava et al., (2014) under Creative Commons Attribution 3.0 Unported License.  
The CARS images were acquired with a Leica TCS SP8 CARS system (Leica Microsystems, 
Mannheim, Germany) consisting of a TCS SP8 confocal microscope combined with a picoEmerald 
laser (APE, Berlin, Germany) offering a fixed Stokes laser line of 1064.5nm and a tuneable Pump 
line from an optical parametric oscillator (780nm to 940nm). A HC PL IRAPO 40x water immersion 
objective was used for the imaging and CARS signal was detected with a non-descanned photon 
multiplier tube detector at the transmitted light side. For imaging of CH2 vibration with a Raman 
shift of 2,868cm−1 pump wavelength of 815.5nm was used. The CARS signal was selected with a 
CARS2000 filter cube placed in front of the detector. Adult animals and embryos were completely 
scanned and recorded as stacks of focal planes. Recordings for quantitative analysis were done at 
fixed settings for mutant and wild type. 
Image analysis 
Single focal planes, containing the highest number of CARS positive structures, from stacks of 
representative embryos and adult hermaphrodites were selected and analysed using ImageJ 
computer program (http://imagej.nih.gov/ij/). Analysis of embryos was performed on images of 
seven mutant and seven wild type embryos inside gravid hermaphrodites (only one and two cell 
early embryonic stages were chosen for comparison). Analysis of adult somatic tissue was 
performed on the distal body region and we compared five different mutant adults with five 
different wild type adults. Automatic particle counting feature of ImageJ program was used for 
determinating the number and the area of CARS positive structures with manual thresholding as 
described on http://imagej.net/Particle_Analysis. Image area required for analysis was first selected 
(the area outside the selected zone was cleared) then the image was converted to an 8-bit scale. 
A manual threshold was applied with settings yielding the biggest number of individually 
recognisable structures (adult tissue threshold setting range was 36–200 and for embryos 11–13 
to 200). Overlapping structures were separated using the ‘Watershed’ command and also by 
the manual line draw feature. ‘Analyse particles’ command generated data sets containing the 
number and area of particles. Microsoft Excel 2003 was used to perform statistical analysis and 
two-tailed Student’s t-test for determining the p-value. Raw data sets are provided as supplement 
and labels in the Excel tables correspond to the marked images also provided as supplement. 
Confocal and Fluorescence-lifetime imaging microscopy 
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Confocal microscopy of live homozygous animals was performed using an inverted Leica SP8 TCS 
SMD FLIM system equipped with a 63× 1.2 NA water immersion objective, a pulsed white light 
laser (470–670 nm), AOBS and two internal hybrid single photon counting detectors, and operated 
by Leica Application Suite X program (Leica Microsystems, Wetzlar, Germany). The GFP 
fluorescence was excited at a wavelength of 488 nm and the emitted light was simultaneously 
recorded in two spectral ranges (Channel 1—495 nm to 525 nm, Channel 2—525 nm to 580 nm; 
the two-channel setup was used to help resolve between spectrally different autofluorescence and 
GFP fluorescence signals). 
Each fluorescent molecule has its own life in an excited state. By detecting differences in lifetime, 
it is possible to distinguish between various molecules present in a given sample. Furthermore, the 
technique can be employed to identify autofluorescence. Excited missions from fluorescent 
proteins like GFP tend to decay slowly compared to autofluorescence produced by other 
complements of the cells. 
 
Figure 24 
The basic concept of fluorescence lifetime imaging microscopy is that following pulsed excitation (from a 
light source such as a femto-second pulsed laser), the sample emission intensity decays exponentially. Time-
gated FLIM captures this decay curve by detecting the signals in a few gates and use the signals to fit the 
curve and calculate the decay characteristic time constant as the fluorescence lifetime. Figure adopted with 
permission from Chang et al., (2007).  
For FLIM acquisitions the single photon counting signal from the internal hybrid detectors, 
acquired during confocal acquisitions, was simultaneously processed by HydraHarp400 TCSPC 
electronics (PicoQuant, Berlin, Germany) and information about the arrival times of all photons 
was stored to a hard-drive in TTTR data format. TTTR is freely accessible 
at https://www.picoquant.com/images/uploads/page/files/14528/technote_tttr.pdf. The data structure, 
program description and user instructions are also freely accessible 
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at https://github.com/PicoQuant/PicoQuant-Time-Tagged-File-Format-
Demos/blob/master/PTU/Matlab/Read_PTU.m. The signal from both time-synchronized channels was 
added up. The false colour scale was used and is based on the average photon arrival time, with 
blue colour representing short lifetime and red colour long lifetime fluorescence (image found in 
original article). 
Protein synthesis and binding studies 
Bacterial and in vitro protein synthesis 
For the purposes of performing in vivo ligand-protein and protein-protein binding analysis we used 
standard commercially available synthesis systems. 
Bl21 pLysS bacteria were transformed with RXR cloned cDNA inserted into pGEX-2T vector 
(Amersham Pharmacia Biotech, Amsterdam, UK). Stocks of transformed bacteria were stored in 
8% glycerol according to the Novagen pET System Manual for protein expression. Bacteria were 
then scraped from stock and incubated in Liquid Broth (LB) with ampicillin (100µg/ml) and 
chloramphenicol (34µg/ml) overnight. The culture was then used to inoculate a 100ml of LB with 
antibiotics and grown to an optical density of OD600 = 0.6 to 0.8 at 37°C. After this the culture was 
induced with 100µl 1M IPTG (isopropyl-D-thiogalactopyranoside) (Sigma-Aldrich, St. Louis, MO, 
USA) and moved to 25°C (RT) for 5 hours. The culture was then centrifuged at 9,000 g for 15 
minutes, the supernatant discarded and the bacterial pellet was resuspended in 10 ml GST binding 
buffer (25mM Tris pH 7.5, 150mM NaCl, 1mM EDTA) with the addition of protease inhibitor (S8820 
Sigma Fast, Sigma-Aldrich, St. Louis, MO, USA or cOmplete™, EDTA-free Protease Inhibitor Cocktail, 
Roche, Basel, Switzerland). Bacteria were then lysed by 6 × 20 s ultrasonication on ice (50 watts, 
30 kHz, highest setting—100%) (Ultrasonic Processor UP50H, Hielscher Ultrasonics GmbH, Teltow, 
Germany) and subsequently incubated with 15 to 20mg glutathione agarose beads (Sigma-
Aldrich®) prepared according to manufacturer’s protocol. Incubation took place at 4°C for about 
10 hours after which the beads were washed according to instructions, resuspended in 
regeneration buffer (50mM Tris–HCl pH7.4, 120mM KCl, 1mM EDTA, 8% glycerol (v/v), 5mM DTT) 
or 50mM TRIS–HCl pH 7.4 + 9% (v/v) glycerol for subsequent thrombin (bovine plasma, Sigma-
Aldrich®) cleavage, if performed, and then adjusted for regeneration buffer conditions. GST-TaRXR 
was eluted from glutathione agarose beads using 10mM reduced glutathione (Sigma-Aldrich, 
StLouis, Mo, USA) in 50mM Tris–HCl buffer pH 8.0. The size of the GST-TaRXR fusion protein was 
checked by polyacrylamide gel electrophoresis. Thrombin cleavage was carried out at room 
temperatire for 4 hours and the quality of the purified protein was assessed by SDS-PAGE. 
The same protocol was used to synthesise the F28F8.5 protein in bacteria i.e. F28F8.5 coding 
sequence was cloned into pGEX-2T vector) and transformed into BL21 Escherichia coli cells and 
the production of protein was induced by isopropyl β-d-1-thiogalactopyranoside (IPTG) (Sigma-
Aldrich). The rest of the protocol was same as used above to produce GST-TaRXR. 
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The MDT-6 protein synthesis was performed by cloning the coding region of mdt-6 into pTNT 
vector (Promega, Madison, WI, USA) and expressed in the rabbit reticulocyte TNT-system 
(Promega, Madison, WI, USA) based on the standard manufacture’s guidance. The in vitro 
transcribed protein was labelled using 35S Methionine (Institute of Isotopes, Budapest, Hungary). 
The Mediator subunit MDT-30’s coding sequence was cloned into pET28a(+) vector (Addgene, 
Cambridge, MA, USA) and transformed into BL21 E. coli cells and induced by IPTG. The lysate from 
bacteria producing His6-MDT-30-FLAG was used directly or purified on HiTrap Chelating HP column 
(GE Healthcare, Chicago, IL, USA). Proteins produced by the TNT system or bacterial lysates of 
bacteria transformed with FLAG labelled Mediator subunits were incubated with glutathione–
agarose (Sigma-Aldrich, St. Louis, MO, USA) adsorbed with equal amounts of GST or GST-F28F8.5. 
Radioactive retinoic acid binding assay 
Radioactive 3H-labelled 9-cis-RA and 3H-labelled AT-RA were obtained from PerkinElmer 
(Waltham, MA, USA). Binding was performed in 100 µl binding buffer (50mM Tris–HCl pH7.4, 
120mM KCl, 1mM EDTA, 5mM DTT, 8% glycerol (v/v), 0.3% to 0.5% (w/v) CHAPS (3-[(3-
Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate, Sigma-Aldrich)) for 2 hours on 
wet ice in a dark room. Work with retinoids was always carried out under indirect illumination with 
a 60W, 120V yellow light bulb (BugLite, General Electric Co, Nela Parc, Cleveland Oh, USA) as 
described Cahnmann, (1995). The protein used for binding was either GST-RXR fusion protein on 
beads with about 375ng/assay and thrombin-cleaved RXR. For estimation of specific binding, 200-
fold-excess of either 9-cis-RA or AT-RA (Sigma-Aldrich) was used. In case of GST-RXR fusion protein, 
50 µl of the supernatant was removed after 30 sec at 1300 g and washed 3x with 1000µl wash 
buffer (50mM Tris–HCl pH7.4, 120mMKCl, 1mM EDTA, 5mM DTT, 8% (v/v) glycerol, 0.5% (w/v) 
CHAPS) removing 900µl after each wash. For cleaved RXR protein, 10µl hydroxyapatite slurry (AG-
1 XB Resin, Bio-Rad, Hercules, CA, USA) suspended in binding buffer (12.7mg/100µl) were added 
to the assay and mixed twice, collecting the apatite slurry by centrifugation (15s at 600 g). 95µl of 
the supernatant was removed and the slurry washed twice with 1ml of wash buffer, removing 
900µl after each wash. The radioactivity of the GST-fusion protein and cleaved protein was 
measured using Packard Tri-Carb 1600TR Liquid Scintillation Analyzer (Packard, A Canberra 
Company, Canberra Industries, Meriden, CT, USA) and Ultima Gold Scintillation Fluid (PerkinElmer, 
Waltham, MA, USA). The fraction of bound 3H-labelled 9-cis-RA and 3H-labelled all-trans-RA was 
determined as a ratio of the bound radioactivity of precipitated GST-TaRXR/total radioactivity used 
at the particular condition (determined as the sum of bound radioactivity and the total radioactivity 
of collected wash fluids) in the absence of non-radioactive competitors or 200-fold-excess of 9-cis-
RA and all-trans-RA in the case of 3H-labelled 9-cis-RA and 40-fold-excess of non-radioactive 
competitors in the case of 3H-labelled all-trans-RA (to compensate for the higher affinity of 9-cis-
RA compared to all-trans-RA in binding to TaRXR). 
 67 
Radioactive protein interaction assay 
The basic principle was to incubate the radioactively labelled mediator subunits with GST-tagged 
F28F8.5. As mentioned before, 35S Methionine labelled MDT-6 was translated using the rabbit 
reticulocyte TNT-system (Promega). While the FLAG-labelled MDT-30 was expressed from 
pET28(+) in BL21 E. coli. Proteins produced by the TNT system or bacterial lysates of bacteria 
transformed with FLAG labelled Mediator subunits were incubated with glutathione–agarose 
(Sigma-Aldrich) adsorbed with equal amounts of GST or GST-F28F8.5. 
The resulting samples (labelled proteins bound to GST- or GST-F28F8.5) were separated by 
polyacrylamide gel electrophoresis. 35S-MDT-6 was visualized by autoradiography and 
subsequently, the gel containing radioactively labelled protein was localised using superimposed 
autoradiograms, excised and the radioactivity determined in the scintillation detector. FLAG-
labelled MDT-30 was determined by Western blot using an anti-FLAG antibody (monoclonal anti-
FLAG, M2 (Sigma-Aldrich) and quantified densitometrically by ImageJ computer program 
(https://imagej.nih.gov/ij/download.html). 
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Results 
The results presented have been divided into three parts, each part corresponds to an article 
published by myself in collaboration my colleagues. 
Results of Part I 
The following section was reprinted and modified under the Creative Commons CC-BY 4.0 license 
from Novotný et al. (2017). Only the most relevant parts, contributing to the philosophy of this 
dissertation, have been shown here. 
Trichoplax adhaerens retinoid X receptor is highly conserved 
Searching the JGI's (Joint Genome Institute of the U.S. Department of Energy) Trichoplax genome 
database allowed us to identify a RXR orthologue as well as verify the full length transcript 
containing the DBD and LBD. The sequence was previously not annotated as the 'best model'. 
Protein Blast analysis showed a high sequence similarity to mammalian RXR (human and mouse) 
with 66% overall sequence identity to human RXR alpha. 
SMART (a simple modular architecture research tool) analysis of the proposed RXR sequence 
in Trichoplax showed a zinc finger DNA binding domain (amino acid residues 16–87) and a ligand 
binding domain (amino acid residues 155–342) with E values <10−40. Blast analysis of the zinc finger 
DBD and LBD revealed a sequence identity of 81% and 70% to human RXR alpha, respectively. Each 
of these domains contained the predicted molecular pattern characteristic for each one. As shown 
below (Fig. 25) the heptad repeat LLLRLPAL, proposed for dimerization activity (Forman and 
Samuels, 1990; Forman and Samuels, 1990a), as well as the LBD signature for 9-cis-RA binding Q-
x(33)-L-x(3)-F-x(2)-R-x(9)-L-x(44)-R-x(63)-H (Egea et al., 2000) were present. From the eleven AA 
residues known to be critical for 9-cis-RA binding (A271, A272, Q 275, L 309, F 313, R 316, L 326, A 
327, R 371, C 432, H 435) nine are conserved and the remaining two amino acids are substituted 
(A327S, and C432T (C432A in Tripedalia cystophora)). This data showing a high sequence identity 
allowed us to hypothesise that the RXR in Trichoplax has similar, if not same, 9-cis-retinoic acid 
binding capability as well as DNA binding capability. 
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Figure 25 
Multiple sequence alignment of selected metazoan homologues of RXR compared with Trichoplax RXR. 
Sequences were aligned with ClustalO, AA residue types coloured according to Clustal scheme in Jalview. 
Sequences from top to bottom (organism, identifier): Trichoplax adhaerens, TaRXR ID 53515; Homo 
sapiens, sp|P19793|RXRA_HUMAN; Homo sapiens, sp|P28702|RXRB_HUMAN; Homo sapiens, 
sp|P48443|RXRG_HUMAN; Xenopus laevis, RXR alpha, sp|P51128|RXRA_XENLA; Aurelia aurita, RXR, 
tr|S5ZWR0|S5ZWR0_AURAU Retinoid X receptor; Tripedalia cystophora, RXR, tr|O96562|O96562_TRICY 
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Retinoic X receptor; Drosophila melanogaster, USP, sp|P20153|USP_DROME. DNA binding domain (DBD, 
red line), Ligand binding domain (LBD, green line), dimerization domain (yellow line) and amino acid 
residues critical for 9-cis-RA binding (conserved—red rectangles, not conserved—pink rectangles) are 
indicated. To allow for specific colour preferences one may download the compared sequences 
(downloadable from the original article's supplementary data) and create the Clustal scheme with different 
colour specifications using the Jalview program (http://www.jalview.org/). 
RXR of Trichoplax adhaerens has conserved ligand binding ability 
To analyse the binding properties of RXR in Trichoplax, we expressed RXR from Trichoplax as a GST-
fusion protein (GST-TaRXR) in bacteria. The fusion protein was then purified and used directly for 
binding studies or cleaved by thrombin and eluted as TaRXR. The binding of 3H-labelled 9-cis-RA 
or 3H-labelled all-trans-RA was determined by measuring total bound radioactivity and the 
radioactivity displaceable by 200-fold excess of non-radioactive competitors. The experiments 
showed that TaRXR (cleaved version) or GST-TaRXR bind 9-cis-RA with high affinity and specificity 
(Fig. 26A and B) which is consistent with the highly conserved LBD. The 9-cis-RA binding assay 
showed high affinity binding to GST-TaRXR with a saturation plateau from 5nM to 10nM (Fig. 26C). 
However, all-trans-retinoic acid was unable to show high affinity binding to GST-TaRXR. 
 
Figure 26 
In vitro binding of retinoic acids to RXR from T. adhaerens. A) Single point analysis of binding preference 
of T. adhaerens RXR (thrombin cleaved) to 3H-labelled 9-cis-RA over all-trans-RA. Radioactive 9-cis-RA (9-cis-
RA∗) binds at a concentration of 4nM to 200 nanograms of T. adhaerens RXR. 200-fold excess of 
unlabeled 9-cis-RA displaces more than 80% of labelled 9-cis-RA from binding to T. adhaerens RXR (9-cis-
RA∗  + 9-cis-RA) while the same molar excess of all-trans-RA (9-cis-RA∗ + AT-RA) which is likely to contain 
approximately 1% spontaneously isomerized 9-cis- RA, competes away less than 50% of bound 3H-labeled 
9-cis-RA. Radioactive 3H-labeld all-trans-RA (AT-RA∗) at identical conditions binds only slightly more than the 
observed non-specific binding. This interaction is not displaced by the excess of non-labelled 9-cis-RA (AT-
RA∗ + 9-cis-RA) nor non-labelled all-trans-RA (AT-RA∗ + AT-RA). Results are expressed as a ratio of the 
radioactivity bound to TaRXR/total radioactivity used for the binding at the given condition. (B) Analysis of 
binding properties of T. adhaerens RXR (in the form of GST-TaRXR) to 3H-labelled 9-cis-RA and 3H-labelled 
all-trans-RA. The experiment differs from the experiment shown in A in 5-fold greater amount of radioactive 
all-trans-RA (and therefore only 40-fold excess of non-radioactive competitors). The experiment shows 
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identical binding properties of GST-TaRXR as those observed with thrombin cleaved TaRXR. (C) Kinetic 
analysis of binding of 3H-labelled 9-cis-RA to T. adhaerens RXR prepared as GST-fusion protein (GST-TaRXR). 
The plateau is reached at around 3 to 5 × 10−9 M. 
9-cis-retinoic acid at nanomolar concentrations can induce gene 
expression of malic enzyme 
To show whether 9-cis-RA has an observable biological effect on T. adharens in vivo. As a known 
metabolic regulator in many other species we speculated that TaRXR is likely to be involved in the 
regulation of metabolic events. RXR is a dimerization partner of TR in mammals and together these 
two NRs are regulators of a wide range of metabolic pathways. We, therefore, searched for an 
orthologue of vertebrate L-malate-NADP+ oxidoreductase (EC 1.1.1.40) in T. adhaerens genome 
since this enzyme is an established reporter of the state of thyroid hormone dependent regulation 
(Dozin et al., 1985, Dozin et al., 1985a, Petty et al., 1990). 
The sequence of the T. adhaerens likely orthologue of vertebrate L-malate-NADP+ oxidoreductase 
was retrieved from the Trichoplax genomic database together with its presumed promoter based 
on the predicted sequence. 
A highly sensitive method of quantitative PCR (Droplet digital PCR) showed an increased 
transcription of the predicted L-malate-NADP+ oxidoreductase gene after incubation of T. 
adhaerens with 9-cis-RA, but not with all-trans-RA. In repeated experiments, we observed that the 
level of induction was higher at 9-cis-RA concentrations in the range of 1 to 10nM, than above 
10nM. We also noticed that the level of the induction slightly varied based on the actual T. 
adhaerens cultures and the algal food composition of the T. adhaerens cultures. 
 
Figure 27 
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The effect of 9-cis-RA on the expression of the T. adhaerens closest putative homologue and likely 
orthologue of L-malate-NADP+ oxidoreductase (EC1.1.1.40). Ten to fifteen animals were cultured in the 
dark overnight with indicated ligands or in medium containing only the solvent used for ligand solutions. 
Total RNA and cDNA were prepared using identical conditions and diluted to the same working 
concentration suitable for ddPCR. In repeated experiments, incubation with 3nM 9-cis-RA induced 
expression of the putative T. adhaerens L-malate-NADP+ oxidoreductase more than four times. Incubation 
with 30nM 9-cis-RA induced enzyme expression also, but to a lesser extent and 30nM all-trans-RA (AT-RA) 
did not upregulate the expression of the predicted L-malate-NADP+ oxidoreductase. 
Results of Part II 
The following section was reprinted and modified under the Creative Commons CC-BY 4.0 license 
from Chughtai et al., (2015). The most relevant parts (including some supplementary data) have 
been shown here. 
W01A8.1 shows structural similarities to vertebrate perilipins 
The mdt-28 gene in the C. elegans database (W01A8.1) was known to code for three possible 
isoforms of the protein MDT-28, these were labelled as isofrom a, b and c (Fig.28). Each of the 
isofrom of the protein was much larger in terms of sequence and mass compared to its putative 
orthologues in mammals. The human MED28 is only 178 amino acid long, as opposed to W01A8.1, 
who’s smallest isofrom (b) is actually 385 amino acids long. This extra length was already a 
surprising fact for us and certainly made W01A8.1 an interesting target of the investigation. 
 
Figure 28 
This is a scheme of W01A8.1 gene, expressed isoforms and preparation of gfp tagged transgene by SOEing 
PCR. Three different protein isoforms are expressed from the W01A8.1 gene. The gene and the expressed 
proteins are denominated as W01A8.1 a, b and c (as accessed in Wormbase WS 246 on March 14, 2015). 
The gene coding for GFP is inserted before the STOP codon in the 7th exon (marked as W01A8.1a/c::gfp) 
or in the 6th exon of isoform b (marked as W01A8.1b::gfp). The transgene based on the first construct 
(covering the upper two isoforms a and c) may lead to the expression of both isoforms a or c fused to GFP 
dependent on the cellular context and is likely to lead also to overexpression of untagged isoform b from 
the extra-chromosomal array. The genomic map was designed using SnapGene software (from GSL Biotech; 
available at snapgene.com).  
In UniProt Knowledgebase human mediator complex 28 (Q9H204) was submitted for BLASTp, PSI-
BLAST and DELTA-BLAST to find possible alignments. Unfortunately, this resulted in no significant 
matches. We then tried a reverse bioinformatic approach and submitted W01A8.1 as a query 
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in BLASTp, PSI-BLAST and DELTA-BLAST. This however also resulted in no targets with a significant 
score. When running Conserved Domain search by submitting W01A8.1a sequence as a query we 
were able to identify two different domains: a MED28 belonging to MED28 superfamily domain a 
Perilipin domain belonging to the Perilipin superfamily domain. 
 
Figure 29 
Conserved Domain Database search excerpt with W01A8.1a (Wormbase sequence) as submitted query. 
The results show two possible domains one belonging to the Perilipin superfamily and the other to the 
MED28 superfamily.   
Despite these non-specific results when a sequence alignment of chordate perilipins 2 and 3 (OMA 
database) was submitted as a query in PSI-BLAST, the C. elegans protein W01A8.1a 
(Q23095_CAEEL) was identified as a highly significant hit (E = 3 × 10−13). A reciprocal PSI-BLAST 
search with the aligned closest nematode homologues of W01A8.1a identified chordate perilipins 
as strong hits with human Perilipin 2 (significance score E = 10−53) appearing in the second iteration 
of the search. Similarly, HHpred profile-to-profile searches with human Perilipin sequences as a 
query of the C. elegans proteome identified proteins coded by W01A8.1 (a, b or c) and reciprocally 
W01A8.1a showed profile homology to all human Perilipins and the corresponding Pfam (Punta et 
al., 2012) Perilipin profile (PF03036). Each available nematode proteome contained only a single 
such Perilipin-related sequence, in stark contrast to the insect and chordate proteomes that had 
2–5 Perilipin paralogues. A sequence alignment of Plin2 and 3 from two selected vertebrates has 
been compared with their nematode homologues. Although the sequence-to-sequence 
comparisons are not sufficient to unravel the sequence homology between vertebrate and 
nematode Perilipin, the similarity appears clearly in the profile-to sequence (PSI-BLAST) and 
profile-to-profile (HHpred) searches. We can conclude that vertebrate Perilipins and the nematode 
W01A8.1 protein show a high degree of statistical homology. 
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Identification of C. elegans protein W01A8.1a as a close orthologue of vertebrate Perilipin. C. elegans 
protein W01A8.1a is compared with nematode orthologues of pairwise sequence identity lower than 70% 
Figure 30 
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and with Plin2 and Plin3 from two diverse vertebrates. Three Perilipin specific domains can be identified 
(marked as red) were identified through homology with human Plin3. The six 11-mer repeats in the 
W01A8.1a were established using the HHrepID algorithm (Biegert and Söding, 2008). The N-Terminal PAT 
domain is through to interact with hormone-sensitive lipase (HSL). The central domain consisting the 
imperfect 11-mer repeats forming amphipathic helices and the apolipoprotein-like 4-helix bundle is known 
to be responsible for the LD affinity and the later has been reported to interact with ABDH5 in mammalian 
Plin1 and 3 (Brasaemle, 2007). Alignment was done using T-coffee alignment of all available nematode 
sequences aligned with vertebrate Plin2 and 3 sequences in three iterations using ProfileAlign routine in 
MyHits suite (myhits.isb-sib.ch). Selected sequences from top to bottom: (Species, database 
identifier): Caenorhabditis elegans, Q23095; Strongyloides ratti, CACX01001972.1; Loa loa, E1G5Y0 and 
ADBU02007219.1; Haemonchus contortus, CDJ80228.1; Bursaphelenchus xylophilus, 
CADV01008520.1; Heterorhabditis bacteriophora, ES742365.1 and ACKM01001830.1; Ascaris suum, 
U1NU60; Homo sapiens 2, PLIN2_HUMAN; Homo sapiens 3, PLIN3_HUMAN; Latimeria chalumnae 2, 
H3AYC0; Latimeria chalumnae 3, GAAA01019375.1. Nucleotide sequences were translated with Wise2 
program (Birney et al., 2004). Amino acid types are coloured according to the Clustal scheme 
(jalview.org/help/html/colourSchemes/clustal.html).  
The alignment encompasses a substantial part of C. elegans and human sequences (e.g., 90% of 
W01A8.1 and 87% of Perilipin 2) and covers all three domains characteristic for perilipins (N-
terminal PAT, imperfect amphiphilic 11-mer repeat (Brasaemle, 2007) and C-terminal four-helix 
bundle (Hickenbottom et al., 2004) covering approximately amino acids 10–100, 125–190 and 
220–380 respectively in W01A8.1a. As W01A8.1 and human perilipins appear to be the best mutual 
reciprocal PSI-BLAST and HHpred hits, W01A8.1 is a very good candidate for a C. 
elegans orthologue of Perilipin. 
Protein databases annotated W01A8.1 as Mediator Complex subunit 28, hence the official protein 
name assignment of MDT-28 in WormBase (WS246). Pfam database (Punta et al., 2012) based the 
Mediator 28 Hidden Markov model profile on a seed alignment of bovine and mosquito Mediator 
28 sequences with W01A8.1. This very profile was probably used subsequently in all automatic 
annotations of the nematode sequences. However, no substantial homology between W01A8.1 
and Mediator 28 exists as shown in the above searches. Since using the WormBase name of 
W01A8.1 (MDT-28) would be misleading, the gene is referred here by the cosmid name W01A8.1, 
which gives rise to at least three protein isoforms designated W01A8.1a, W01A8.1b, and W01A8.1c 
from at least seven different transcripts 
(W01A8.1a.1, W01A8.1a.2, W01A8.1b.1, W01A8.1b.2, W01A8.1b.3, W01A8.1c.1, W01A8.1c.2). 
The three protein isoforms are 415, 385, and 418 amino acid residues in length for isoform a, b, 
and c, respectively. According to the C. elegans nomenclature, we suggest to 
rename W01A8.1 as plin-1 (isoform a, b, and c) and proteins PLIN-1 (isoform a, b, and c). 
W01A8.1 protein is cytoplasmic and reside primarily on lipid droplets 
If the proteins encoded by W01A8.1 act as perilipins, they would be expected to be associated with 
lipid droplets (Kozusko et al., 2015). To test this, we created translational reporter transgenes 
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regulated by the putative endogenous promoter expressing isoform b and lines in which the 
genomic locus was tagged by an in-frame C-terminal GFP cassette (Fig. 28). The second transgene, 
W01A8.1a/c::gfp, is likely to express not only high levels of a and c tagged isoforms, but also the 
native isoform b. The translational fusion constructs resulted in high levels of cytoplasmic proteins 
present in intestinal and epidermal cells on vesicular structures with the characteristic appearance 
of lipid droplets. This pattern of expression and cellular distribution was observed beginning at the 
three-fold embryonic stage and continued throughout development to adulthood (Fig. 31). To 
confirm that the observed GFP-associated vesicular structures were indeed lipid droplets, 
transgenic animals were stained with the lipophilic reagent LipidTox as previously 
described (O’Rourke et al., 2009). The translational GFP fusion protein reporters were localised at 
the periphery of fat droplets that were LipidTox positive. 
 
Figure 31 
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The expression W01A8.1::gfp reporter genes in transgenic strains. W01A8.1a/c::GFP is shown in (A, C, E, 
G), and (I), and corresponding areas in Nomarski optics are shown in (B, D, F, H) and (J). (A) The onset of 
expression of W01A8.1a/c::GFP in epidermal cells and in intestinal cells of the three-fold embryo. (C) The 
expression of W01A8.1a/c::GFP in intestinal cells of an L2 larva. (E) and (G) W01A8.1a/c::GFP expression in 
epidermal cells and intestinal cells of a young adult hermaphrodite. (G) GFP fluorescence around lipid 
droplet-like structures in the intestine that are marked by arrows and arrowheads. The corresponding image 
in Nomarski optics is in (H). (I) A higher magnification the lipid droplet-like structures in epidermal cells 
labelled by W01A8.1a/c::GFP (shown in Nomarski optics in the J). (K) Lipid droplets of an unfixed intestine 
labelled by W01A8.1b::GFP (corresponding Nomarski image is in L). (M, N) and (O) Part of the intestine of 
an adult larva expressing W01A8.1b::GFP (M) with the corresponding staining of lipid droplets by LipidTox 
(N). (O) LipidTox-positive lipid droplets (red) with W01A8.1b::GFP on the periphery (green) in this merged 
view. Bars represent 50 µm in (B, H, J, L) and (N) and 100 µm in (D) and (F).  
Human Perilipins label identical compartments as W01A8.1 protein 
in C. elegans 
We prepared transgenic C. elegans lines expressing human PLIN1, PLIN2 and PLIN3 fused to GFP 
and regulated by the W01A8.1 promoter. PLIN1::GFP and PLIN2::GFP were localised on spherical 
cytoplasmic structures primarily in gut and epidermal cells (Figs 32. A, C, D and F) with identical 
appearance as W01A8.1 translational reporter GFP tagged proteins and Drosophila PLIN1::GFP 
expressed in C. elegans as reported by Liu et al. (2014). PLIN3 expression was diffusely cytoplasmic 
and only faintly defined spherical structures (Figs 32. G and I). The structures clearly labelled with 
PLIN1::GFP and PLIN2::GFP were also positive in LipidTox staining (shown for PLIN2::GFP in Figs. J 
– L). We conclude that W01A8.1 is localised on the same structures as human PLIN1 and PLIN2. 
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Figure 32 
Expression of human perilipins fused to GFP in C. elegans. (A–C) Expression of human PLIN1::GFP in live 
transgenic C. elegans. PLIN1::GFP is localised on vesicles with an appearance of lipid droplets. PLIN2::GFP 
(D–F) is localised in transgenic animals on vesicular structures with an appearance of lipid droplets similarly 
as PLIN1::GFP. PLIN3::GFP (G, H and I) yields a more diffuse cytoplasmic pattern with faintly stained vesicular 
structures. (A, D) and (G) and details in (C, F) and (I) show GFP in fluorescence microscopy and (B, E) and 
(H) corresponding areas to (A, D) and (G) in Nomarski optics. (J, K) and (L) show PLIN2::GFP in fluorescence 
microscopy (J) in fixed C. elegans stained with LipidTox (K). The area indicated by the white rectangle in (J) 
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and (K) is magnified and merged for co-localization of PLIN2::GFP (green) and LipidTox (red) in (L). Arrows 
indicate lipid droplets clearly marked by GFP with the LipidTox positive content. Bars represent 50 µm.  
W01A8.1 knockdown alters the appearance of lipid droplets in early 
embryos and has an effect on brood size 
To test the function of W01A8.1, we used RNAi done by germline injection and by feeding. 
W01A8.1 RNAi made by microinjections and feeding resulted in significantly smaller brood size, 
with approximately 30% less progeny. RNAi made by microinjections resulted in ∼52% reduced 
progeny laid in the first 24 h after microinjections and after 48 h ∼28% reduction in progeny laid 
compared to controls (n = 260, n = 550, for day one and n = 1,000, n = 1,400 for day two). 
Repetition of knockdown by RNAi feeding over two generations confirmed this observation. dsRNA 
feeding caused the W01A8.1 specific group to produce ∼30% fewer larvae compared to controls, 
the experiment was repeated twice independently with consistent findings. We confirmed, using 
RT-qPCR, that feeding based knockdown resulted in approximately 45% decrease in W01A8.1 
transcripts (data not shown). 
 
Figure 33 
Analysis of the number of progeny after W01A8.1 gene inhibition by RNAi. The graph shows the knockdown 
effect of W01A8.1 gene on the amount of progeny compared to controls. Wild type animals were treated 
with RNAi (dsRNA feeding) directed against W01A8.1 for two generations and the amount of progeny was 
determined during a 24-hour period per one parent animal (21 parent animals were scored in both 
categories). The data presented here shows (y-axis) the average number of progeny per parent, n = 1,278 
and n = 1,813, respectively, p < 0.05. The SD is indicated. 
Staining of adult hermaphrodites with LipidTox (after formaldehyde fixation) revealed larger lipid 
droplets in early embryos derived from adults inhibited for W01A8.1 (Figs 34. A and B) compared 
to controls (Figs 34. C and D). 
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Figure 34 
Loss of W01A8.1 function results in abnormal lipid droplet appearance. (A) and (B) An embryo from a 
hermaphrodite inhibited for W01A8.1 function by RNAi. Large lipid droplets stained by LipidTox (B) are 
visible also in Nomarski optics (A) in contrast with a control embryo that has only small and more evenly 
distributed lipid droplets (C—Nomarski optics and D—LipidTox staining). (E–J, L) and (M) Images of structures 
observed in animals with disrupted W01A8.1. (E) and (F) show structures with the appearance of lipid 
droplets in the intestine of an animal with disrupted W01A8.1 balanced with the synthetic 
transgene W01A8.1(synth)::gfp. GFP tagged synthetic W01A8.1a is localised on lipid droplets-like vesicular 
structures (E). (F) Shows the same area stained with LipidTox. (G) Shows in magnification a merged image 
of the area indicated by white rectangles in (E) and (F). Arrows indicate W01A8.1(synth)::GFP labelled lipid 
droplets (green) positive for lipids in LipidTox staining (red). (H) and (I) show an embryo of a parent with 
disrupted W01A8.1 that had confirmed a loss of the balancing transgene. Large LipidTox stained droplets 
are visible in Nomarski optics (H) as well as in LipidTox staining (I). Their enlargement is clearly visible in 
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comparison with the wild type embryo shown in (C) and (D). (J) and (K) are images of live animals. (J) Shows 
an embryo with disrupted W01A8.1 and confirmed loss of the balancing transgene. Large vesicular 
structures are formed around the dividing nucleus (arrows). (K) Shows a control embryo with normal 
appearance of the nuclear periphery (arrow). (L) and (M) show a one cell embryo from a parent with 
disrupted W01A8.1 and confirmed loss of extrachromosomal array containing W01A8.1(a)synth::gfp after 
fixation and staining by LipidTox with large lipid droplets around the dividing nucleus visible in Nomarski 
optics (L) and positive for lipids in LipidTox staining (M) indicated by arrows. Bars represent 10 µm.  
Targeted disruption of W01A8.1 results in early embryonic defects but 
not lethality 
In order to eliminate the W01A8.1 function completely, we designed a CRISPR/Cas9-mediated 
gene editing approach to eliminate almost the entire coding region. 
We also included a rescuing plasmid consisting of isoform a that was prepared as cDNA synthesized 
in vitro using synonymous codons (W01A8.1(a)synth::gfp) that is protected against CRISPR/Cas9 
targeted editing but allows the production of the wild type isoform a at the protein level. 
 
Figure 35 
Outline of the procedure carried out to obtain animals with disrupted W01A8.1 gene and worms with a 
rescue array. A PCR confirmation of the deletion is shown below. A PCR confirmation of the deletion is shown 
below.  
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Figure 36 
Analysis of W01A8.1 gene by PCR in wild type animals and animals subjected to CRISPR/Cas9 targeted gene 
deletion. Specific primers efficiently amplify full length fragment in wild type animals (WT) while mutant 
animals show homozygous deletion in W01A8.1 gene.  
Lines that expressed the GFP fusion transgene were morphologically normal and 
W01A8.1(a)synth::GFP was found on lipid droplet-like structures as expected (Figs 34.E and F) that 
also stained positive by LipidTox (Figs 34.F and G). This transgenic strain yielded lines either carrying 
or losing the rescuing transgene in the background of a disrupted endogenous W01A8.1. The 
elimination of W01A8.1 was easily monitored by PCR (Fig. 36). Surprisingly, animals with the 
deleted W01A8.1 locus that lost the extra-chromosomal rescuing array were able to reproduce 
normally. From several lines that had a confirmed disruption of W01A8.1 and a confirmed loss of 
the extrachromosomal array, the line CK123 (KV001) was selected and used for subsequent 
analyses. As was observed in W01A8.1 RNAi embryos, loss of W01A8.1 activity resulted in the 
formation of large LipidTox-positive structures (Figs 34.H and I) that were clearly bigger than 
droplets observed in control embryos using the same protocol (Figs 34. C and D). These large lipid-
containing structures were observable in live mutant embryos (Fig 34.J) but not in wild type 
embryos (Fig 34.K) using Nomarski optics. Viewing through multiple focal planes in live, developing 
embryos lacking W01A8.1 showed that these large lipid droplets are present in embryos during 
the early mitotic divisions and were localised around the nucleus. Staining with LipidTox (after 
fixation) confirmed the lipid content in the vesicular structures arranged around dividing nucleus 
(Figs.34L and M). These large vesicles persist through the two-cell stage, disappearing in most 
embryos with more than 6 cells. On fixed embryos stained with LipidTox, larger than wild type lipid 
droplets are visible until late embryonic stages, including three-fold embryos. 
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To visualise lipid-containing structures in W01A8.1 null mutants and wild-type in vivo, we used 
CARS microscopy (done with kind help of Dr. Zhongxiang Jiang, Leica Microsystems, Mannheim, 
Germany). CARS microscopy clearly confirmed the formation of large lipid-containing vesicles in 
early embryos and allowed detailed analysis of the W01A8.1 null phenotype. CARS microscopy also 
confirmed the gradual increase of the size of lipid-containing structures during oogenesis (Figs. 
37A and B), the sudden re-localisation of these structures to the periphery of the dividing nucleus 
in the first embryonic division (Fig. 37E), and the propagation of this phenotype, although with 
gradually diminishing appearance, throughout embryonic development (Figs. 37F and H). CARS 
microscopy detected this phenomenon also in wild type animals, although the size of lipid-
containing structures was smaller making the phenomenon of the sudden re-localisation of lipid-
containing structures less obvious (Figs. 37C, D and G) than in W01A8.1 null embryos. In contrast 
to embryos, lipid-containing structures in intestinal and epidermal cells of adult W01A8.1 null 
mutants (Figs. 37J and L) were smaller than lipid-containing structures in control animals (Figs. 37I 
and K). 
 
Figure 37 
Analysis of lipid containing structures in live wild type animals and in animals with disrupted W01A8.1 by 
CARS microscopy. CARS microscopy was performed using constant magnification and intensity settings 
(20% laser intensity) with the exception of control embryos (C and G) that were examined at 30% laser 
intensity since the lipid content was lower in wild type. The brightness of the entire figure was digitally 
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enhanced using Adobe Photoshop brightness setting (+150 units) for better visibility of structures. Arrows 
indicate lipid containing structures in paired panels. (A) The germline of a wild type adult hermaphrodite 
animal with small lipid containing structures in oocytes and an increase in their number and size during 
oogenesis. (B) The germline of a mutant hermaphrodite animal. Lipid containing structures are bigger 
compared to the control animal yet distributed evenly in mutant oocytes. (C) Lipid containing structures 
localize around the nucleus in one cell wild type embryos. This tendency of the association of the lipid 
containing structures with nuclear periphery can be seen also during later developmental stages in wild type 
embryos (D). (E, F) and (H) Enlarged lipid containing structures arranged around the nuclei in mutant 
embryos. (F) The formation of clusters of lipid containing structures on the periphery of nuclei. (G) Shows a 
wild type embryo at later stage of the development. (H) The lipid containing structures progressively diminish 
in size in mutant embryos during later stages of embryonic development (arrowhead). (I) and (J) Lipid 
containing structures in enterocytes of wild type (I) and mutant (J) animals. In contrast to embryos, which 
exhibit higher CARS signal and bigger lipid containing structures in mutant animals, gut cells in adult animals 
show the opposite, that is, a reduced fat-related CARS signal and smaller lipid containing structures in 
mutant animals. Similarly, lipid containing structures in epidermal cells (K and L) are bigger in wild type 
animals as shown in the (K) and smaller in mutant animals (L). Bars represent 50 µm.  
The morphometric analysis confirmed that null mutant embryos of W01A8.1 contained larger lipid 
containing structures as observed by CARS microscopy (Figs. 37A and B) that represent a larger 
total area (Fig. 38C), as determined by quantifying individual focal planes images. Moreover, 
morphometry revealed many smaller structures with area 1–4 AU (arbitrary units) with given 
threshold settings (Figs. 38A and E). There was an obvious inverse correlation in the number of 
larger and smaller structures (with area <5 AU) between embryos and somatic tissues. The analysis 
in Figs. 38B and F shows that inclusion of small structures into analysis does not significantly affect 
the results but affects only the standard deviation of the particle size distribution indicating that 
the results are independent on the setting of the limit for the size of lipid-containing structures. 
The probability of the results was assayed using Student’s t-test and found to be statistically 
significant as the probability of this result, assuming the null hypothesis (no difference between 
control and experimental sets) was less than 0.0001. 
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Figure 38 
Morphometric analysis of lipid-containing structures by CARS microscopy in wild type and W01A8.1 null 
animals. Morphometric analysis was performed on CARS positive structures in single focal plane images 
acquired from representative mutant and wild type animal image stacks. (A–D) compare early embryos from 
mutant (MUT) and wild type (WT) animals using seven representative CARS images. (A) shows the mean 
area of all individually recognizable structures and (B) shows the mean area of all individually recognizable 
structures with an area bigger or equal to 5 arbitrary units (derived from pixels at the same settings). (C) 
compares the total area of all CARS positive structures in mutant and wild type embryos while (D) compares 
the total number of individually recognizable CARS positive structures (lipid-containing structures—LCS) in 
the same embryos. (E–H) compare adult somatic tissue (tail region) from mutants and wild type 
hermaphrodites using five representative CARS images. (E) shows the mean area of all individually 
recognizable CARS positive structures and (F) shows the mean area of all individually recognizable structures 
with an area bigger or equal to 5 arbitrary units. (G) compares the total area of all CARS positive structures 
in mutant and wild type tail regions while (H) compares the total number of individually recognizable CARS 
containing structures (LCS) in the same regions. Vertical bars in (A, B, E) and (F) represent Standard 
Deviation. The results presented in (A, B, E) and (F) are statistically significant in two-tailed Student’s t-test 
(p < 0.0001).  
Despite the fact that there were a larger number of individually recognizable lipid-containing 
structures in wild type embryos (38D), the mean area of these structures in mutants was 
considerably larger (38C). In contrast, adult mutant animals contained smaller, more numerous 
lipid-containing structures (38E, F and H) that covered a smaller total area (38G) (and therefore 
volume) compared to wild type controls. The morphometric analysis confirms that there is more 
CARS positive signal and therefore most likely more fat in W01A8.1 null embryos (despite lower 
threshold used for analysis of wild type embryos) and reduced CARS positive signal (and less fat) in 
adult tissues of W01A8.1 null animals compared to controls. 
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The analysis of the number of progeny laid by animals lacking W01A8.1 in comparison to wild type 
animals showed a decrease of progeny in mutant animals statistically significant on day 3 (Fig. 39). 
 
Figure 39 
Analysis of the number of progeny laid by mutants with disrupted W01A8.1 and confirmed loss of the 
extrachromosomal array (CK123, KV001) and control N2 animal. The values show a mild statistically 
significant difference in the number of progeny laid by mutant worms CK123 compared to wild type N2 
animals during day 3 (Two-Tailed T-Test, p = 0.04962). Bars indicate SD. 
Results of Part III 
Here I present the summary of the results from the third publication, which is relevant to the 
discussion of this dissertation. This section was modified under the Creative Commons CC-BY 4.0 
license from Kostrouchová et al., (2017). The details of the results can be found in the original 
article. 
F28F8.5 identifies as the closest homologue of vertebrate Mediator 
complex subunit 28 in C. elegans 
To identify the C. elegans homologue of MED28, we queried protein databases with curated 
SwissProt sequences from UniProtKB. They comprised several mammalian and insect proteins 
(e.g., human MED28_HUMAN and D. melanogaster MED28_DROME). The more sensitive profile-
to-profile HHblitz and HHpred algorithms provided hits to a C. elegans annotated protein F28F8.5a 
and b with highly significant E-values. According to Wormbase (WS248), two protein isoforms are 
produced from the F28F8.5 gene, isoform a with the length of 200 amino acids and isoform b that 
has a two amino acid insertion at position 20 of the N-terminal evolutionarily non-conserved 
region. The best results were obtained when pre-aligned vertebrate and insect MED28 
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homologues were used as a query in three iterations (E < 10-48 and the probability of true positive 
>99.99%). When the pre-aligned nematode sequences homologues to F28F8.5 were used to query 
profiles of human or Drosophila sequences in reciprocal searches, MED28 proteins were obtained 
with equally significant scores. BLAST and PSI-BLAST searches in their standard settings were not 
able to reveal a significant hit (E < 10-3); the only nematode hit was a Trichinella spiralis protein 
(E5RZQ1). However, when the searches in protein databases were limited to sequences 
from Ecdysozoa with Insecta excluded (conservative inclusion threshold E < 10-6) in the first two 
iterations and then continued in the complete database of sequences from all species in the 
subsequent iterations, the final hits of F28F8.5 included human and Drosophila MED28. PSI-BLAST 
with T. spiralis query sequence in database limited to Ecdysozoa in the first two iterations provided 
both human and Drosophila MED28 and F28F8.5 in one run (E < 10-8). We concluded from these 
searches that F28F8.5 is a homologue of MED28 and very likely its previously unrecognised 
orthologue. 
All PSI-BLAST MED28 homologues possess variable N- and C-termini of 3–80 amino acids showing 
no conservation across Metazoa. This conservation is loose even just 
within Drosophilae or Caenorhabditae sequences. Only the central core of about 110 amino acids 
is preserved in metazoan evolution. Figure 36 shows a sequence alignment of this conserved core 
of selected MED28 homologues. All sequences are predicted to fold into three helices forming a 
putative coiled-coil fold (UniProt annotation). Submitting the alignment to HHpred for 3D structure 
recognition reveals a structural fold of yeast MED21 (PDB identifier 1ykh_B). It is indeed a three-
helix coiled-coil forming a heterodimer with MED7. It can be expected that MED28 forms a very 
similar fold interacting with a yet to be determined subunit of the MED complex. 
F28F8.5 is essential for life and localises to the nucleus and the 
cytoplasm 
According to the genetic data from WormBase, it is suggested that the F28F8.5 gene can be 
expressed as both an individual and multi-gene transcript, located as the last gene in a four-gene 
operon (CEOP5444) that is both SL-1 and SL-2 trans-spliced. 
 
Figure 40 
Image taken from WormBase Genome Browser tool. The operon CEOP5444, marked with a green solid 
line, showing the four genes under its regulation. F28F8.5 can be seen as the last gene in the operon.  
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To determine the intracellular localisation of F28F8.5, we edited the F28F8.5 gene using 
CRISPR/Cas9 technology. We inserted the gene coding for GFP directly in front of the first codon. 
The arrangement used in our experiment employed a self-excising cassette (SEC) that was added 
after gfp. This genetic editing strategy is based on several publications (Dickinson et al., 2013; 
Ward, 2015; Dickinson et al., 2015; Dickinson and Goldstein, 2016), for technical details I refer to 
the original article. 
This strategy initially creates a disrupted F28F8.5 gene and a null allele that can be picked out by 
GFP expression alone, which is regulated by the endogenous promoter of F28F8.5. We discovered 
that only the heterozygous animals could be propagated as the homozygotes tagged with this 
method were sterile. The results suggest that F28F8.5 gene is essential for life, based on the 
assumption that the tag modification the genome doesn’t affect the expression of the other genes 
in the operon. 
By heat shock we induced the removal of the SEC from the edited F28F8.5 gene, this was 
phenotypically visualised by the continuous GFP::F28F8.5 fusion protein expression and loss of the 
Rol phenotypic marker. The resulting endogenous locus, as designed, had an N-terminus GFP-
tagged F28F8.5 gene. We were able to maintain these as homozygous animals, demonstrating this 
edited allele is fully functional. Note that both known protein isoforms of F28F8.5 (a and b) would 
be tagged on their N-terminus with GFP by this method. 
The GFP::F28F8.5 pattern was ubiquitous, both nuclear and cytoplasmic from embryos to adults. 
Prominent nuclear localisation was found in oocytes, zygotes, larvae, and adults. Cells with clear 
nuclear accumulation of GFP::F28F8.5 included epidermal, intestinal, pharyngeal, uterine and 
vulval muscle cells. The gonad expressed gfp::F28F8.5 and mitotic as well as meiotic nuclei 
accumulated GFP::F28F8.5 protein. 
Confocal microscopy was used to determine the subcellular distribution of GFP::F28F8.5. Confocal 
scanning through multiple focal planes revealed a strong GFP signal in the nuclei and cytoplasm in 
all developmental stages of life. Due to the overlap of the emission spectra of autofluorescence 
(from gut granules) and GFP, we used Fluorescence Lifetime Imaging Microscopy (FLIM) to 
distinguish between the two. The principle is based on the fact that that autofluorescence is likely 
to produce a signal with a short fluorescence lifetime as opposed to GFP. The result was clear, 
autofluorescent structures were clearly detected while fluorescence from GFP::F28F8.5, with a 
longer lifetime, was detected in the germline, in oocytes and embryos and in most somatic nuclei 
of larvae as well as adult animals. 
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Figure 41 
Analysis of GFP::F28F8.5 expression in homozygous animals with edited F28F8.5 gene by confocal 
microscopy and fluorescence lifetime imaging microscopy (FLIM). All confocal images of GFP fluorescence 
are recorded in Channel 1 (495–525 nm). FLIM images (panel C, D, E, F, H, and I) are calculated from merged 
recordings in Channel 1 and Channel 2 (525–585 nm). Panels A image was recorded in Nomarski optics at 
the same optical focus as in corresponding confocal images of GFP fluorescence (panel B). Arrowheads 
indicate nuclei of enterocytes. Panels D to F and H show selected focal planes in FLIM. Panel G shows the 
calibration table for FLIM in the range of 1–3 ns used in all panels presenting FLIM analysis. Panel I shows the 
distal part of a male expressing GFP:F28F8.5 in male specific structures, in nuclei as well as in rays (marked 
by arrowheads) indicating that GFP::F28F8.5 is expressed not only in cell nuclei but also in the cytoplasmic 
structures. Bars represent 50 μm. 
F28F8.5 interacts with Mediator complex subunits and regulates 
development 
To truly understand the relationship between our newly identified gene F28F8.5 and the Mediator 
complex’s other members we attempted to determine the in vitro interaction of the protein 
F28F8.5 with known members of the complex. We expressed 35S-labeled MDT-6, a known 
interacting partner, in rabbit reticulocyte lysate and assayed its binding to bacterially expressed 
GST-F28F8.5 or to GST only. We saw a strong interaction (∼7.7-fold enrichment) between MDT-6 
to F28F8.5. Furthermore, we assayed the interaction between GST-F28F8.5 and MDT-30, due to 
the technical difficulties we were unable to produce the labelled protein in the rabbit reticulocyte 
system. Therefore, we expressed MDT-30 containing a FLAG sequence inserted at the C-terminus 
and a His6 sequence positioned at the N-terminus. After expression in bacteria and purification on 
a nickel column, we found that the MDT-30-FLAG bound F28F8.5 preferentially (∼2.5-fold 
enrichment) in comparison to GST alone, as revealed by Western blot using an anti-FLAG antibody. 
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Several experiments using knock-down by RNAi and homozygotic disruption by CRISPR/Cas9 
approach revealed that F28F8.5 is essential for proper development. The progeny exhibited 
embryonic and larval arrest and a range of less severe phenotypes, including defective molting, 
protruding vulvae that often burst, male tail ray defects and uncoordinated (Unc) movement. The 
defects were exacerbated in animals lacking both functional alleles of the F25F8.5 gene.  
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Discussion 
Structurally localised proteins show pleiotropic interactions 
and influence gene expression 
It was suggested and discussed in our previous work (Kostrouch et al., 2014) that NR conveyed 
signals are integrated with cellular status through the Mediator complex in Metazoa. This indicated 
a possible connection between proteome status and gene expression by SKP-1 and BIR in C. 
elegans through interaction with various nuclear and cytoplasmic proteins (e.g. transcription 
factors and cytoskeletal proteins). In this work a potential link between SKP-1 and BIR-1 was 
studied. These two proteins are co-expressed from one operon and whose loss of function 
phenotypes have been linked to the regulation of gene expression and development. SKIP is an 
ancient transcriptional cofactor which interacts with several transcription factors including nuclear 
receptors (Baudino et al., 1998; Barry et al., 2003; Fantappié et al., 2008) such as Notch (Zhou et 
al., 2000), Wnt/beta-catenin (Wang et al., 2010), TGF beta and Smad protein complexes (Leong et 
al., 2001). Furthermore, it has also been identified as a component of splicing machinery in; yeast; 
mammals (Zhang et al., 2003); and plants (Wang et al., 2012), and functions in transcription 
activating and inhibiting complexes (Kostrouchova et al., 2002; Leong et al., 2004). In C. elegans, 
SKIP is essential for normal development and its loss results in multiple phenotypes including larval 
transition and molting that is dependent upon NHR-23 (Kostrouchova et al., 2002). For some 
reason in C. elegans, SKIP (SKP-1) is co-organised in an operon together with a mitotic and 
microtubule organising protein BIR-1, a homologue of the vertebrate protein Survivin that is 
expressed predominantly in fast dividing cells and is up-regulated in most if not all human 
cancers (Li et al., 1998). Operons are polycistronic clusters of genes transcribed from a promoter 
at the 5’ end of the cluster and by definition operons inherently lead to co-expression of co-
organised genes, at least at the transcriptional level. Based on these presumptions the concept of 
the two proteins being functionally linked was conceivable. It had already been shown that both 
BIR-1 and SKIP are involved in gene expression regulation and development of C. elegans, 
furthermore, these factors act cooperatively in activating expression in a heterologous transfection 
system with thyroid receptor (Kostrouchova et al., 2003; Libý et al., 2006). 
This work suggested a working model of how two proteins, one structural and another, a 
transcriptional cofactor could be involved in a protein regulatory network influencing gene 
expression at a transcriptional level. By searching for their interacting proteins using yeast two-
hybrid screens it was observed that SKP-1 and BIR-1 interact with a wide variety of partially 
overlapping categories of proteins but not directly with each other. The regulatory potential of BIR-
1 was experimentally visualised using a short time overproduction of BIR-1 in synchronised C. 
elegans larvae and by a whole proteome differential display. This hinted that elevated levels of BIR-
1 project to immediate whole proteome changes. For the purposes of validation, the concept that 
certain proteins which are known to be structurally bound such as ribosomal proteins (RPS3 and 
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RPL5), non-muscle myosin and TAC-1 (a transcription cofactor and a centrosome-associated 
protein) were studied further. The results indicated that SKP-1 and BIR-1 are linked more than 
previously thought. They have the potential to link the proteome status with major cellular 
regulatory pathways including gene expression, ribosomal stress pathway, apoptosis and cell 
division. SKP-1 and BIR-1 could be regarded as proteome sensors. Based on the results obtained 
one could speculate that these pleiotropic protein interactions of SKP-1 and BIR-1 may be a part 
of a proteome regulatory network with the capacity to project proteomic states towards gene 
expression regulation. If such proteomic signalling would be observed as a more general 
mechanism by which proteome composition projects towards gene expression, then it may be 
suggested as a sort of ‘Proteome’ code. Such regulatory loops would possibly include proteins that 
are localised in specific cellular structures and when they are liberated or synthesised in excess of 
cellular needs then they assume their additional regulatory roles. In fact, such inhibition of gene 
expression was shown to be the auto-regulatory mechanism for RPL-12, which was shown to affect 
its own splicing most likely through a sensor affecting transcription (Mitrovich and Anderson, 
2000). 
These experiments as published in Kostrouch et al., (2014) lead us to search for more examples of 
proteins that may be involved in complex regulatory loops. As it is an established concept that 
cellular signalling through NRs and the Mediator complex represents evolutionarily conserved 
mechanisms that play a key role in regulating gene expression at the level of transcription. The 
Mediator complex functions by serving as a molecular bridge between DNA-bound transcriptional 
activators and the basal transcriptional machinery. Mediator complex co-activates NR-regulated 
gene expression by facilitating the recruitment and activation of the RNA polymerase II-associated 
basal transcriptional apparatus. Importantly, Mediator complex acts in concert with other NR co-
activators involved in chromatin remodelling to initiate transcription of NR target genes in a 
multistep manner (Chen and Roeder, 2011). Based on these premises, it could be hypothesised 
that the individual protein components of the Mediator complex would allow one to explore the 
potential influence of many structurally restricted and/or localised proteins on gene expression. 
RXR shows evolutionarily conserved mechanism of gene 
expression 
An important aspect that wasn’t investigated, until our data, was the functional level of NR 
conservation in basal metazoans. Investigating NRs in C. elegans as several pros and cons. One of 
the contrā of using C. elegans as a model for NR research is the fact that there are 284 NRs (Taubert 
et al., 2011) expressed by the genome, thus making the investigatory task complicated. Another 
contrā is the rather lack of high evolutionary conservation of many key vertebrate NRs in C. elegans. 
For instance, the worm lacks a single close orthologue of one of the major metabolic regulators, 
RXR, in its genome (Kostrouchova and Kostrouch, 2015). Kostrouchova and Kostrouch, (2015) 
explain that although the most ancient subfamily of NRs is the NR2 subfamily and all the members 
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are most conserved among many phyla (e.g. diploblasts, vertebrates and mollusks), in nematodes 
the conservation is less apparent and one major founder, RXR, which is highly conserved between 
diploblastic species, vertebrates and mollusks, happens to be missing in C. elegans. As described in 
the sections above (Trichoplax adhaerens as a model organism), genetic analysis has revealed that 
T. adhaerens is one of the most basal diploblastic species of metazoans known with a highly 
conserved set of NRs. This very concept as well T. adhaerens’ evolutionary position presented an 
appealing opportunity. Until our data no published work had shown the functional conservation of 
RXR in T. adhaerens. Our data as published in Novotný et al., (2017) demonstrate the presence of 
9-cis- RA binding RXR in Placozoa and argues for the existence of ligand regulated NRs at the base 
of metazoan evolution. The presence of functional nuclear receptors in T. adhaerens and their 
proposed regulatory network support the hypothesis of a basic regulatory mechanism by NRs, 
which may have been subspecialised with the appearance of new NRs in order to cope with new 
environmental and behavioural challenges during the course of early metazoan evolution and 
developmental regulatory needs of increasingly more complex metazoan species. Keeping with our 
published finding were there data provided by Reitzel et al., (2018). They concluded supporting 
the hypotheses that the original RXR protein in metazoans bound a ligand with structural similarity 
to 9-cis-retinoic acid; the DNA motif recognised by RXR has changed little in more than 1 billion 
years of evolution and the suite of processes regulated by this transcription factor diversified early 
in animal evolution. 
W01A8.1 shows more structural similarities to vertebrate 
Perilipins than to MED28 
As it had already been established through several previous publications that MED28 was an 
interacting partner with many other proteins including cytoskeletal proteins (Wiederhold et al., 
2004). These potential properties made it an ideal candidate for our investigation. 
Our initial search for MED28 homologue in C. elegans was performed back in 2014, simply 
searching for MED28 in C. elegans databases yielded a positive result. The search yielded a gene 
sequence name W01A8.1 which had been curated as mdt-28 and had been described as an 
orthologue of mammalian MED28. It is very likely that the Mediator complex being an essential 
part of the functional transcription process, would be conserved throughout eukaryotes. And there 
is sufficient data to support that claim, in fact, the structure and subunit organisation are also 
conserved between yeast and humans (Conaway and Conaway, 2011; Conaway and Conaway, 
2011a; Conaway et al., 2005; Malik and Roeder, 2010). So, its existence is not really a surprise, in 
fact, its absence in nematodes would be much more astonishing. The review published in 2015 
established a list of known mediator members in C. elegans (Grants et al.,2015). The authors 
established a list of the putative C. elegans Mediator subunits along with their mammalian 
orthologues, alternative names, sequence number and even the hypothetical location within 
Mediator, this was also based on the work by Kuang-Lei Tsai (Tsai et al., 2014). 
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A report by Zhang et al., (2012) focused on LD proteomics, they isolated and analysed LD resident 
proteins from C. elegans. In this large-scale proteomics analysis, it was revealed that many proteins 
with diverse functions are resident or associated with lipid droplets. Of great interest to us was 
that fact that W01A8.1 could also be found on LDs and they also annotated the protein as a 
Mediator complex member protein involved in transcription. 
However, we first, using basic comparative protein analysis, established that protein annotated as 
the C. elegans MED28 did show significant sequence homology to MED28 but rather showed close 
structural homology to another protein known to exist in other species as Perilipin. We then 
investigated the sequence alignment of C. elegans and human homologues of Perilipin which, 
however, did not appear visually very informative, but the underlying evolutionary conserved 
homology was statistically very significant. This notion has two issues firstly, it fundamentally 
challenged the pre-existing view of C. elegans carrying a Perilipin homologue in its genome (Lee et 
al., 2014). Secondly, it raised a serious, but an exciting, question about the true homologue of 
MED28 in C. elegans. Furthermore, despite the statistically significant structural similarity of 
W01A8.1 to Perilipin the protein sequence analysed using Conserved Domain searches yielded 
results showing W01A8.1 containing both domains. This was not only apparent in our searches but 
also showed to be the case by other investigators. Vrablik et al., (2015) and Na et al., (2015) also 
investigated the C. elegans protein W01A8.1 and published findings at a similar time frame to 
ours. Vrablik et al., (2015) state that even though the protein shares sequence similarity to the 
transcriptional Mediator complex protein 28, it also contains an N-terminal domain similarity to 
pfam 03036, which is a conserved domain associated with the Perilipin family. The figure below, 
taken from the publication, highlights the two domains. 
 
Figure 42 
Image adopted under Creative Commons license from Vrablik et al., (2015) showing Conserved superfamily 
domains of C. elegans W01A8.1.  
Based on the knowledge at hand one could potentially postulate a dual role of the protein W01A8.1 
in C. elegans i.e. a transcriptional role, associated with the MED28 superfamily domain, and a role 
as a structural regulator of LD, associated with the Perilipin Domain. 
Na et al., (2015) identified W01A8.1 as one of the major LD resident proteins which they referred 
to as a component of the multi-subunit transcriptional Mediator complex. Nonetheless, they also 
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went a step further and determined the regions of W01A8.1 protein responsible for its LD 
targeting. Below is the figure (adapted with permission) from the publication showing that the LD 
targeting domain partly overlaps the so-called ‘MED28 superfamily’ domain. The authors 
demonstrated that truncation mutant peptides containing amino acids 211 through 275 of 
W01A8.1 formed ring structures around LipidTox-stained LDs in CHO K2 cells. 
 
Figure 43 
Figure adopted with permission from Na et al., (2015) showing various showing the protein sequence with 
relation to hydrophobicity. Truncations of W01A8.1 were made based on hydrophobicity (indicated with red 
vertical lines) and potential alpha helices (indicated with blue vertical lines). M1-M4 are the different 
truncated proteins that were fused with GFP, expressed in Chinese hamster ovary (CHO K2) cells, and co-
imaged with LipidTox staining using confocal microscopy. The M3 peptide sequence containing the amino 
acids 211 through 275 was able to target GFP around LDs. 
There could be many possible explanations for the apparent dichotomous evolution at least at the 
level of the primary sequence of W01A8.1 i.e. containing conserved domains of two different 
proteins. Looking at Perilipin from an evolutionary point of view, it is a scaffolding protein which 
could have resulted in co-evolution of interacting domains and divergence of non-docking 
sequences, thus the function could be conserved even with limited amino acid conservation across 
species. The evolutionary plasticity is apparent in the alignment of the human Perilipin paralogues 
where only the knowledge of the three-dimensional structure enabled observations of the 
similarities in the C-terminal domains (Hickenbottom et al., 2004). It is possible to imagine that the 
nematode sequences have diverged beyond the point where pairwise comparisons used in routine 
searches can reveal homology, hence the difficulty in identifying the nematode orthologues. Only 
rigorous statistical analysis of the hidden Markov profiles of a great number of diverse sequences 
made it possible to identify the conserved domain composition. However, one should not rule out 
potential association of W01A8.1 with the members of the Mediator complex or for that matter 
with the transcriptional apparatus. 
 96 
The binding ability of Perilipins to LDs is conserved 
We conducted several experiments that allowed us to better understand the enigma of W01A8.1. 
We first created several constructs with W01A8.1 fused to GFP at the C-Terminus. The first attempt 
was done using a plasmid-based extrachromosomal approach. Promoter and coding sequence 
of W01A8.1a isoform was cloned into a GFP expression vector and injected into the gonadal tissue 
using the standard protocol. However, this resulted in embryonic lethality and we were unable to 
obtain a viable GFP expressing line. These effects were most likely attributable to the 
overexpression of the gene, often associated with plasmid-based extrachromosomal arrays. We 
then used another approach known as Fusion PCR to localise W01A8.1. With this method, we were 
successfully able to obtain a viable GFP line. This experiment revealed, for the very first time, a 
distinct pattern of cytoplasmic distribution which was at the time not known. W01A8.1 formed 
ring-like structures in the cytoplasm and the signal could be observed in almost all tissues. It was 
quite clear that these ring-like structures were most likely intracellular fat/lipid droplets as we were 
aware of the statistical similarity of W01A8.1 to Perilipins beforehand. To prove that these 
structures were truly LDs we used Lipid staining dyes to chemically label them. 
Lipid labelling in C. elegans can be rather tricky and can produce varied results depending upon the 
method used. A commonly used dye Nile red is a phenoxazone, lipophilic dye, derived from Nile 
blue that is concentrated in hydrophobic environments when used in vivo or in cell lines (Fowler 
and Greenspan, 1985; Greenspan et al., 1985). In hydrophobic environments, Nile red undergoes 
an increase in yellow-gold fluorescence, making it a useful marker of intracellular lipid 
droplets (Bonilla and Prelle, 1987; Fowler et al., 1987). Other examples of dyes used include 
BODIPY-labeled fatty acids which have similar properties when used in cell cultures. Both stains 
have been used as vital dyes on living cell cultures and tissues, or, in the case of C. elegans, on living 
animals. Nile red and BODIPY-labeled fatty acids stain living worms when the dyes are mixed with 
their food, E. coli bacteria (Ashrafi et al., 2003). Many researchers involved in the field of C. 
elegans metabolism have extensively used these fluorescent dyes to assess fat stores, as they stain 
vesicular structures in C. elegans’ main fat storage organ, the intestine. Several publications have 
used Nile red as a proxy for fat content in C. elegans, accrediting a lipid regulatory role to many 
genes with an altered Nile red staining phenotype. In many studies, Nile red poorly stains the 
germline, eggs, and hypodermis, tissues which are known to be high in lipid content by other 
methods. Furthermore, for certain mutant worms (daf2 mutants), lipid storage revealed by 
biochemical analysis showed paradoxical findings to those obtained with Nile red or BODIPY-fatty 
acids staining (Soukas et al., 2009; Wang et al., 2008). These discrepancies led to a landmark 
discovery by O’Rourke et al. (2009), who showed that when Nile red is used as vital dye, it 
accumulates into lysosome-related organelles (LROs). And Nile red-positive LROs do not contain 
the major C. elegans lipid stores. Moreover, they show that the major lipid stores are contained 
within independent specialised neutral lipid-containing vesicles (LDs). In addition, they also 
revealed that Nile red and BODIPY-labeled fatty acids, when used on fixed C. elegans, are able to 
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stain the neutral lipid-containing vesicles. The authors also recommend fixative-based dyes like 
LipidTOX and Oil Red O to localise lipids in C. elegans. 
When fixed and stained W01A8.1::GFP worms that clearly revealed to us our prediction 
that W01A8.1 encapsulates neutral lipid-containing compartments (LDs). The expression was 
detectable in almost all tissues of the worm as well as embryos. Despite the fixation and staining 
protocols, it was often difficult to achieve complete penetrance of the fixative and/or stain in all 
worms and tissue. This was very often the case for embryos, which are covered with the 
infamous chitin layer, making the staining process notoriously unreliable. And in spite of proper 
fixation and staining, several fixation artefacts were often visible. Sometimes we observed very 
large coalesced LipidTox stained fat-containing structures that were not visible in living worms 
before fixation. Regardless of the fixation artefacts, it became clear to us that W01A8.1 is a protein 
that is abundantly present on lipid-containing structures that were positively stained with LipidTox 
and also Oil Red O. To our knowledge this was the very first published direct evidence 
that W01A8.1 is surrounding LDs in C. elegans. 
If W01A8.1 was truly a Perilipin family member, then the compartment it encapsulates should 
theoretically be also labelled by Perilipins form other species in C. elegans. Another group ran 
similar experiments and expressed Drosophila PLIN1::GFP in C. elegans to address whether it can 
mark lipid droplets, act as a fat storage indicator, reveal tissue-specific fat storage patterns and 
serve as a marker to identify fat storage regulatory genes (Liu et al., 2014). Their experiments were 
able to show that Drosophila Perilipin was able to localise to LDs in C. elegans. We wanted to see 
if this would also be the case for human Perilipins. We decided to investigate with Perilipin 1, 2 and 
3 (Fig. 32) each marked with GFP using a natural promoter of W01A8.1. We used an 
extrachromosomal plasmid-based approach and injected the plasmids into the C. elegans gonads 
and then selected for positive progeny. We were actually relatively successful in selecting the 
worms carrying the arrays. This may perhaps be an indication that the slight overexpression was 
not toxic to cells. Nevertheless, the data gathered was actually consistent with what is already 
known about human Perilipins in human cells. Perilipin 1, when expressed in C. elegans, localised 
to the same LipidTox staining compartment. However, we observed that there were a significantly 
higher number of LDs and despite being easy to select the line, it was not easy to maintain. This 
may be again attributed to potential toxicity of human Perilipin interfering with normal lipid 
metabolism. Perilipin 2 showed a similar pattern but was easier to maintain and did not lead to an 
increased number of total LDs. Perilipin 3 showed a dramatically different expression profile and 
was primarily cytoplasmic i.e. not associated to LDs, which is actually analogous to the findings in 
mammalian cells (Itabe et al., 2017). One thing of note is the fact that these experiments were 
conducted on a wild-type background with normal W01A8.1. Overall our data and the data 
reported by Liu et al., (2014) implied that LDs found in C. elegans are, at least from a Perilipin 
binding ability point of view, similar. Perilipin’s position on the surface of LDs is a critical element 
in enabling it to regulate lipolysis, so it is not surprising that this targeting is evolutionarily 
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conserved in all cell types in which Perilipins are present and this is a very suggestive clue in line 
with the notion of W01A8.1 being a Perilipin homologue. 
Concerning the targeting sequence of Perilipin, Rowe et al., (2016) hypothesised that initial 
detection of, and interaction with, the LD surface by the 11-mer repeats triggers the 4-helix bundle 
to unfold and anchor the protein to the LD, although this proposed sequential model has yet to be 
formally proven. Their data highlights the importance of amphipathic helices in detecting specific 
phospholipid membrane environments, which in the case of Perilipins means that they are ideally 
placed to precisely coordinate lipid release from droplets. However, protein truncation data 
presented by Na et al., (2015), shown in Fig. 43, indicates that the amino acids 211 through 275 of 
W01A8.1 are responsible for the targeting to LDs. This region, based on our alignment (Fig. 25), 
only partially overlaps with the 4-helix bundle. Therefore, it could suggest that although Perilipins 
from other species are able to bind LDs in C. elegans the evolution of the binding ability W01A8.1 
or rather a Perilipin-related protein could be different and may even implicate other evolutionary 
pressures acting upon W01A8.1 such as a potential transcriptional role, which is suggested by the 
presence of MED28 superfamily domain. 
W01A8.1 deficiency in embryos is reminiscent of Perilipin 
deficiency in other species 
To see the effects of W01A8.1 knock-down as well as knock-out on C. elegans RNAi and 
CRISPR/Cas9 mediated deletion approaches were employed. From the body of knowledge at hand 
regarding Perilipin from other species, it was difficult to predict if W01A8.1 would be lethal or not. 
In mammalian systems there are five Perilipin members, therefore, it is not easy to truly assess the 
viability as many Perilipins have redundant functions. Although deletion mutants are viable one 
cannot forget about the possible compensatory mechanisms taken over by other members of the 
family (Bell et al., 2008; Bulankina et al., 2009). Data from Drosophila suggests that Perilipin 
deletion mutants are viable but proper lipid homeostasis in flies is lacking (Beller et al., 2010; Bi et 
al., 2012). 
We conducted RNAi experiments using the injection and feeding method, one caveat of RNAi in C. 
elegans is achieving consistent knockdown throughout each worm and between experiments. 
Using both methods we were able to see some phenotypes despite the fact that not only a 45% 
knockdown could be quantified using RT-qPCR for the feeding experiments. We observed a 
reduced brood size of 30% fewer progeny and clumped lipid droplets in the germ line. 
Furthermore, we proceeded to create a null mutant using the aforementioned CRISPR/Cas9 
technique. The morphological phenotype of the mutant was consistent with what was observed 
by RNAi, however, we didn’t observe any significant differences in brood size. Our initial 
explanation for the discrepancy was ascribed to the fact that RNAi induced an acute deficiency 
which was harder to compensate for in comparison to null mutants. Additionally, our 
 99 
morphological findings are in line with other publications (published at a later date to our) from Na 
et al., (2015) and Vrablik et al., (2015). 
We had already realised the experimental limitation of lipid assessment in C. elegans when using 
fixative dyes so we turned to Coherent anti-Stokes Raman Scattering (CARS) microscopy for a much 
more precise phenotypical analysis. CARS microscopy literally and figuratively shed new light on 
our understanding of W01A8.1. When it is thought of as a true orthologue of Perilipin then one 
can begin to explain the phenotypes seen. Analysis of lipid-containing structures in developing 
embryos and in adult tissues suggested that W01A8.1 protein isoforms could differ in embryos 
than in adult tissues and/or lipid-containing structures in embryos are likely to differ from those of 
adult tissues, additionally other cell-specific mechanisms could be responsible. The characteristic 
aggregation of lipid-containing structures around the embryonic nuclei clearly detected in C. 
elegans embryos by CARS microscopy are reminiscent of lipid droplets reported in hepatitis C virus 
(HCV) infected cells (Boulant et al., 2008). Essentially the work of Welte et al., (2005) and Boulant 
et al., (2008) provided the much-needed insight into the potential mechanism behind some of the 
observed phenomena, at least with regards to the embryonic phenotype. Boulant et al., 
(2008) show conclusively that attachment of the hepatitis C core protein to LDs induces 
aggregation around the nucleus in HCV-infected cells. This redistribution is accompanied by a loss 
in Perilipin 2 from the surface of LDs as increasing amounts of the core protein associated with the 
LDs. 
 
Figure 44 
Image taken with permission from Boulant et al., (2008) shown hepatitis C virus Core Protein induces lipid 
droplet redistribution in a microtubule- and dynein-dependent manner.  
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Detection of lipids in vivo showed that the depletion of the Perilipin homologue affects the 
intracellular distribution of lipid droplets, which is in agreement with the role of Perilipin 
homologue LSD2 (PLIN2) in the movement of lipid droplets in Drosophila (Welte et al., 2005). They 
showed that Perilipin is specifically required for the regulated transport of lipid droplet 
in Drosophila. In wild-type Drosophila embryos, lipid droplets are transported toward the centre 
of the syncytial embryo just prior to cellularisation (during phase II), which results in increased 
translucence (clearing) of the peripheral cytoplasm. However, in Perilipin mutant embryos, the 
peripheral cytoplasm fails to clear completely and the embryo remains mildly hazy throughout 
embryogenesis. They found that the Perilipin is required to regulate the motor-driven motion of 
lipid droplets in Drosophila embryos. In the absence of Perilipin, droplets move in a vigorous 
pattern, but their motion cannot be regulated. Thus, the phenotypical changes observed in 
embryos after knockdown and knockout of W01A8.1 are ascribable to the functions of Perilipin. 
W01A8.1 affects lipid content differently in somatic and 
embryonic tissue 
At this point, one can be convinced that W01A8.1 can be a very promising candidate for a Perilipin 
homologue in C. elegans. However, to be Perilipin it also has to have an effect on lipid content and 
not just distribution. To put things in context, below is an illustration showing the basic lipolytic 
process involving key players. 
 
Figure 45 
Enzymes and regulatory proteins involved in lipolysis (Adapted from Lass et al., (2011)). Mammalian proteins 
are indicated above and their C. elegans orthologues below. Triacylglycerides (TAG) are progressively 
hydrolysed to diacylglycerides (DAG), monoacylglycerides (MAG) and glycerol (G) by lipases for each of 
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these steps: adipose triacylglycerol lipase (ATGL) and hormone-sensitive lipase (HSL). LID-1 is proposed to 
be orthologues of ABHD5/CGI58 in C. elegans. The access of ATGL and HSL to lipid droplets is regulated 
by Perilipin, which is under the control of protein kinase A (PKA) Xie and Roy, (2015); Lee et al., (2014). 
W01A8.1 is proposed to be a Perilipin orthologue in the present work.  
CARS microscopy was also used to quantify the total fat content in somatic and embryonic tissue. 
Our data strongly suggested that in somatic tissue there was approximately 30% less fat compared 
to wild-type controls and the situation was reversed for the embryonic tissue where there was 
approximately 30% more fat. The finding of the somatic tissue TAG content was also confirmed 
by Na et al., (2015), who quantified TAG/total protein content of L4 larvae (without embryos). 
Although they claim that the difference was minor, one has to note that L4 stage worms already 
have an almost mature germ line with developing unfertilised eggs. We believe that could be 
contributing to some of the TAG measured as in our CARS imaging one can also observe the 
increased fat content in developing egg cells. 
If one presumes that W01A8.1 is Perilipin then it is possible to start to explain the somatic 
phenotype in context of lipolysis. Different Perilipins behave differently in mammalian systems so 
to have a direct correlation can be tricky. Generally speaking, Perilipins effectively protect stored 
triacylglycerides from lipolysis under basal conditions, however, when hormonal signals 
activate PKA, Perilipins mediate the increase in lipolysis. Deficiency of both Perilipins leads to a 
reduced fat content in mammalian cells. Their overexpression is linked to increased fat content 
(Sztalryd and Brasaemle, 2017). With respect to our observed findings, we found in absence 
of W01A8.1 reduced overall fat content. And although we didn’t make specific experimentation on 
the overexpression phenotype we did observe enlarged LDs, when we inadvertently overexpressed 
the W01A8.1 using the fusion PCR technique to create a translational fusion with GFP. 
In general, these observations in somatic tissue after knockout and mild overexpression 
of W01A8.1 are better attributed to Perilipin than to MED28. Furthermore, Perilipins were also 
implicated in the regulation of lipophagy (Kaushik and Cuervo, 2015; Kaushik and Cuervo, 2016). 
With regards to lipophagy as an alternative pathway in C. elegans, we have also discussed and 
proposed this process being regulated by W01A8.1 (Chughtai et al., 2015). And our recent 
experimentation also shows that C. elegans embryos lacking W01A8.1 have increased autophagic 
activity. These experiments have been already published in a Pre-Print article awaiting review 
(Kaššák et al., 2019). This would be consistent with the role of Perilipins being protectors against 
lipophagy. 
F28F8.5 is most likely the real orthologue of mammalian 
Mediator complex 28 
Having fairly strong lines of evidence suggesting W01A8.1 as a Perilipin orthologue it was 
interesting to find the true MED28 orthologue. Our experimentation of W01A8.1 had already 
shown us that despite containing a MED28 superfamily domain in the primary sequence it didn’t 
 102 
show strong phenotypical attributes, namely a strong presence in the nucleus as well as a 
developmental disorder in case of deficiency. By searching for another possible orthologue of 
MED28 it could absolve W01A8.1 for being the member of the highly conserved Mediator 
complex. 
Although individual Mediator complex subunits were shown to be associated with specific 
functions (reviewed by Grants et al., (2015)), the function of the nematode orthologue of MED28 
could not be studied since it not been truly identified. MED28 has a special position among 
Mediator subunit proteins for its dual regulatory role, one as a Mediator subunit (Sato et al., 2004; 
Beyer et al., 2007) and the second, which is cytoplasmic, as a cytoskeletal associated 
protein (Wiederhold et al., 2004; Lee et al., 2006; Lu et al., 2006; Huang et al., 2012a). One could 
anticipate that the interaction of cytoplasmic proteins with MED28 may be able to influence gene 
expression by the translocation of MED28 to the nucleus. A great example that is relatable to the 
above-mentioned scenario is the beta-catenin protein. The protein acts as an adaptor of 
interaction between the cytoskeleton and cell adhesion molecules that critically regulates gene 
expression in the Wnt pathway. 
Thinking it was unlikely that a MED28 orthologue would be absent in nematodes, we searched for 
it using the conserved features of MED28 orthologues from various phyla. Herein we identified a 
previously uncharacterised protein, F28F8.5, as the closest MED28 orthologue. In terms of 
subcellular localisation of F28F8.5 it localised to both nuclear and cytoplasmic compartments in 
most, if not all, cells throughout development. Interestingly, the phenotypes that we observed in 
F28F8.5 knock-down and loss of function experiments overlap with the EGFR regulatory cascade 
in C. elegans, especially the developmental defects of the vulva and of male-specific structures, 
most obviously, male rays (Grants et al., 2015; Grants et al., 2016). Our observation of the 
expression of F28F8.5 in male rays and the defective development of male-specific structures 
after F28F8.5 RNAi support the cytoplasmic role of F28F8.5, that is in mammals mediated by 
Grb2 (Wiederhold et al., 2004). This cytoplasmic function of F28F8.5 is supported by the known 
involvement of the nematode homologue of Grb2, SEM-5, in the regulation of development of 
male rays. F28F8.5 protein contains a predicted SH2 binding site for Grb2 in the loop positioned 
in-between the two helices of F28F8.5, similarly as MED28 (identified using the site prediction tool 
Motif Scan http://scansite.mit.edu/motifscan_seq.phtml) (Wiederhold et al., 2004). Although, it has to 
be stressed that there are no close structures available for a high-probability prediction of the 
structure of F28F8.5. The burst through vulva phenotype is also likely to be connected to LET-
60/Ras signalling that also supports the conservation of the dual, nuclear and cytoplasmic 
functions, of MED28 homologues throughout the evolution of Metazoa (Ecsedi et al., 
2015). F28F8.5 was also shown to have tissue-specific functions, as in the anchor cell where it is 
important for the regulation of anchor cell translocation across the basement membrane during 
the formation of the developing vulva (Matus et al., 2010)). 
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Last but not least, our data showing the binding of previously experimentally identified members 
(MED6 and MED30) in C. elegans with F28F8.5, truly provides sufficient evidence that F28F8.5 is 
the real orthologue of mammalian MED28. Furthermore, it absolves W01A8.1 from a very 
important task of being a highly conserved putative transcriptional regulator. 
W01A8.1 influences the lipid droplet surface area 
Having W01A8.1 exonerated from a potential orthologue of mammalian MED28 one can begin to 
analyse W01A8.1 in context of the whole lipid droplet being part of the super complex regulatory 
network of a cell. 
The cellular cytoplasm is a congested space with thousands of proteins, RNA molecules, 
metabolites, etc swimming among several organelles. Zhang et al., 2012 and others have shown 
that many proteins from various functional categories can be found on LDs. Because many proteins 
can find refuge on the LD surface, the area can get crowded. This phenomenon is known 
as macromolecular crowding as proposed by Kory et al., (2015). They claim that macromolecular 
crowding plays a major role in determining LD protein composition. For instance, protein crowding 
may dictate which proteins bind to LD surfaces during LD expansion versus shrinkage. They say that 
during lipolysis or shrinkage the surface gets crowded and only proteins with high affinity could 
stay on while others with weaker affinity to the LDs are essentially pushed out. The authors go 
even further and suggest that Perilipins might serve such a crowding-related regulatory function. 
They demonstrated, that Drosophila Perilipin has a high binding affinity for LDs and is efficient in 
competing other proteins off the LD surface. Perilipin proteins might, therefore, increase the 
stringency of proteins binding to LDs, effectively limiting binding to those proteins with relatively 
high affinity, thereby regulating the LD protein composition through a type of molecular 
proofreading. 
We also observed the effects of W01A8.1 on the LD surface area. In null mutant embryos of 
W01A8.1, one can observe a relatively large LD surface area and the opposite is the case for the 
somatic tissue. This concept actually has many far-reaching implications on the indirect 
transcriptional regulatory ability of LDs or rather proteins affecting the size of LDs. So, one can 
argue that cytoplasmic events or in this case the size of lipid droplets can profoundly affect nuclear 
events. One major example of this is the implication of LDs in suppressing the activity of a 
transcription factor by keeping it out of the nucleus (Ueno et al., 2013). An LD protein Fsp27, also 
known as CIDEC, is expressed in adipocytes and is known to promote fusion between droplets, 
causing the formation of a single droplet per cell (Gong et al., 2011; Jambunathan et al., 2011). 
Yeast two-hybrid interaction screen revealed the transcription factor NFAT5 (Nuclear factor of 
activated T cells) is a potential Fsp27 partner of interaction. NFAT5 is cytoplasmic under hypotonic 
conditions and translocates to the nucleus upon hypertonic stress to activate osmoprotective 
genes (Aramburu et al., 2006). The research suggests that Fsp27 is able to sequester NFAT5 in the 
cytoplasm and interferes with its nuclear trafficking. And since in adipocytes endogenous Fsp27 is 
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associated with lipid droplets, this interaction would retain NFAT5 at the droplet surface, 
something that remains to be demonstrated directly. 
Figure 46 
Taken from Kory et al. (2015) with permission. Illustration showing the release of low affinity protein due to 
LD shrinkage.  
There are also other very relevant examples of LD surfaces as protein depots which have the ability 
to affect nuclear events. A Drosophila specific example is of histone storage on LDs. LD attachment 
of histones is mediated by a protein called Jabba, which functions as an anchor for histones. 
Histones are absent from embryonic LDs in Jabba mutants, and the expression of Jabba in 
cultured Drosophila cells is sufficient to induce recruitment of histones to LDs (Li et al., 2012; 
Kolkhof et al., 2017). An enzyme CCT1 (CTP:phosphocholine cytidylyltransferase) also displays 
dramatic exchange between lipid droplets and the nucleus. CCT1 is an enzyme that catalyses the 
rate-limiting step in the synthesis of the phospholipid phosphatidylcholine (PC) on the LD surface. 
In Drosophila cells, CCT1 is usually present in the nucleus, but under conditions in which cells 
synthesise new triglycerides and expand the hydrophobic core of droplets, CCT1 accumulates at 
the droplet surface (Guo et al., 2008; Krahmer et al., 2011). 
In general, these examples are highlighting how cytoplasmic cues or rather metabolic cues in form 
of ‘Proteome’ signalling affect nuclear events including transcription. As a point of note here, this 
notion of affecting nuclear events doesn’t exclude other pathways, such as lipid signalling affecting 
transcriptional regulation (Georgiadi and Kersten, 2012). 
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Nuclear lipid droplets and nuclear Perilipin 
LDs have been primarily considered cytoplasmic organelles. There have been ever increasing 
reports of the existence of LDs in the nucleus too.  Briefly, LDs are known to be extensions of the 
phospholipid monolayer of the endoplasmic reticulum (ER), where the synthesis of neutral lipids 
occurs. Enzymes such as diacylglycerol O-acyltransferases (DGAT) form triacylglycerides (TAGs) and 
acetyl-CoA acetyltransferase form sterol esters (Hashemi and Goodman, 2015; Olzmann and 
Carvalho, 2018). Although many aspects of the process remain still unclear it is known that the 
initial budding process begins at the ER with the TAG synthesis machinery present on the ER 
membrane. After initial LDs (iLDs) are formed, a subset of them recruit enzymes via ER–LD 
membrane bridges and acquire the capacity to locally synthesise TAGs, converting them to 
expanding LDs (eLDs) (Wilfling et al., 2013; Farese and Walther, 2016). Expanding LD formation 
requires the Arf1/COP-I proteins to recruit TAG synthesis enzymes (Wilfling et al., 2014). 
The observations of LDs in the nucleus have been around for a while dating back to the 
70’s (Hillman and Hillman, 1975) but recently more advanced methods (biochemical and electron 
microscopic) have also observed nuclear LDs (Layerenza et al., 2013; Uzbekov and Roingeard, 
2013). But these findings are not consistent and not observed in all cell types. In the last few 
years, Ohsaki et al. (2016) used confocal and electron microscopy to investigate nuclear LDs in 
mammalian cells. They discovered that the LDs were located in the nucleoplasm and were not just 
an extension of the nuclear membrane. The authors also said that LD existence in the nucleus was 
scarce and varied among cell types. Furthermore, they were able to find Perilipin 3 in the nucleus 
bound to the nuclear LD surface. Another exciting discovery made, was the association of these 
nuclear LDs with nuclear bodies. The group investigated this and found that various nuclear bodies 
such as Cajal bodies, speckles, and paraspeckles, which were labelled by antibodies to coilin, SC35, 
and PSF, respectively, did not exhibit a relationship with nuclear LDs. In contrast, promyelocytic 
leukaemia (PML) nuclear bodies labelled with anti-PML antibody co-localised with nuclear LDs. 
They went further and showed that the PML-II protein played a critical role in nuclear LD 
formation. The function of PML bodies is still a bit of a mystery, but PML bodies have been 
implicated in a diverse range of functions including nuclear storage of proteins, post-translational 
modifications of proteins, direct involvement with transcription, and chromatin 
regulation (Lallemand-Breitenbach and de Thé, 2010). 
Farese and Walther, (2016) discussed the implications and compared the cytoplasmic to nuclear 
LDs and they say that the nuclear LDs appear to be most closely related to expanding LDs found in 
the cytoplasm. Similar to cytoplasmic eLDs, nuclear LDs were found to co-localise with the TAG 
synthesis enzyme DGAT2 and its substrates, which should enable them to expand by locally 
synthesising TAGs. Nuclear LDs also have the CTP:phosphocholine cytidylyltransferase α (CCT) 
found on the surface for synthesising phosphatidylcholine (PC). 
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Figure 47 
Proposed Model of cytoplasmic and nuclear LDs taken with permission from Farese and Walther, (2016). 
Initial lipid droplets (iLDs) are formed from the endoplasmic reticulum (ER). A subset of iLDs can be 
converted to expanding lipid droplets (eLDs) via the establishment of ER–LD membrane bridges and re-
localisation of triacylglyceride synthesis enzymes, such as DGAT2, to their surfaces. CTP:phosphocholine 
cytidylyltransferase α (CCT-α) binds to eLDs with a relative deficiency of phosphatidylcholine (PC) on their 
surfaces, where it is activated and catalyses PC synthesis. Nuclear LDs form in association with invaginations 
of the inner nuclear membrane and also are marked by DGAT2 and CCT-α. Nuclear LDs are found in close 
proximity to PML bodies and may depend on PML proteins for formation.  
In a very recent publication of Liu et al., (2018) the authors looked at one of the most commonly 
found proteins on C. elegans LDs (Yang et al., 2012; Zhang et al., 2012; Na et al., 2015). Apart 
from W01A8.1 these studies revealed that a large set of hydroxysteroid dehydrogenases (HSDs) 
are targeted to LDs. HSDs which belong to the superfamily of short-chain 
dehydrogenases/reductases (SDRs), are important enzymes involved in lipid metabolism and 
especially in steroid hormone metabolism. A member of the HSD family DHS-9 tagged with GFP 
was expressed in the intestine, and was found at high levels in the nucleus and at lower levels in 
the cytosol. The nuclear signal was diffuse but puncta were found in the nucleoplasm. Using 
advanced confocal microscopy (Airyscan) they showed clustered rings of GFP tagged DHS-9. They 
probed further and asked if these structures would co-localise with mCherry tagged W01A8.1. This 
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experiment showed no co-localisation. However, they expressed W01A8.1::mCherry with a 
nuclear localisation signal (NLS) to see if the proteins would co-localise to the nuclear LDs. These 
transgenic animals showed a co-localisation of the W01A8.1::mCherry::NLS with DHS-9::GFP. This 
data provided tantalising insights into the complex regulatory link between metabolic processes 
and nuclear events. Studying nuclear LDs is a challenging task not only because of their scarcity but 
also due to their size. With regards to why W01A8.1 needed a NLS to localise to LDs could perhaps 
be explained, firstly, the protein comes in three isoforms and one would have to thoroughly 
investigate all three and secondly, it is possible that the real NLS (or rather hidden NLS) of W01A8.1 
maybe actually shielded by the fluorescent protein attachment. 
Another landmark discovery by Gallardo-Montejano et al., (2016) actually showed that 
mammalian Perilipin 5 is involved in nuclear receptor-based transcriptional regulation. This recent 
exciting finding demonstrated in mouse cells Perilipin 5, under certain conditions, can translocate 
from the LD surface to the nucleoplasm and modulate gene expression. They showed that Perilipin 
5’s nuclear localisation is PKA-dependent. They also found that Perilipin 5 assembles into a complex 
with PGC-1α and SIRT-1. PGC-1 α (Peroxisome proliferator-activated receptor gamma coactivator 
1-alpha) is a transcriptional regulator important for mitochondrial biogenesis and function and 
SIRT-1 (Sirtuin 1) is a deacetylase that controls PGC-1 α’s acetylation status and activity. Perilipin 5 
mediates the activation of PCG-1α via its acetylation status. A protein known as Deleted in breast 
cancer 1 (DBC1) interacts with SIRT1 and inhibits its deacetylase activity. Their data suggested that 
Perilipin 5 is a regulator of the SIRT1-DBC1 complex during catecholamine stimulation and it 
influences the SIRT1 deacetylase activity in a manner that does not involve changes in total cellular 
NAD+ levels but rather through displacement of DBC1. All of this consequently affects target genes 
that promote fatty acid oxidation and mitochondrial efficiency. The dual role of Perilipin5 at the LD 
surface and in the nucleus was proposed to coordinate the release of FAs during lipolysis and their 
efficient usage by mitochondria. And if we keep with the theme of this thesis, one must also not 
forget to mention the C-terminal region of PGC-1α has been shown to play a vital role in interacting 
with the Mediator complex in particular with MED1 (Wallberg et al., 2003; Martínez-Redondo et 
al., 2015). 
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Figure 48 
Mechanism of PLIN5 based regulation of gene expression. Adopted under creative common licence 
from Gallardo-Montejano et al., (2016). PLIN5 under basal conditions is localised only to cytoplasmic LDs 
and upon PKA based phosphorylation enriches in the nucleus and forms transcriptional complexes with the 
transcriptional co-regulator PGC-1α. This leads to activation of the deacetylase activity of SIRT1 by displacing 
DBC1 (Deleted in Breast Cancer-1), an inhibitor of SIRT1, thus promoting PGC-1α activity by deacetylation. 
PGC-1α also interacts with the Mediator complex via MED1 subunit. By this interaction in the nucleus, a 
cytoplasmic protein is able to exert control over transcriptional events.   
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Conclusion and final remarks 
In this body of work, several lines of evidence have been presented showing support of the 
hypothesis that NR-Mediator signalling pathway displays a high degree of evolutionary 
conservation. We provide results showing the ligand binding ability and biological response 
capacity of retinoic X receptor at the base of metazoan evolution. This is in line with the notion 
that the direct sensing ability is central to the NR-Mediator pathway. 
Furthermore, we gathered data to prove that the previously denominated MED28 orthologue 
W01A8.1 is in fact involved in the regulation of lipid metabolism and is related to the Perilipin 
family of proteins that have been previously thought to be absent in nematodes. 
Keeping in mind the potential regulatory functions of structurally localised protein I argue and 
make a case for W01A8.1 that, although it could not be localised in the nucleus, the presence of a 
Mediator domain could indicate a potential interaction with the highly conserved NR-Mediator 
axis. 
Moreover, we were able to identify the true MED28 orthologue as F28F8.5 in C. elegans. Thereby 
showing that the Mediator subunit 28 is truly a conserved member of the Mediator complex and 
possesses the potential to connect cytoplasmic events to regulation of gene transcription. This 
supports the concept that the general architecture of the NR-Mediator signalling axis is conserved 
across species. 
Additionally, our efforts have led to the discovery of Perilipin-dependent lipid metabolism in C. 
elegans and provide an incentive to study the concept of ‘Proteome’ signalling as a general 
principle, not restricted to only the members of the Mediator complex.  
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